: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

Flying Publisher

Oliena Studio

Stroke and language recovery: 9000+ videos

Español • Italiano • Sardu • English | PDF+

Gynecology

Free Subscription

Articles published in Gynecol Oncol
Retrieve available abstracts of 703 articles:
HTML format
Text format

Single Articles

August 2019

SHUKLA V, Varghese VK, Kabekkodu SP, Mallya S, et al
Enumeration of deregulated miRNAs in liquid and tissue biopsies of cervical cancer.
Gynecol Oncol. 2019 Aug 18. pii: S0090-8258(19)31463.
PubMed Text format Abstract available

BIANCHI A, Lopez S, Altwerger G, Bellone S, et al
PARP-1 activity (PAR) determines the sensitivity of cervical cancer to olaparib.
Gynecol Oncol. 2019 Aug 18. pii: S0090-8258(19)31461.
PubMed Text format Abstract available

MATSUO K, Cripe JC, Kurnit KC, Kaneda M, et al
Recurrence, death, and secondary malignancy after ovarian conservation for young women with early-stage low-grade endometrial cancer.
Gynecol Oncol. 2019 Aug 16. pii: S0090-8258(19)31458.
PubMed Text format Abstract available

LITTELL RD, Kumar A, Einstein MH, Karam A, et al
Advanced communication: A critical component of high quality gynecologic cancer care: A Society of Gynecologic Oncology evidence based review and guide.
Gynecol Oncol. 2019 Aug 16. pii: S0090-8258(19)31450.
PubMed Text format Abstract available

LIU YL, Zhou Q, Iasonos A, Emengo VN, et al
Subsequent therapies and survival after immunotherapy in recurrent ovarian cancer.
Gynecol Oncol. 2019 Aug 14. pii: S0090-8258(19)31457.
PubMed Text format Abstract available

WEBBER K, Carolus E, Mileshkin L, Sommeijer D, et al
OVQUEST - Life after the diagnosis and treatment of ovarian cancer - An international survey of symptoms and concerns in ovarian cancer survivors.
Gynecol Oncol. 2019 Aug 12. pii: S0090-8258(19)31460.
PubMed Text format Abstract available

KILTS TP, Glaser GE, Langstraat CL, Kumar A, et al
Comparing risk stratification criteria for predicting lymphatic dissemination in endometrial cancer.
Gynecol Oncol. 2019 Aug 10. pii: S0090-8258(19)31456.
PubMed Text format Abstract available

WADE KNS, Brady MF, Thai T, Wang Y, et al
Measurements of adiposity as prognostic biomarkers for survival with anti-angiogenic treatment in epithelial ovarian cancer: An NRG Oncology/Gynecologic Oncology Group ancillary data analysis of GOG 218.
Gynecol Oncol. 2019 Aug 10. pii: S0090-8258(19)31409.
PubMed Text format Abstract available

WESTON E, Raker C, Huang D, Parker A, et al
Opioid use after minimally invasive hysterectomy in gynecologic oncology patients.
Gynecol Oncol. 2019 Aug 9. pii: S0090-8258(19)31453.
PubMed Text format Abstract available

TORTORELLA L, Casarin J, Multinu F, Cappuccio S, et al
Sentinel lymph node biopsy with cervical injection of indocyanine green in apparent early-stage endometrial cancer: predictors of unsuccessful mapping.
Gynecol Oncol. 2019 Aug 8. pii: S0090-8258(19)31459.
PubMed Text format Abstract available

NARASIMHULU DM, Kumar A, Weaver AL, McGree ME, et al
Using an evidence-based triage algorithm to reduce 90-day mortality after primary debulking surgery for advanced epithelial ovarian cancer.
Gynecol Oncol. 2019 Aug 8. pii: S0090-8258(19)31455.
PubMed Text format Abstract available

LATHAM AH, Chen L, Hou JY, Tergas AI, et al
Sequencing of therapy in women with stage III endometrial carcinoma receiving adjuvant combination chemotherapy and radiation.
Gynecol Oncol. 2019 Aug 6. pii: S0090-8258(19)31410.
PubMed Text format Abstract available

ZAMORANO AS, Hagemann AR, Morrison L, Lee JA, et al
Pre-diagnosis body mass index, physical activity and ovarian cancer mortality.
Gynecol Oncol. 2019 Aug 2. pii: S0090-8258(19)31449.
PubMed Text format Abstract available

KIM SI, Lee M, Lee S, Suh DH, et al
Impact of laparoscopic radical hysterectomy on survival outcome in patients with FIGO stage IB cervical cancer: A matching study of two institutional hospitals in Korea.
Gynecol Oncol. 2019 Aug 2. pii: S0090-8258(19)31408.
PubMed Text format Abstract available

PUECHL AM, Chino F, Havrilesky LJ, Davidson BA, et al
Place of death by region and urbanization among gynecologic cancer patients: 2006-2016.
Gynecol Oncol. 2019 Aug 1. pii: S0090-8258(19)31402.
PubMed Text format Abstract available

KAHR HS, Christiansen OB, Hogdall C, Grove A, et al
Endometrial cancer does not increase the 30-day risk of venous thromboembolism following hysterectomy compared to benign disease. A Danish National Cohort Study.
Gynecol Oncol. 2019 Aug 1. pii: S0090-8258(19)31411.
PubMed Text format Abstract available

July 2019

BALACHANDRAN K, Salawu A, Ghorani E, Kaur B, et al
When to stop human chorionic gonadotrophin (hCG) surveillance after treatment with chemotherapy for gestational trophoblastic neoplasia (GTN): A national analysis on over 4,000 patients.
Gynecol Oncol. 2019 Jul 30. pii: S0090-8258(19)31448.
PubMed Text format Abstract available

RANDALL LM, Wenham RM, Low PS, Dowdy SC, et al
A phase II, multicenter, open-label trial of OTL38 injection for the intra-operative imaging of folate receptor-alpha positive ovarian cancer.
Gynecol Oncol. 2019 Jul 27. pii: S0090-8258(19)31396.
PubMed Text format Abstract available

RAMONDETTA LM, Hu W, Thaker PH, Urbauer DL, et al
Prospective pilot trial with combination of propranolol with chemotherapy in patients with epithelial ovarian cancer and evaluation on circulating immune cell gene expression.
Gynecol Oncol. 2019 Jul 25. pii: S0090-8258(19)31353.
PubMed Text format Abstract available

KATO K, Omi M, Fusegi A, Takeshima N, et al
Modified posterior pelvic exenteration with pelvic side-wall resection requiring both intestinal and urinary reconstruction during surgery for ovarian cancer.
Gynecol Oncol. 2019 Jul 24. pii: S0090-8258(19)31404.
PubMed Text format Abstract available

WISSING M, Mitric C, Amajoud Z, Abitbol J, et al
Risk factors for lymph nodes involvement in obese women with endometrial carcinomas.
Gynecol Oncol. 2019 Jul 24. pii: S0090-8258(19)31405.
PubMed Text format Abstract available

BARTELS HC, Rogers AC, McSharry V, McVey R, et al
A meta-analysis of morbidity and mortality in primary cytoreductive surgery compared to neoadjuvant chemotherapy in advanced ovarian malignancy.
Gynecol Oncol. 2019 Jul 23. pii: S0090-8258(19)31397.
PubMed Text format Abstract available

IGNATOV A, Lebius C, Ignatov T, Ivros S, et al
Lymph node micrometastases and outcome of endometrial cancer.
Gynecol Oncol. 2019 Jul 22. pii: S0090-8258(19)31407.
PubMed Text format Abstract available

CYBULSKA P, Paula ADC, Tseng J, Leitao MM Jr, et al
Molecular profiling and molecular classification of endometrioid ovarian carcinomas.
Gynecol Oncol. 2019 Jul 21. pii: S0090-8258(19)31398.
PubMed Text format Abstract available

XIANG L, Ye S, Yang H
Total pelvic peritonectomy for ovarian cancer with extensive peritoneal carcinomatosis in pelvic cavity.
Gynecol Oncol. 2019 Jul 17. pii: S0090-8258(19)31352.
PubMed Text format Abstract available

GADDUCCI A, Zannoni GF
Uterine smooth muscle tumors of unknown malignant potential: A challenging question.
Gynecol Oncol. 2019 Jul 17. pii: S0090-8258(19)31351.
PubMed Text format Abstract available

ZANFAGNIN V, Huang Y, Mc Gree ME, Weaver AL, et al
Predictors of extensive lymphatic dissemination and recurrences in node-positive endometrial cancer.
Gynecol Oncol. 2019 Jul 16. pii: S0090-8258(19)31391.
PubMed Text format Abstract available

SAMUEL D, Vilardo N, Isani SS, Kuo DYS, et al
Readability assessment of online gynecologic oncology patient education materials from major governmental, non-profit and pharmaceutical organizations.
Gynecol Oncol. 2019 Jul 16. pii: S0090-8258(19)31347.
PubMed Text format Abstract available

LIU B, Li L, Wang M, Wei L, et al
Health-related quality of life in locally advanced cervical cancer patients treated with neoadjuvant therapy followed by radical surgery: A single-institutional retrospective study from a prospective database.
Gynecol Oncol. 2019 Jul 12. pii: S0090-8258(19)31354.
PubMed Text format Abstract available

LIM SL, Puechl AM, Broadwater G, Ehrisman JA, et al
Gender variation in Medicare utilization and payments in gynecologic oncology.
Gynecol Oncol. 2019 Jul 11. pii: S0090-8258(19)31318.
PubMed Text format Abstract available

HUBBARD AK, Poynter JN
Global incidence comparisons and trends in ovarian germ cell tumors by geographic region in girls, adolescents and young women: 1988-2012.
Gynecol Oncol. 2019 Jul 11. pii: S0090-8258(19)31348.
PubMed Text format Abstract available

ALIMENA S, Yang DD, Melamed A, Mahal BA, et al
Racial disparities in brachytherapy administration and survival in women with locally advanced cervical cancer.
Gynecol Oncol. 2019 Jul 7. pii: S0090-8258(19)31338.
PubMed Text format Abstract available

KUMAR A, Martin DP, Dhanorker SR, Brandt SR, et al
Improving the rate of surgical normothermia in gynecologic surgery.
Gynecol Oncol. 2019 Jul 5. pii: S0090-8258(19)31349.
PubMed Text format Abstract available

SUZUKI K, Nagao S, Shibutani T, Yamamoto K, et al
Phase II trial of paclitaxel, carboplatin, and bevacizumab for advanced or recurrent cervical cancer.
Gynecol Oncol. 2019 Jul 5. pii: S0090-8258(19)31262.
PubMed Text format Abstract available

MATSUO K, Huang Y, Zivanovic O, Shimada M, et al
Effectiveness of postoperative chemotherapy for stage IC mucinous ovarian cancer.
Gynecol Oncol. 2019 Jul 3. pii: S0090-8258(19)31337.
PubMed Text format Abstract available

PAIK ES, Lim MC, Kim MH, Kim YH, et al
Comparison of laparoscopic and abdominal radical hysterectomy in early stage cervical cancer patients without adjuvant treatment: Ancillary analysis of a Korean Gynecologic Oncology Group Study (KGOG 1028).
Gynecol Oncol. 2019 Jul 1. pii: S0090-8258(19)31339.
PubMed Text format Abstract available

June 2019

XIANG M, English DP, Kidd EA
Defining the survival benefit of adjuvant pelvic radiotherapy and chemotherapy versus chemotherapy alone in stages III-IVA endometrial carcinoma.
Gynecol Oncol. 2019 Jun 27. pii: S0090-8258(19)31336.
PubMed Text format Abstract available

PRENDERGAST EN, Holman LL, Liu AY, Lai TS, et al
Comprehensive genomic profiling of recurrent endometrial cancer: Implications for selection of systemic therapy.
Gynecol Oncol. 2019 Jun 27. pii: S0090-8258(19)31332.
PubMed Text format Abstract available

ABDULFATAH E, Wakeling E, Sakr S, Al-Obaidy K, et al
Molecular classification of endometrial carcinoma applied to endometrial biopsy specimens: Towards early personalized patient management.
Gynecol Oncol. 2019 Jun 24. pii: S0090-8258(19)31323.
PubMed Text format Abstract available

KRANAWETTER M, Ataseven B, Grimm C, Schneider S, et al
Low anterior resection syndrome (LARS) in patients with epithelial ovarian cancer after primary debulking surgery.
Gynecol Oncol. 2019 Jun 21. pii: S0090-8258(19)31331.
PubMed Text format Abstract available

CANAZ E, Grabowski JP, Richter R, Braicu EI, et al
Survival and prognostic factors in patients with recurrent low-grade epithelial ovarian cancer: An analysis of five prospective phase II/III trials of NOGGO metadata base.
Gynecol Oncol. 2019 Jun 20. pii: S0090-8258(19)31327.
PubMed Text format Abstract available

HENGEVELD EM, Zusterzeel PLM, Lajer H, Hogdall CK, et al
The value of surgical staging in patients with apparent early stage epithelial ovarian carcinoma.
Gynecol Oncol. 2019 Jun 20. pii: S0090-8258(19)31317.
PubMed Text format Abstract available

FUH KC, Java JJ, Chan JK, Kapp DS, et al
Differences in presentation and survival of Asians compared to Caucasians with ovarian cancer: An NRG Oncology/GOG Ancillary study of 7914 patients.
Gynecol Oncol. 2019 Jun 19. pii: S0090-8258(19)31257.
PubMed Text format Abstract available

ARMBRUSTER SD, Previs R, Soliman PT, Westin SN, et al
Clinicopathologic features and treatment in patients with early stage uterine clear cell carcinoma: A 16-year experience.
Gynecol Oncol. 2019 Jun 18. pii: S0090-8258(19)31278.
PubMed Text format Abstract available

TANG M, O'Connell RL, Amant F, Beale P, et al
PARAGON: A Phase II study of anastrozole in patients with estrogen receptor-positive recurrent/metastatic low-grade ovarian cancers and serous borderline ovarian tumors.
Gynecol Oncol. 2019 Jun 18. pii: S0090-8258(19)31322.
PubMed Text format Abstract available

DOTTINO JA, He W, Sun CC, Zhao H, et al
Centers for Medicare and Medicaid Services' Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) scores and gynecologic oncology surgical outcomes.
Gynecol Oncol. 2019 Jun 14. pii: S0090-8258(19)31280.
PubMed Text format Abstract available

MARIANI A, Wang C, Oberg AL, Riska SM, et al
Genes associated with bowel metastases in ovarian cancer.
Gynecol Oncol. 2019 Jun 14. pii: S0090-8258(19)31321.
PubMed Text format Abstract available

LIU JF, Gordon M, Veneris J, Braiteh F, et al
Safety, clinical activity and biomarker assessments of atezolizumab from a Phase I study in advanced/recurrent ovarian and uterine cancers.
Gynecol Oncol. 2019 Jun 13. pii: S0090-8258(19)31265.
PubMed Text format Abstract available

PACHE B, Joliat GR, Hubner M, Grass F, et al
Cost-analysis of Enhanced Recovery After Surgery (ERAS) program in gynecologic surgery.
Gynecol Oncol. 2019 Jun 13. pii: S0090-8258(19)31281.
PubMed Text format Abstract available

CYBULSKA P, Sioulas V, Orfanelli T, Zivanovic O, et al
Secondary surgical resection for patients with recurrent uterine leiomyosarcoma.
Gynecol Oncol. 2019 Jun 12. pii: S0090-8258(19)31259.
PubMed Text format Abstract available

HORNER W, Peng K, Pleasant V, Brackmann M, et al
Trends in surgical complexity and treatment modalities utilized in the management of ovarian cancer in an era of neoadjuvant chemotherapy.
Gynecol Oncol. 2019 Jun 11. pii: S0090-8258(19)31267.
PubMed Text format Abstract available

BOITANO TKL, Barrington DA, Batra S, McGwin G Jr, et al
Differences in referral patterns based on race for women at high-risk for ovarian cancer in the southeast: Results from a Gynecologic Cancer Risk Assessment Clinic.
Gynecol Oncol. 2019 Jun 10. pii: S0090-8258(19)31275.
PubMed Text format Abstract available

BERGAMINI A, Cormio G, Ferrandina G, Lorusso D, et al
Conservative surgery in stage I adult type granulosa cells tumors of the ovary: Results from the MITO-9 study.
Gynecol Oncol. 2019 Jun 10. pii: S0090-8258(19)31273.
PubMed Text format Abstract available

HARDING BN, Delaney JA, Urban RR, Weiss NS, et al
Post-diagnosis use of antihypertensive medications and the risk of death from ovarian cancer.
Gynecol Oncol. 2019 Jun 6. pii: S0090-8258(19)31274.
PubMed Text format Abstract available

KIM JS, Turbov J, Rosales R, Thaete LG, et al
Combination simvastatin and metformin synergistically inhibits endometrial cancer cell growth.
Gynecol Oncol. 2019 Jun 6. pii: S0090-8258(19)31266.
PubMed Text format Abstract available

FRAZER JL, Hook CE, Addley HC, Jackson CR, et al
Recurrent ovarian immature teratoma in a 12-year-old girl: Implications for management.
Gynecol Oncol. 2019 Jun 5. pii: S0090-8258(19)31277.
PubMed Text format Abstract available

KORSHOLM M, Gyrd-Hansen D, Mogensen O, Moller S, et al
Long term resource consequences of a nationwide introduction of robotic surgery for women with early stage endometrial cancer.
Gynecol Oncol. 2019 Jun 5. pii: S0090-8258(19)31271.
PubMed Text format Abstract available

MOORE KN, Gunderson CC, Sabbatini P, McMeekin DS, et al
A phase 1b dose escalation study of ipafricept (OMP54F28) in combination with paclitaxel and carboplatin in patients with recurrent platinum-sensitive ovarian cancer.
Gynecol Oncol. 2019 Jun 4. pii: S0090-8258(19)30496.
PubMed Text format Abstract available

WRIGHT JD, Chen L, Buskwofie A, Tergas AI, et al
Regionalization of care for women with ovarian cancer.
Gynecol Oncol. 2019 Jun 3. pii: S0090-8258(19)31269.
PubMed Text format Abstract available

WILLOWS K, Kupets R, Diong C, Vicus D, et al
Rates over time and regional variation of radical minimally invasive surgery for cervical cancer: A population based study.
Gynecol Oncol. 2019 Jun 3. pii: S0090-8258(19)31263.
PubMed Text format Abstract available

WETHINGTON SL, Fader AN
ProMisE on the horizon: molecular classification of endometrial cancer in young women.
Gynecol Oncol. 2019;153:465-466.
PubMed Text format

BACKES FJ, Cohen D, Salani R, Cohn DE, et al
Prospective clinical trial of robotic sentinel lymph node assessment with isosulfane blue (ISB) and indocyanine green (ICG) in endometrial cancer and the impact of ultrastaging (NCT01818739).
Gynecol Oncol. 2019;153:496-499.
PubMed Text format Abstract available

GUAN Y, Luan Y, Xie Y, Zhou H, et al
Chloride channel-3 is required for efficient tumour cell migration and invasion in human cervical squamous cell carcinoma.
Gynecol Oncol. 2019;153:661-669.
PubMed Text format Abstract available

SHERMAN-SAMIS M, Onallah H, Holth A, Reich R, et al
SOX2 and SOX9 are markers of clinically aggressive disease in metastatic high-grade serous carcinoma.
Gynecol Oncol. 2019;153:651-660.
PubMed Text format Abstract available

ZIGRAS T, Kupets R, Barbera L, Covens A, et al
Uptake of sentinel lymph node procedures in women with vulvar cancer over time in a population based study.
Gynecol Oncol. 2019;153:574-579.
PubMed Text format Abstract available

May 2019

NASIOUDIS D, Kahn R, Chapman-Davis E, Frey MK, et al
Impact of hospital surgical volume on complete gross resection (CGR) rates following primary debulking surgery for advanced stage epithelial ovarian carcinoma.
Gynecol Oncol. 2019 May 31. pii: S0090-8258(19)31260.
PubMed Text format Abstract available

GRETTE K, Long B, Finan MA, Rocconi RP, et al
Intraperitoneal (IP) port cytology after completion of primary therapy for advanced stage ovarian cancer: A novel approach to a "second look".
Gynecol Oncol. 2019 May 31. pii: S0090-8258(19)31236.
PubMed Text format Abstract available

NASIOUDIS D, Haggerty AF, Giuntoli RL 2nd, Burger RA, et al
Adjuvant chemotherapy is not associated with a survival benefit for patients with early stage mucinous ovarian carcinoma.
Gynecol Oncol. 2019 May 30. pii: S0090-8258(19)31233.
PubMed Text format Abstract available

MILESHKIN L, Edmondson R, O'Connell RL, Sjoquist KM, et al
Phase 2 study of anastrozole in recurrent estrogen (ER)/progesterone (PR) positive endometrial cancer: The PARAGON trial - ANZGOG 0903.
Gynecol Oncol. 2019 May 23. pii: S0090-8258(19)31232.
PubMed Text format Abstract available

GUDGEON JM, Varner MW, Hashibe M, Williams MS, et al
Is immunohistochemistry-based screening for Lynch syndrome in endometrial cancer effective? The consent's the thing.
Gynecol Oncol. 2019 May 23. pii: S0090-8258(19)31231.
PubMed Text format Abstract available

MATSUO K, Mandelbaum RS, Machida H, Yoshihara K, et al
Decreasing secondary primary uterine cancer after breast cancer: A population-based analysis.
Gynecol Oncol. 2019 May 23. pii: S0090-8258(19)31258.
PubMed Text format Abstract available

MULTINU F, Casarin J, Cappuccio S, Keeney GL, et al
Ultrastaging of negative pelvic lymph nodes to decrease the true prevalence of isolated paraaortic dissemination in endometrial cancer.
Gynecol Oncol. 2019 May 22. pii: S0090-8258(19)31234.
PubMed Text format Abstract available

LIU JF, Gray KP, Wright AA, Campos S, et al
Results from a single arm, single stage phase II trial of trametinib and GSK2141795 in persistent or recurrent cervical cancer.
Gynecol Oncol. 2019 May 20. pii: S0090-8258(19)31228.
PubMed Text format Abstract available

COHEN PA, Powell A, Bohm S, Gilks CB, et al
Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data.
Gynecol Oncol. 2019 May 19. pii: S0090-8258(19)31181.
PubMed Text format Abstract available

STASENKO M, Cybulska P, Feit N, Makker V, et al
Brain metastasis in epithelial ovarian cancer by BRCA1/2 mutation status.
Gynecol Oncol. 2019 May 18. pii: S0090-8258(19)31229.
PubMed Text format Abstract available

BROWN CL
50th Annual Meeting of the Society of Gynecologic Oncology.
Gynecol Oncol. 2019 May 18. pii: S0090-8258(19)31148.
PubMed Text format

CHAPMAN BV, Swanick CW, Ning MS, Allen PK, et al
Adjuvant combined-modality therapy for stage IIIC endometrioid and non-endometrioid endometrial cancer.
Gynecol Oncol. 2019 May 17. pii: S0090-8258(19)31227.
PubMed Text format Abstract available

GIL KM, Pugh SL, Klopp AH, Yeung AR, et al
Expanded validation of the EPIC bowel and urinary domains for use in women with gynecologic cancer undergoing postoperative radiotherapy.
Gynecol Oncol. 2019 May 16. pii: S0090-8258(19)31184.
PubMed Text format Abstract available

GRANDI G, Perrone AM, Chiossi G, Friso S, et al
Increasing BMI is associated with both endometrioid and serous histotypes among endometrial rather than ovarian cancers: a case-to-case study.
Gynecol Oncol. 2019 May 16. pii: S0090-8258(19)31186.
PubMed Text format Abstract available

MARU Y, Tanaka N, Itami M, Hippo Y, et al
Efficient use of patient-derived organoids as a preclinical model for gynecologic tumors.
Gynecol Oncol. 2019 May 14. pii: S0090-8258(19)31230.
PubMed Text format Abstract available

TOMAO F, Musacchio L, Di Mauro F, Boccia SM, et al
Is BRCA mutational status a predictor of platinum-based chemotherapy related hematologic toxicity in high-grade serous ovarian cancer patients?
Gynecol Oncol. 2019 May 9. pii: S0090-8258(19)30504.
PubMed Text format Abstract available

FILIPPOVA OT, Chi DS, Long Roche K, Sonoda Y, et al
Geriatric co-management leads to safely performed cytoreductive surgery in older women with advanced stage ovarian cancer treated at a tertiary care cancer center.
Gynecol Oncol. 2019 May 8. pii: S0090-8258(19)31185.
PubMed Text format Abstract available

VAN ARSDALE A, Miller DT, Kuo DY, Isani S, et al
Association of obesity with survival in patients with endometrial cancer.
Gynecol Oncol. 2019 May 3. pii: S0090-8258(19)30493.
PubMed Text format Abstract available

HOPPENOT C, Peters P, Cowan M, Moore ED, et al
Malignant bowel obstruction due to uterine or ovarian cancer: Are there differences in outcome?
Gynecol Oncol. 2019 May 2. pii: S0090-8258(19)31183.
PubMed Text format Abstract available

LEDERMANN JA
Do increased tumor infiltrating lymphocytes co-existing with Homologous Recombination Deficiency provide clues to enhance immunotherapy of ovarian cancer?
Gynecol Oncol. 2019;153:213-214.
PubMed Text format

BLOK F, Dasgupta S, Dinjens WNM, Roes EM, et al
Retrospective study of a 16year cohort of BRCA1 and BRCA2 carriers presenting for RRSO: Prevalence of invasive and in-situ carcinoma, with follow-up.
Gynecol Oncol. 2019;153:326-334.
PubMed Text format Abstract available

AVIKI EM, Abu-Rustum NR
When surgical innovation and payment systems collide: The sentinel lymph node story.
Gynecol Oncol. 2019;153:215-216.
PubMed Text format

FOKOM DOMGUE J, Messick C, Milbourne A, Guo M, et al
Prevalence of high-grade anal dysplasia among women with high-grade lower genital tract dysplasia or cancer: Results of a pilot study.
Gynecol Oncol. 2019;153:266-270.
PubMed Text format Abstract available

SYKES P, Eva L, van der Griend R, McNally O, et al
Pathological process has a crucial role in sentinel node biopsy for vulvar cancer.
Gynecol Oncol. 2019;153:292-296.
PubMed Text format Abstract available

KRASNER CN, Castro C, Penson RT, Roche M, et al
Final report on serial phase II trials of all-intraperitoneal chemotherapy with or without bevacizumab for women with newly diagnosed, optimally cytoreduced carcinoma of Mullerian origin.
Gynecol Oncol. 2019;153:223-229.
PubMed Text format Abstract available

POLTERAUER S, Schwameis R, Grimm C, Hillemanns P, et al
Lymph node ratio in inguinal lymphadenectomy for squamous cell vulvar cancer: Results from the AGO-CaRE-1 study.
Gynecol Oncol. 2019;153:286-291.
PubMed Text format Abstract available

April 2019

SPIRTOS NM, Enserro D, Homesley HD, Gibbons SK, et al
The addition of paclitaxel to doxorubicin and cisplatin and volume-directed radiation does not improve overall survival (OS) or long-term recurrence-free survival (RFS) in advanced endometrial cancer (EC): A randomized phase III NRG/Gynecologic Oncolo
Gynecol Oncol. 2019 Apr 30. pii: S0090-8258(19)30433.
PubMed Text format Abstract available

BOUBERHAN S, Shea M, Kennedy A, Erlinger A, et al
Financial toxicity in gynecologic oncology.
Gynecol Oncol. 2019 Apr 30. pii: S0090-8258(19)30498.
PubMed Text format Abstract available

MOHANKUMAR K, Li X, Sridharan S, Karki K, et al
Nuclear receptor 4A1 (NR4A1) antagonists induce ROS-dependent inhibition of mTOR signaling in endometrial cancer.
Gynecol Oncol. 2019 Apr 30. pii: S0090-8258(19)31180.
PubMed Text format Abstract available

ANGIOLO G, Silvestro C, Guerrieri ME, Damiano AG, et al
Placental site trophoblastic tumor and epithelioid trophoblastic tumor: Clinical and pathological features, prognostic variables and treatment strategy.
Gynecol Oncol. 2019 Apr 29. pii: S0090-8258(19)30184.
PubMed Text format Abstract available

MANDELBAUM RS, Chen L, Shoupe D, Paulson RJ, et al
Patterns of utilization and outcome of ovarian conservation for young women with minimal-risk endometrial cancer.
Gynecol Oncol. 2019 Apr 26. pii: S0090-8258(19)31151.
PubMed Text format Abstract available

DANIELE G, Arenare L, Scambia G, Pisano C, et al
Prognostic role of chemotherapy-induced neutropenia in first-line treatment of advanced ovarian cancer. A pooled analysis of MITO2 and MITO7 trials.
Gynecol Oncol. 2019 Apr 24. pii: S0090-8258(19)30507.
PubMed Text format Abstract available

FRANCIS SR, Ager BJ, Do OA, Huang YJ, et al
Recurrent early stage endometrial cancer: Patterns of recurrence and results of salvage therapy.
Gynecol Oncol. 2019 Apr 24. pii: S0090-8258(19)31174.
PubMed Text format Abstract available

POLCHER M, Rottmann M, Brugger S, Mahner S, et al
Lymph node dissection in endometrial cancer and clinical outcome: A population-based study in 5546 patients.
Gynecol Oncol. 2019 Apr 23. pii: S0090-8258(19)30497.
PubMed Text format Abstract available

KENNARD JA, Stephens AJ, Ahmad S, Zhu X, et al
Sentinel lymph nodes (SLN) in endometrial cancer: The relationship between primary tumor histology, SLN metastasis size, and non-sentinel node metastasis.
Gynecol Oncol. 2019 Apr 23. pii: S0090-8258(19)31152.
PubMed Text format Abstract available

ENGLISH DP, Huang M
Highlights from the Society of Gynecologic Oncology's 50th Annual Meeting on Women's Cancer.
Gynecol Oncol. 2019 Apr 22. pii: S0090-8258(19)31150.
PubMed Text format

MA S, Wang J, Han Y, Guo F, et al
Platinum single-agent vs. platinum-based doublet agent concurrent chemoradiotherapy for locally advanced cervical cancer: A meta-analysis of randomized controlled trials.
Gynecol Oncol. 2019 Apr 18. pii: S0090-8258(19)30508.
PubMed Text format Abstract available

GORE M, Hackshaw A, Brady WE, Penson RT, et al
An international, phase III randomized trial in patients with mucinous epithelial ovarian cancer (mEOC/GOG 0241) with long-term follow-up: and experience of conducting a clinical trial in a rare gynecological tumor.
Gynecol Oncol. 2019 Apr 17. pii: S0090-8258(19)30491.
PubMed Text format Abstract available

BOGANI G, Chiappa V, Vinti D, Somigliana E, et al
Long-term results of fertility-sparing treatment for early-stage cervical cancer.
Gynecol Oncol. 2019 Apr 16. pii: S0090-8258(19)30502.
PubMed Text format Abstract available

LUCIDO CT, Wynja E, Madeo M, Williamson CS, et al
Innervation of cervical carcinoma is mediated by cancer-derived exosomes.
Gynecol Oncol. 2019 Apr 16. pii: S0090-8258(19)31149.
PubMed Text format Abstract available

BALAYA V, Mathevet P, Magaud L, Bonsang-Kitzis H, et al
Predictive factors of unexpected lymphatic drainage pathways in early-stage cervical cancer.
Gynecol Oncol. 2019 Apr 16. pii: S0090-8258(19)30503.
PubMed Text format Abstract available

ALHILLI MM, Elson P, Rybicki L, Khorana AA, et al
Delay in time to surgery and impact on survival in patients with endometrial cancer: A National Cancer Database Analysis.
Gynecol Oncol. 2019 Apr 15. pii: S0090-8258(19)30437.
PubMed Text format Abstract available

SWAILES AL, Hossler CE, Kesterson JP
Pathway to the Papanicolaou smear: The development of cervical cytology in twentieth-century America and implications in the present day.
Gynecol Oncol. 2019 Apr 14. pii: S0090-8258(19)30499.
PubMed Text format Abstract available

LEE L, Matulonis U
Immunotherapy and radiation combinatorial trials in gynecologic cancer: A potential synergy?
Gynecol Oncol. 2019 Apr 14. pii: S0090-8258(19)30490.
PubMed Text format Abstract available

MOORE RG, Blackman A, Miller MC, Robison K, et al
Multiple biomarker algorithms to predict epithelial ovarian cancer in women with a pelvic mass: Can additional makers improve performance?
Gynecol Oncol. 2019 Apr 13. pii: S0090-8258(19)30501.
PubMed Text format Abstract available

GAILLARD SL, Andreano KJ, Gay LM, Steiner M, et al
Constitutively active ESR1 mutations in gynecologic malignancies and clinical response to estrogen-receptor directed therapies.
Gynecol Oncol. 2019 Apr 13. pii: S0090-8258(19)30505.
PubMed Text format Abstract available

LEFKOWITS C, Bevis K, Carey EC, Sheeder J, et al
Gynecologic oncology providers endorse practice-changing impact of communication skills training.
Gynecol Oncol. 2019 Apr 9. pii: S0090-8258(19)30435.
PubMed Text format Abstract available

PIGNATA S, Scambia G, Lorusso D, De Giorgi U, et al
The MITO CERV-2 trial: A randomized phase II study of cetuximab plus carboplatin and paclitaxel, in advanced or recurrent cervical cancer.
Gynecol Oncol. 2019 Apr 9. pii: S0090-8258(19)30495.
PubMed Text format Abstract available

XU X, Kong X, Liu T, Zhou L, et al
Metastasis-associated protein 1, modulated by miR-30c, promotes endometrial cancer progression through AKT/mTOR/4E-BP1 pathway.
Gynecol Oncol. 2019 Apr 9. pii: S0090-8258(19)30500.
PubMed Text format Abstract available

HORSBOEL TA, Kjaer SK, Johansen C, Suppli NP, et al
Increased risk for depression persists for years among women treated for gynecological cancers - a register-based cohort study with up to 19years of follow-up.
Gynecol Oncol. 2019 Apr 8. pii: S0090-8258(19)30494.
PubMed Text format Abstract available

REIJNEN C, Kusters-Vandevelde HVN, Prinsen CF, Massuger LFAG, et al
Mismatch repair deficiency as a predictive marker for response to adjuvant radiotherapy in endometrial cancer.
Gynecol Oncol. 2019 Apr 3. pii: S0090-8258(19)30270.
PubMed Text format Abstract available

BOGANI G, Murgia F, Ditto A, Raspagliesi F, et al
Sentinel node mapping vs. lymphadenectomy in endometrial cancer: A systematic review and meta-analysis.
Gynecol Oncol. 2019 Apr 2. pii: S0090-8258(19)30489.
PubMed Text format Abstract available

LAGO V, Fotopoulou C, Chiantera V, Minig L, et al
Risk factors for anastomotic leakage after colorectal resection in ovarian cancer surgery: A multi-centre study.
Gynecol Oncol. 2019 Apr 2. pii: S0090-8258(19)30434.
PubMed Text format Abstract available

HARPER DM, Nieminen P, Donders G, Einstein MH, et al
The efficacy and safety of Tipapkinogen Sovacivec therapeutic HPV vaccine in cervical intraepithelial neoplasia grades 2 and 3: Randomized controlled phase II trial with 2.5years of follow-up.
Gynecol Oncol. 2019 Apr 2. pii: S0090-8258(19)30484.
PubMed Text format Abstract available

LEITAO MM JR
The change in landscape after a new landmark is constructed: Radical hysterectomy for early cervical cancer and Minimally Invasive Surgery.
Gynecol Oncol. 2019;153:1-2.
PubMed Text format

VAN BAAL JOAM, Van de Vijver KK, Algera MD, van der A MA, et al
The effect of adjuvant chemotherapy on survival in patients with FIGO stage I high-grade serous ovarian cancer.
Gynecol Oncol. 2019 Apr 1. pii: S0090-8258(19)30492.
PubMed Text format Abstract available

PUECHL AM, Edwards J, Suri A, Nakayama J, et al
The association between progesterone receptor expression and survival in women with adult granulosa cell tumors.
Gynecol Oncol. 2019;153:74-79.
PubMed Text format Abstract available

MANNING-GEIST BL, Alimena S, Del Carmen MG, Goodman A, et al
Infection, thrombosis, and oncologic outcome after interval debulking surgery: Does perioperative blood transfusion matter?
Gynecol Oncol. 2019;153:63-67.
PubMed Text format Abstract available

March 2019

COSGROVE CM, Cohn DE, Rhoades J, Felix AS, et al
The prognostic significance of aortic lymph node metastasis in endometrial cancer: Potential implications for selective aortic lymph node assessment.
Gynecol Oncol. 2019 Mar 30. pii: S0090-8258(19)30486.
PubMed Text format Abstract available

VENERIS JT, Lee EK, Goebel EA, Nucci MR, et al
Diagnosis and management of a recurrent polymerase-epsilon (POLE)-mutated endometrial cancer.
Gynecol Oncol. 2019 Mar 29. pii: S0090-8258(19)30482.
PubMed Text format Abstract available

DE ARRUDA FN, Oonk MHM, Mourits MJE, de Graeff P, et al
Determinants of health-related quality of life in elderly ovarian cancer patients: The role of frailty and dependence.
Gynecol Oncol. 2019 Mar 29. pii: S0090-8258(19)30485.
PubMed Text format Abstract available

LAAKSONEN MA, Arriaga ME, Canfell K, MacInnis RJ, et al
The preventable burden of endometrial and ovarian cancers in Australia: A pooled cohort study.
Gynecol Oncol. 2019 Mar 29. pii: S0090-8258(19)30275.
PubMed Text format Abstract available

LEE EK, Liu JF
Antibody-drug conjugates in gynecologic malignancies.
Gynecol Oncol. 2019 Mar 28. pii: S0090-8258(19)30438.
PubMed Text format Abstract available

SECORD AA, McCollum M, Davidson BA, Broadwater G, et al
Phase II trial of nintedanib in patients with bevacizumab-resistant recurrent epithelial ovarian, tubal, and peritoneal cancer.
Gynecol Oncol. 2019 Mar 28. pii: S0090-8258(19)30441.
PubMed Text format Abstract available

GUO Y, Cui W, Pei Y, Xu D, et al
Platelets promote invasion and induce epithelial to mesenchymal transition in ovarian cancer cells by TGF-beta signaling pathway.
Gynecol Oncol. 2019 Mar 27. pii: S0090-8258(19)30136.
PubMed Text format Abstract available

BRITTON H, Huang L, Lum A, Leung S, et al
Molecular classification defines outcomes and opportunities in young women with endometrial carcinoma.
Gynecol Oncol. 2019 Mar 25. pii: S0090-8258(19)30271.
PubMed Text format Abstract available

MORONEY MR, Davies KD, Wilberger AC, Sheeder J, et al
Molecular markers in recurrent stage I, grade 1 endometrioid endometrial cancers.
Gynecol Oncol. 2019 Mar 22. pii: S0090-8258(19)30273.
PubMed Text format Abstract available

DISILVESTRO PA
Shaping the standard of care in ovarian cancer management: A review of Gynecologic Oncology Group (GOG)/NRG oncology clinical trials of the past twenty years.
Gynecol Oncol. 2019 Mar 22. pii: S0090-8258(19)30130.
PubMed Text format Abstract available

MACHIDA H, Matsuo K, Yamagami W, Ebina Y, et al
Trends and characteristics of epithelial ovarian cancer in Japan between 2002 and 2015: A JSGO-JSOG joint study.
Gynecol Oncol. 2019 Mar 21. pii: S0090-8258(19)30436.
PubMed Text format Abstract available

LIN AJ, Ma S, Markovina S, Schwarz J, et al
Clinical outcomes after isolated pelvic failure in cervical cancer patients treated with definitive radiation.
Gynecol Oncol. 2019 Mar 21. pii: S0090-8258(19)30297.
PubMed Text format Abstract available

HEILMANN T, Pfisterer J, Hempel AM, Sass S, et al
Early treatment modifications improve chemotherapy adherence in ovarian cancer patients >/=70years.
Gynecol Oncol. 2019 Mar 21. pii: S0090-8258(19)30125.
PubMed Text format Abstract available

LAWRENSON K, Song F, Hazelett DJ, Kar SP, et al
Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.
Gynecol Oncol. 2019 Mar 19. pii: S0090-8258(19)30133.
PubMed Text format Abstract available

HILLMAN RT, Sanchez-Migallon A, Meyer LA, Iniesta MD, et al
Patient characteristics and opioid use prior to discharge after open gynecologic surgery in an enhanced recovery after surgery (ERAS) program.
Gynecol Oncol. 2019 Mar 19. pii: S0090-8258(19)30274.
PubMed Text format Abstract available

ROZENHOLC A, Samouelian V, Warkus T, Gauthier P, et al
Green versus blue: Randomized controlled trial comparing indocyanine green with methylene blue for sentinel lymph node detection in endometrial cancer.
Gynecol Oncol. 2019 Mar 19. pii: S0090-8258(19)30296.
PubMed Text format Abstract available

HUANG M, Kamath P, Schlumbrecht M, Miao F, et al
Identifying disparities in germline and somatic testing for ovarian cancer.
Gynecol Oncol. 2019 Mar 16. pii: S0090-8258(19)30155.
PubMed Text format Abstract available

WATSON CH, Lopez-Acevedo M, Broadwater G, Kim AH, et al
A pilot study of lower extremity lymphedema, lower extremity function, and quality of life in women after minimally invasive endometrial cancer staging surgery.
Gynecol Oncol. 2019 Mar 15. pii: S0090-8258(19)30131.
PubMed Text format Abstract available

RATNER E, Bala M, Louie-Gao M, Aydin E, et al
Increased risk of brain metastases in ovarian cancer patients with BRCA mutations.
Gynecol Oncol. 2019 Mar 12. pii: S0090-8258(19)30152.
PubMed Text format Abstract available

LAVIE O, Chetrit A, Novikov I, Sadetzki S, et al
Fifteen-year survival of invasive epithelial ovarian cancer in women with BRCA1/2 mutations - the National Israeli Study of Ovarian Cancer.
Gynecol Oncol. 2019 Mar 11. pii: S0090-8258(19)30132.
PubMed Text format Abstract available

PRESCOTT LS, Taylor JS, Enbaya A, Marten CA, et al
Choosing Wisely: Decreasing the incidence of perioperative blood transfusions in gynecologic oncology.
Gynecol Oncol. 2019 Mar 11. pii: S0090-8258(19)30156.
PubMed Text format Abstract available

RUENGKHACHORN I, Phithakwatchara N, Viriyapak B, Sangkarat S, et al
Comparison of oncologic outcomes of unanticipated cervical carcinoma in women undergoing inadvertent simple hysterectomy and those undergoing surgical treatment after preoperative diagnosis.
Gynecol Oncol. 2019 Mar 11. pii: S0090-8258(19)30135.
PubMed Text format Abstract available

MORA PAR, Sun SY, Velarde GC, Filho JR, et al
Can carboplatin or etoposide replace actinomycin-d for second-line treatment of methotrexate resistant low-risk gestational trophoblastic neoplasia?
Gynecol Oncol. 2019 Mar 8. pii: S0090-8258(19)30153.
PubMed Text format Abstract available

MURAKAMI R, Matsumura N, Michimae H, Tanabe H, et al
The mesenchymal transition subtype more responsive to dose dense taxane chemotherapy combined with carboplatin than to conventional taxane and carboplatin chemotherapy in high grade serous ovarian carcinoma: A survey of Japanese Gynecologic Oncology G
Gynecol Oncol. 2019 Mar 7. pii: S0090-8258(19)30120.
PubMed Text format Abstract available

FELIP I, Moiola CP, Megino-Luque C, Lopez-Gil C, et al
Therapeutic potential of the new TRIB3-mediated cell autophagy anticancer drug ABTL0812 in endometrial cancer.
Gynecol Oncol. 2019 Mar 7. pii: S0090-8258(19)30150.
PubMed Text format Abstract available

WRIGHT TC JR, Parvu V, Stoler MH, Kodsi S, et al
HPV infections and cytologic abnormalities in vaccinated women 21-34years of age: Results from the baseline phase of the Onclarity trial.
Gynecol Oncol. 2019 Mar 7. pii: S0090-8258(19)30126.
PubMed Text format Abstract available

DOO DW, Kirkland CT, Griswold LH, McGwin G, et al
Comparative outcomes between robotic and abdominal radical hysterectomy for IB1 cervical cancer: Results from a single high volume institution.
Gynecol Oncol. 2019 Mar 6. pii: S0090-8258(19)30149.
PubMed Text format Abstract available

SON JH, Kim J, Shim J, Kong TW, et al
Comparison of posterior rectal dissection techniques during rectosigmoid colon resection as part of cytoreductive surgery in patients with epithelial ovarian cancer: Close rectal dissection versus total mesorectal excision.
Gynecol Oncol. 2019 Mar 4. pii: S0090-8258(19)30139.
PubMed Text format Abstract available

MERT I, Kumar A, Torres D, Huang Y, et al
Should mucosal bowel invasion in ovarian cancer be assigned to FIGO stage IV disease?
Gynecol Oncol. 2019 Mar 2. pii: S0090-8258(19)30128.
PubMed Text format Abstract available

BOGANI G, Mariani A, Paolini B, Ditto A, et al
Low-volume disease in endometrial cancer: The role of micrometastasis and isolated tumor cells.
Gynecol Oncol. 2019 Mar 1. pii: S0090-8258(19)30137.
PubMed Text format Abstract available

MOSS HA, Melamed A, Wright JD
Measuring cause-and-effect relationships without randomized clinical trials: Quasi-experimental methods for gynecologic oncology research.
Gynecol Oncol. 2019;152:533-539.
PubMed Text format Abstract available

CALO C, Elliott JO, Clements A, Reid G, et al
Cervical cancer radiation therapy compliance rates based on location of radiation therapy.
Gynecol Oncol. 2019;152:528-532.
PubMed Text format Abstract available

ZAKEM SJ, Robin TP, Smith DE, Amini A, et al
Evolving trends in the management of high-intermediate risk endometrial cancer in the United States.
Gynecol Oncol. 2019;152:522-527.
PubMed Text format Abstract available

GRESSEL GM, Dioun SM, Richley M, Lounsbury DW, et al
Utilizing the Patient Reported Outcomes Measurement Information System (PROMIS(R)) to increase referral to ancillary support services for severely symptomatic patients with gynecologic cancer.
Gynecol Oncol. 2019;152:509-513.
PubMed Text format Abstract available

MEYER LA, Shi Q, Lasala J, Iniesta MD, et al
Comparison of patient reported symptom burden on an enhanced recovery after surgery (ERAS) care pathway in patients with ovarian cancer undergoing primary vs. interval tumor reductive surgery.
Gynecol Oncol. 2019;152:501-508.
PubMed Text format Abstract available

WANG XS, Shi Q, Williams LA, Cleeland CS, et al
Validation and application of a module of the MD Anderson Symptom Inventory for measuring perioperative symptom burden in patients with gynecologic cancer (the MDASI-PeriOp-GYN).
Gynecol Oncol. 2019;152:492-500.
PubMed Text format Abstract available

KUMAR A, Nesbitt KM, Bakkum-Gamez JN
Quality improvement in gynecologic oncology: Current successes and future promise.
Gynecol Oncol. 2019;152:486-491.
PubMed Text format Abstract available

NGUYEN JMV, Sadeghi M, Gien LT, Covens A, et al
Impact of a preventive bundle to reduce surgical site infections in gynecologic oncology.
Gynecol Oncol. 2019;152:480-485.
PubMed Text format Abstract available

VELENTZIS LS, Smith MA, Simms KT, Lew JB, et al
Pathways to a cancer-free future: A protocol for modelled evaluations to maximize the future impact of interventions on cervical cancer in Australia.
Gynecol Oncol. 2019;152:465-471.
PubMed Text format Abstract available

KWON JS, Tinker AV, Hanley GE, Pansegrau G, et al
BRCA mutation testing for first-degree relatives of women with high-grade serous ovarian cancer.
Gynecol Oncol. 2019;152:459-464.
PubMed Text format Abstract available

TAYLOR JS, Zhang N, Rajan SS, Chavez-MacGregor M, et al
How we use hospice: Hospice enrollment patterns and costs in elderly ovarian cancer patients.
Gynecol Oncol. 2019;152:452-458.
PubMed Text format Abstract available

FOOTE JR, Secord AA, Liang MI, Ehrisman JA, et al
Targeted composite value-based endpoints in platinum-sensitive recurrent ovarian cancer.
Gynecol Oncol. 2019;152:445-451.
PubMed Text format Abstract available

SUIDAN RS, He W, Sun CC, Zhao H, et al
National trends, outcomes, and costs of radiation therapy in the management of low- and high-intermediate risk endometrial cancer.
Gynecol Oncol. 2019;152:439-444.
PubMed Text format Abstract available

HALL MT, Smith MA, Lew JB, O'Hallahan J, et al
The combined impact of implementing HPV immunisation and primary HPV screening in New Zealand: Transitional and long-term benefits, costs and resource utilisation implications.
Gynecol Oncol. 2019;152:472-479.
PubMed Text format Abstract available

FELDER M, Kapur A, Rakhmilevich AL, Qu X, et al
MUC16 suppresses human and murine innate immune responses.
Gynecol Oncol. 2019;152:618-628.
PubMed Text format Abstract available

SHEU J, Palileo A, Chen MY, Hoepner L, et al
Hospice utilization in advanced cervical malignancies: An analysis of the National Inpatient Sample.
Gynecol Oncol. 2019;152:594-598.
PubMed Text format Abstract available

February 2019

BROOKS RA, Tritchler DS, Darcy KM, Lankes HA, et al
GOG 8020/210: Risk stratification of lymph node metastasis, disease progression and survival using single nucleotide polymorphisms in endometrial cancer: An NRG oncology/gynecologic oncology group study.
Gynecol Oncol. 2019 Feb 28. pii: S0090-8258(19)30138.
PubMed Text format Abstract available

TIMMERMANS M, van der Hel O, Sonke GS, Van de Vijver KK, et al
The prognostic value of residual disease after neoadjuvant chemotherapy in advanced ovarian cancer; A systematic review.
Gynecol Oncol. 2019 Feb 27. pii: S0090-8258(19)30129.
PubMed Text format Abstract available

ARQUIETTE JM, Moss HA, Truong T, Pieper CF, et al
Impact of a documentation intervention on health-assessment metrics on an inpatient gynecologic oncology service.
Gynecol Oncol. 2019 Feb 27. pii: S0090-8258(19)30119.
PubMed Text format Abstract available

BARRINGTON DA, Dilley SE, Smith HJ, Straughn JM Jr, et al
Pembrolizumab in advanced recurrent endometrial cancer: A cost-effectiveness analysis.
Gynecol Oncol. 2019 Feb 24. pii: S0090-8258(19)30123.
PubMed Text format Abstract available

JORGENSEN SL, Mogensen O, Petersen MA, Wu CS, et al
New insights into early recovery after robotic surgery for endometrial cancer.
Gynecol Oncol. 2019 Feb 23. pii: S0090-8258(19)30111.
PubMed Text format Abstract available

MORSE CB, Toukatly MN, Kilgore MR, Agnew KJ, et al
Tumor infiltrating lymphocytes and homologous recombination deficiency are independently associated with improved survival in ovarian carcinoma.
Gynecol Oncol. 2019 Feb 22. pii: S0090-8258(19)30121.
PubMed Text format Abstract available

HUEPENBECKER SP, Cusworth SE, Kuroki LM, Lu P, et al
Continuous epidural infusion in gynecologic oncology patients undergoing exploratory laparotomy: The new standard for decreased postoperative pain and opioid use.
Gynecol Oncol. 2019 Feb 21. pii: S0090-8258(19)30127.
PubMed Text format Abstract available

MCGUIRE S, Kara B, Hart PC, Montag A, et al
Inhibition of fascin in cancer and stromal cells blocks ovarian cancer metastasis.
Gynecol Oncol. 2019 Feb 20. pii: S0090-8258(19)30059.
PubMed Text format Abstract available

MESQUITA KA, Alabdullah M, Griffin M, Toss MS, et al
ERCC1-XPF deficiency is a predictor of olaparib induced synthetic lethality and platinum sensitivity in epithelial ovarian cancers.
Gynecol Oncol. 2019 Feb 20. pii: S0090-8258(19)30124.
PubMed Text format Abstract available

MATSUO K, Machida H, Mandelbaum RS, Grubbs BH, et al
Mucinous borderline ovarian tumor versus invasive well-differentiated mucinous ovarian cancer: Difference in characteristics and outcomes.
Gynecol Oncol. 2019 Feb 20. pii: S0090-8258(19)30106.
PubMed Text format Abstract available

MATSUO K, Mandelbaum RS, Adams CL, Roman LD, et al
Performance and outcome of pelvic exenteration for gynecologic malignancies: A population-based study.
Gynecol Oncol. 2019 Feb 18. pii: S0090-8258(19)30105.
PubMed Text format Abstract available

RODRIGUEZ-FREIXINOS V, Lheureux S, Mandilaras V, Clarke B, et al
Impact of somatic molecular profiling on clinical trial outcomes in rare epithelial gynecologic cancer patients.
Gynecol Oncol. 2019 Feb 18. pii: S0090-8258(19)30108.
PubMed Text format Abstract available

EINSTEIN MH, Ndlovu N, Lee J, Stier EA, et al
Cisplatin and radiation therapy in HIV-positive women with locally advanced cervical cancer in sub-Saharan Africa: A phase II study of the AIDS malignancy consortium.
Gynecol Oncol. 2019 Feb 15. pii: S0090-8258(19)30065.
PubMed Text format Abstract available

VAN WALREE IC, Hamaker ME, van de Poll-Franse LV, Vos MC, et al
Older ovarian cancer survivors report lower long-term health-related quality of life than younger survivors: A study from the population-based profiles registry.
Gynecol Oncol. 2019 Feb 13. pii: S0090-8258(19)30104.
PubMed Text format Abstract available

NAUMANN RW, Coleman RL, Brown J, Moore KN, et al
Phase III trials in ovarian cancer: The evolving landscape of front line therapy.
Gynecol Oncol. 2019 Feb 12. pii: S0090-8258(19)30113.
PubMed Text format Abstract available

LIANG J, Wolsiefer K, Zestcott CA, Chase D, et al
Implicit bias toward cervical cancer: Provider and training differences.
Gynecol Oncol. 2019 Feb 7. pii: S0090-8258(19)30055.
PubMed Text format Abstract available

SUSZYNSKA M, Klonowska K, Jasinska AJ, Kozlowski P, et al
Large-scale meta-analysis of mutations identified in panels of breast/ovarian cancer-related genes - Providing evidence of cancer predisposition genes.
Gynecol Oncol. 2019 Feb 4. pii: S0090-8258(19)30069.
PubMed Text format Abstract available

HUTCHCRAFT ML, Smith B, McLaughlin EM, Hade EM, et al
Conization pathologic features as a predictor of intermediate and high risk features on radical hysterectomy specimens in early stage cervical cancer.
Gynecol Oncol. 2019 Feb 2. pii: S0090-8258(19)30068.
PubMed Text format Abstract available

LIM SL, Havrilesky LJ, Habib AS, Secord AA, et al
Cost-effectiveness of hyperthermic intraperitoneal chemotherapy (HIPEC) at interval debulking of epithelial ovarian cancer following neoadjuvant chemotherapy.
Gynecol Oncol. 2019 Feb 1. pii: S0090-8258(19)30067.
PubMed Text format Abstract available

VOGEL RI, Niendorf K, Petzel S, Lee H, et al
A patient-centered mobile health application to motivate use of genetic counseling among women with ovarian cancer: A pilot randomized controlled trial.
Gynecol Oncol. 2019 Feb 1. pii: S0090-8258(19)30062.
PubMed Text format Abstract available

VASSILAKOS P, Poncet A, Catarino R, Viviano M, et al
Cost-effectiveness evaluation of HPV self-testing offered to non-attendees in cervical cancer screening in Switzerland.
Gynecol Oncol. 2019 Feb 1. pii: S0090-8258(19)30064.
PubMed Text format Abstract available

ORSULIC S, Karlan BY
Can molecular subtyping be used to triage women with advanced ovarian cancer to Primary Debulking Surgery or Neoadjuvant Chemotherapy?
Gynecol Oncol. 2019;152:221-222.
PubMed Text format

SOONG TR, Howitt BE, Horowitz N, Nucci MR, et al
The fallopian tube, "precursor escape" and narrowing the knowledge gap to the origins of high-grade serous carcinoma.
Gynecol Oncol. 2019;152:426-433.
PubMed Text format Abstract available

XIN W, Hua K, Ding J
The way to display the chylous tubes and to prevent chylous leakage in laparoscopic para-aortic lymphadenectomy.
Gynecol Oncol. 2019;152:434-435.
PubMed Text format

SMITH JA, Le T, Martin GA, Gaikwad A, et al
Identifying the need to refine the potential patient risk factors for niraparib-induced thrombocytopenia.
Gynecol Oncol. 2019;152:265-269.
PubMed Text format Abstract available

FLEM KARLSEN K, McFadden E, Florenes VA, Davidson B, et al
Soluble AXL is ubiquitously present in malignant serous effusions.
Gynecol Oncol. 2019;152:408-415.
PubMed Text format Abstract available

XIA P, Huang M, Zhang Y, Xiong X, et al
NCK1 promotes the angiogenesis of cervical squamous carcinoma via Rac1/PAK1/MMP2 signal pathway.
Gynecol Oncol. 2019;152:387-395.
PubMed Text format Abstract available

January 2019

HINCHCLIFF EM, Bednar EM, Lu KH, Rauh-Hain JA, et al
Disparities in gynecologic cancer genetics evaluation.
Gynecol Oncol. 2019 Jan 30. pii: S0090-8258(19)30066.
PubMed Text format Abstract available

NISHIO S, Mikami Y, Tokunaga H, Yaegashi N, et al
Analysis of gastric-type mucinous carcinoma of the uterine cervix - An aggressive tumor with a poor prognosis: A multi-institutional study.
Gynecol Oncol. 2019 Jan 29. pii: S0090-8258(19)30063.
PubMed Text format Abstract available

HOSKINS P, Eccleston A, Hurry M, Dyer M, et al
Targeted surgical prevention of epithelial ovarian cancer is cost effective and saves money in BRCA mutation carrying family members of women with epithelial ovarian cancer. A Canadian model.
Gynecol Oncol. 2019 Jan 28. pii: S0090-8258(19)30061.
PubMed Text format Abstract available

MODUGNO F, Goughnour SL, Wallack D, Edwards RP, et al
Breastfeeding factors and risk of epithelial ovarian cancer.
Gynecol Oncol. 2019 Jan 25. pii: S0090-8258(19)30060.
PubMed Text format Abstract available

CHOI HJ, Heo JH, Park JY, Jeong JY, et al
A novel PI3K/mTOR dual inhibitor, CMG002, overcomes the chemoresistance in ovarian cancer.
Gynecol Oncol. 2019 Jan 25. pii: S0090-8258(19)30045.
PubMed Text format Abstract available

HURLEY RM, Wahner Hendrickson AE, Visscher DW, Ansell P, et al
53BP1 as a potential predictor of response in PARP inhibitor-treated homologous recombination-deficient ovarian cancer.
Gynecol Oncol. 2019 Jan 24. pii: S0090-8258(19)30058.
PubMed Text format Abstract available

YANG B, Xu Y, Zhu Q, Xie L, et al
Treatment efficiency of comprehensive hysteroscopic evaluation and lesion resection combined with progestin therapy in young women with endometrial atypical hyperplasia and endometrial cancer.
Gynecol Oncol. 2019 Jan 21. pii: S0090-8258(19)30056.
PubMed Text format Abstract available

HOLSCHNEIDER CH, Petereit DG, Chu C, Hsu IC, et al
Brachytherapy: A critical component of primary radiation therapy for cervical cancer: For the Society of Gynecologic Oncology (SGO) and the American Brachytherapy Society (ABS).
Gynecol Oncol. 2019 Jan 17. pii: S0090-8258(18)31297.
PubMed Text format Abstract available

GOODMAN CR, Hatoum S, Seagle BL, Donnelly ED, et al
Association of chemotherapy and radiotherapy sequence with overall survival in locoregionally advanced endometrial cancer.
Gynecol Oncol. 2019 Jan 16. pii: S0090-8258(19)30040.
PubMed Text format Abstract available

PRODROMIDOU A, Iavazzo C, Fotiou A, Psomiadou V, et al
The application of fibrin sealant for the prevention of lymphocele after lymphadenectomy in patients with gynecological malignancies: A systematic review and meta-analysis of randomized controlled trials.
Gynecol Oncol. 2019 Jan 16. pii: S0090-8258(19)30044.
PubMed Text format Abstract available

UPPENDAHL LD, Felices M, Bendzick L, Ryan C, et al
Cytokine-induced memory-like natural killer cells have enhanced function, proliferation, and in vivo expansion against ovarian cancer cells.
Gynecol Oncol. 2019 Jan 15. pii: S0090-8258(19)30039.
PubMed Text format Abstract available

DING J, Cheng XY, Liu S, Ji HY, et al
Apatinib exerts anti-tumour effects on ovarian cancer cells.
Gynecol Oncol. 2019 Jan 14. pii: S0090-8258(19)30043.
PubMed Text format Abstract available

CRIPE JC, Buchanan TR Jr, Kuroki LM, Wan L, et al
Association between body mass index and surgical menopausal symptoms in patients with early stage endometrial cancer.
Gynecol Oncol. 2019 Jan 14. pii: S0090-8258(19)30042.
PubMed Text format Abstract available

BREGAR A, Mojtahed A, Kilcoyne A, Kurra V, et al
CT prediction of surgical outcome in patients with advanced epithelial ovarian carcinoma undergoing neoadjuvant chemotherapy.
Gynecol Oncol. 2019 Jan 11. pii: S0090-8258(18)31476.
PubMed Text format Abstract available

KIM SI, Cho JH, Seol A, Kim YI, et al
Comparison of survival outcomes between minimally invasive surgery and conventional open surgery for radical hysterectomy as primary treatment in patients with stage IB1-IIA2 cervical cancer.
Gynecol Oncol. 2019 Jan 11. pii: S0090-8258(19)30041.
PubMed Text format Abstract available

OH SH, Park SJ, Lee EJ, Yim GW, et al
Pelvic lymphadenectomy by vaginal natural orifice transluminal endoscopic surgery (vNOTES) for early-stage endometrial cancer.
Gynecol Oncol. 2019 Jan 10. pii: S0090-8258(19)30002.
PubMed Text format

MCCUAIG JM, Tone AA, Maganti M, Romagnuolo T, et al
Modified panel-based genetic counseling for ovarian cancer susceptibility: A randomized non-inferiority study.
Gynecol Oncol. 2019 Jan 10. pii: S0090-8258(18)31541.
PubMed Text format Abstract available

FABBRO M, Moore KN, Dorum A, Tinker AV, et al
Efficacy and safety of niraparib as maintenance treatment in older patients (>/=70years) with recurrent ovarian cancer: Results from the ENGOT-OV16/NOVA trial.
Gynecol Oncol. 2019 Jan 9. pii: S0090-8258(18)31473.
PubMed Text format Abstract available

STOLER MH, Wright TC Jr, Parvu V, Yanson K, et al
Stratified risk of high-grade cervical disease using onclarity HPV extended genotyping in women, >/=25years of age, with NILM cytology.
Gynecol Oncol. 2019 Jan 9. pii: S0090-8258(18)31538.
PubMed Text format Abstract available

WAGNER P, Kommoss FKF, Kommoss S, Hartkopf AD, et al
Unexpected malignant uterine pathology: Incidence, characteristics and outcome in a large single-center series of hysterectomies for presumed benign uterine disease.
Gynecol Oncol. 2019 Jan 8. pii: S0090-8258(18)31540.
PubMed Text format Abstract available

BONAZZOLI E, Cocco E, Lopez S, Bellone S, et al
PI3K oncogenic mutations mediate resistance to afatinib in HER2/neu overexpressing gynecological cancers.
Gynecol Oncol. 2019 Jan 7. pii: S0090-8258(19)30004.
PubMed Text format Abstract available

WANG J, Du Y, Dong J, Zhou Y, et al
Clinical significance of genotyping for human papillomavirus (HPV) 16 18/45 combined with cytology in cervical exfoliated cells in HPV oncogenic mRNA-positive women.
Gynecol Oncol. 2019 Jan 7. pii: S0090-8258(18)31542.
PubMed Text format Abstract available

MATSUO K, Hom MS, Yabuno A, Shida M, et al
Association of statins, aspirin, and venous thromboembolism in women with endometrial cancer.
Gynecol Oncol. 2019 Jan 4. pii: S0090-8258(18)31534.
PubMed Text format Abstract available

JERZAK KJ, Duska L, MacKay HJ
Endocrine therapy in endometrial cancer: An old dog with new tricks.
Gynecol Oncol. 2019 Jan 4. pii: S0090-8258(18)31518.
PubMed Text format Abstract available

YAO T, DeJong SR, McGree ME, Weaver AL, et al
Frailty in ovarian cancer identified the need for increased postoperative care requirements following cytoreductive surgery.
Gynecol Oncol. 2019 Jan 3. pii: S0090-8258(18)31539.
PubMed Text format Abstract available

FULK K, Milam MR, Li S, Yussuf A, et al
Women with breast and uterine cancer are more likely to harbor germline mutations than women with breast or uterine cancer alone: A case for expanded gene testing.
Gynecol Oncol. 2019 Jan 3. pii: S0090-8258(18)31535.
PubMed Text format Abstract available

LONG B, Lilyquist J, Weaver A, Hu C, et al
Cancer susceptibility gene mutations in type I and II endometrial cancer.
Gynecol Oncol. 2019;152:20-25.
PubMed Text format Abstract available

RUSH CM, Goodfellow PJ
Diverse mutational signatures in endometrial cancer: implications for tumor etiology and evolution.
Gynecol Oncol. 2019;152:1-2.
PubMed Text format

PARK SJ, Kim HS
Laterally extended endopelvic resection with nephrectomy for vaginal cancer.
Gynecol Oncol. 2019;152:218-219.
PubMed Text format

NICA A, Covens A, Vicus D, Kupets R, et al
Sentinel lymph nodes in vulvar cancer: Management dilemmas in patients with positive nodes and larger tumors.
Gynecol Oncol. 2019;152:94-100.
PubMed Text format Abstract available

SAND FL, Nielsen DMB, Frederiksen MH, Rasmussen CL, et al
The prognostic value of p16 and p53 expression for survival after vulvar cancer: A systematic review and meta-analysis.
Gynecol Oncol. 2019;152:208-217.
PubMed Text format Abstract available

LOOPIK DL, Bekkers RLM, Massuger LFAG, Melchers WJG, et al
Justifying conservative management of CIN2 in women younger than 25years - A population-based study.
Gynecol Oncol. 2019;152:82-86.
PubMed Text format Abstract available

SALCEDO MP, Sood AK, Dos Reis R, Ramalingam P, et al
Perineural invasion (PNI) in vulvar carcinoma: A review of 421 cases.
Gynecol Oncol. 2019;152:101-105.
PubMed Text format Abstract available

SULLIVAN MW, Camacho FT, Mills AM, Modesitt SC, et al
Missing information in statewide and national cancer databases: Correlation with health risk factors, geographic disparities, and outcomes.
Gynecol Oncol. 2019;152:119-126.
PubMed Text format Abstract available

December 2018

LING DC, Vargo JA, Glaser SM, Kim H, et al
Outcomes after definitive re-irradiation with 3D brachytherapy with or without external beam radiation therapy for vaginal recurrence of endometrial cancer.
Gynecol Oncol. 2018 Dec 29. pii: S0090-8258(18)31536.
PubMed Text format Abstract available

MATULONIS UA, Sill MW, Makker V, Mutch DG, et al
A randomized phase II study of cabozantinib versus weekly paclitaxel in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.
Gynecol Oncol. 2018 Dec 23. pii: S0090-8258(18)31460.
PubMed Text format Abstract available

ZHANG L, Jiang Y, Lu X, Zhao H, et al
Genomic characterization of cervical cancer based on human papillomavirus status.
Gynecol Oncol. 2018 Dec 20. pii: S0090-8258(18)31516.
PubMed Text format Abstract available

ROSS JGC, Escamilla V, Lee NK, Diane Yamada S, et al
Geospatial patterns of access to self-care resources for obesity among endometrial cancer survivors in a high poverty urban community.
Gynecol Oncol. 2018 Dec 20. pii: S0090-8258(18)31470.
PubMed Text format Abstract available

RAUH-HAIN JA, Hidrue MK, Gaccione P, Melamed A, et al
Variation in resource utilization associated with the surgical management of ovarian cancer.
Gynecol Oncol. 2018 Dec 19. pii: S0090-8258(18)31513.
PubMed Text format Abstract available

MYSONA D, Pyrzak A, Purohit S, Zhi W, et al
A combined score of clinical factors and serum proteins can predict time to recurrence in high grade serous ovarian cancer.
Gynecol Oncol. 2018 Dec 18. pii: S0090-8258(18)31515.
PubMed Text format Abstract available

CEPPI L, Galli F, Lamanna M, Magni S, et al
Ovarian function, fertility, and menopause occurrence after fertility-sparing surgery and chemotherapy for ovarian neoplasms.
Gynecol Oncol. 2018 Dec 18. pii: S0090-8258(18)31452.
PubMed Text format Abstract available

BULLS HW, Hoogland AI, Kennedy B, James BW, et al
A longitudinal examination of associations between age and chemotherapy-induced peripheral neuropathy in patients with gynecologic cancer.
Gynecol Oncol. 2018 Dec 14. pii: S0090-8258(18)31458.
PubMed Text format Abstract available

NIE D, Gong H, Mao X, Li Z, et al
Systemic immune-inflammation index predicts prognosis in patients with epithelial ovarian cancer: A retrospective study.
Gynecol Oncol. 2018 Dec 14. pii: S0090-8258(18)31454.
PubMed Text format Abstract available

ANGELES MA, Martinez-Gomez C, Martinez A, Ferron G, et al
En bloc pelvic resection for ovarian carcinomatosis: Hudson procedure in 10 steps.
Gynecol Oncol. 2018 Dec 14. pii: S0090-8258(18)31471.
PubMed Text format

DAVIDSON BA, Broadwater G, Crim A, Boccacio R, et al
Surgical complexity score and role of laparoscopy in women with advanced ovarian cancer treated with neoadjuvant chemotherapy.
Gynecol Oncol. 2018 Dec 14. pii: S0090-8258(18)31475.
PubMed Text format Abstract available

RODRIGUEZ-FREIXINOS V, Farinas-Madrid L, Gil-Martin M, Barretina-Ginesta P, et al
Chemotherapy and PARP inhibitors in heavily pretreated BRCA1/2 mutation ovarian cancer (BMOC) patients.
Gynecol Oncol. 2018 Dec 12. pii: S0090-8258(18)31456.
PubMed Text format Abstract available

XIANG M, English DP, Kidd EA
National patterns of care and cancer-specific outcomes of adjuvant treatment in patients with serous and clear cell endometrial carcinoma.
Gynecol Oncol. 2018 Dec 12. pii: S0090-8258(18)31472.
PubMed Text format Abstract available

NORQUIST BM
Challenges in the identification of inherited risk of ovarian cancer: where should we go from here?
Gynecol Oncol. 2018 Dec 8. pii: S0090-8258(18)31459.
PubMed Text format

BEDNAR EM, Sun CC, Camacho B, Terrell J, et al
Disseminating universal genetic testing to a diverse, indigent patient population at a county hospital gynecologic oncology clinic.
Gynecol Oncol. 2018 Dec 8. pii: S0090-8258(18)31457.
PubMed Text format Abstract available

LAW KE, Hildebrand EA, Hawthorne HJ, Hallbeck MS, et al
A pilot study of non-routine events in gynecological surgery: Type, impact, and effect.
Gynecol Oncol. 2018 Dec 6. pii: S0090-8258(18)31455.
PubMed Text format Abstract available

VARGA A, Piha-Paul S, Ott PA, Mehnert JM, et al
Pembrolizumab in patients with programmed death ligand 1-positive advanced ovarian cancer: Analysis of KEYNOTE-028.
Gynecol Oncol. 2018 Dec 3. pii: S0090-8258(18)31418.
PubMed Text format Abstract available

DUSKA LR
Evolving times and paradigms in endometrial cancer: Incorporating and interpreting new data and technologic advances.
Gynecol Oncol. 2018;151:393-394.
PubMed Text format

GAFFNEY DK, Hashibe M, Kepka D, Maurer KA, et al
Too many women are dying from cervix cancer: Problems and solutions.
Gynecol Oncol. 2018;151:547-554.
PubMed Text format Abstract available

VAN DER LINDEN M, van Esch E, Bulten J, Dreef E, et al
The immune cell infiltrate in the microenvironment of vulvar Paget disease.
Gynecol Oncol. 2018;151:453-459.
PubMed Text format Abstract available

November 2018

TORRES D, Kumar A, Bakkum-Gamez JN, Weaver AL, et al
Mesenchymal molecular subtype is an independent predictor of severe postoperative complications after primary debulking surgery for advanced ovarian cancer.
Gynecol Oncol. 2018 Nov 28. pii: S0090-8258(18)31420.
PubMed Text format Abstract available

HAY CM, Donovan HS, Campbell GB, Taylor SE, et al
Chemotherapy in older adult gynecologic oncology patients: Can a phenotypic frailty score predict tolerance?
Gynecol Oncol. 2018 Nov 28. pii: S0090-8258(18)31451.
PubMed Text format Abstract available

STANLEY B, Hollis RL, Nunes H, Towler JD, et al
Endocrine treatment of high grade serous ovarian carcinoma; quantification of efficacy and identification of response predictors.
Gynecol Oncol. 2018 Nov 27. pii: S0090-8258(18)31450.
PubMed Text format Abstract available

PENN CA, Kamdar NS, Morgan DM, Spencer RJ, et al
Preoperatively predicting non-home discharge after surgery for gynecologic malignancy.
Gynecol Oncol. 2018 Nov 26. pii: S0090-8258(18)31449.
PubMed Text format Abstract available

SUBRAMANIAM A, Einerson BD, Blanchard CT, Erickson BK, et al
The cost-effectiveness of opportunistic salpingectomy versus standard tubal ligation at the time of cesarean delivery for ovarian cancer risk reduction.
Gynecol Oncol. 2018 Nov 23. pii: S0090-8258(18)31405.
PubMed Text format Abstract available

ALBEESH R, Turgeon GA, Alfieri J, Mansure JJ, et al
Adjuvant therapy in stage III endometrial cancer confined to the pelvis.
Gynecol Oncol. 2018 Nov 22. pii: S0090-8258(18)31364.
PubMed Text format Abstract available

FRIJSTEIN MM, Lok CAR, van Trommel NE, Ten Kate-Booij MJ, et al
Management and prognostic factors of epithelioid trophoblastic tumors: Results from the International Society for the Study of Trophoblastic Diseases database.
Gynecol Oncol. 2018 Nov 22. pii: S0090-8258(18)31416.
PubMed Text format Abstract available

WISWELL S, Bell JG, McHale J, Elliott JO, et al
The effect of art therapy on the quality of life in patients with a gynecologic cancer receiving chemotherapy.
Gynecol Oncol. 2018 Nov 22. pii: S0090-8258(18)31446.
PubMed Text format Abstract available

WAGNER BE, Langstraat CL, McGree ME, Weaver AL, et al
Beyond prophylaxis: Extended risk of venous thromboembolism following primary debulking surgery for ovarian cancer.
Gynecol Oncol. 2018 Nov 21. pii: S0090-8258(18)31422.
PubMed Text format Abstract available

JAVELLANA M, Hoppenot C, Lengyel E
The road to long-term survival: Surgical approach and longitudinal treatments of long-term survivors of advanced-stage serous ovarian cancer.
Gynecol Oncol. 2018 Nov 21. pii: S0090-8258(18)31404.
PubMed Text format Abstract available

BOLAND JL, Zhou Q, Martin M, Callahan MK, et al
Early disease progression and treatment discontinuation in patients with advanced ovarian cancer receiving immune checkpoint blockade.
Gynecol Oncol. 2018 Nov 20. pii: S0090-8258(18)31445.
PubMed Text format Abstract available

SANJIDA S, Janda M, McPhail SM, Kissane D, et al
How many patients enter endometrial cancer surgery with psychotropic medication prescriptions, and how many receive a new prescription perioperatively?
Gynecol Oncol. 2018 Nov 19. pii: S0090-8258(18)31419.
PubMed Text format Abstract available

ZHU B, Pan Y, Zheng X, Zhang Q, et al
A clinical, biologic and mechanistic analysis of the role of ZNF692 in cervical cancer.
Gynecol Oncol. 2018 Nov 19. pii: S0090-8258(18)31423.
PubMed Text format Abstract available

HEITZ F, Harter P, Avall-Lundqvist E, Reuss A, et al
Early tumor regrowth is a contributor to impaired survival in patients with completely resected advanced ovarian cancer. An exploratory analysis of the Intergroup trial AGO-OVAR 12.
Gynecol Oncol. 2018 Nov 19. pii: S0090-8258(18)31406.
PubMed Text format Abstract available

PRADER S, Vollmar N, du Bois A, Heitz F, et al
Pattern and impact of metastatic cardiophrenic lymph nodes in advanced epithelial ovarian cancer.
Gynecol Oncol. 2018 Nov 18. pii: S0090-8258(18)31363.
PubMed Text format Abstract available

GONZALEZ MARTIN A, Oza AM, Embleton AC, Pfisterer J, et al
Exploratory outcome analyses according to stage and/or residual disease in the ICON7 trial of carboplatin and paclitaxel with or without bevacizumab for newly diagnosed ovarian cancer.
Gynecol Oncol. 2018 Nov 15. pii: S0090-8258(18)31166.
PubMed Text format Abstract available

ZHANG Q, Wang C, Cliby WA
Cancer-associated stroma significantly contributes to the mesenchymal subtype signature of serous ovarian cancer.
Gynecol Oncol. 2018 Nov 15. pii: S0090-8258(18)31415.
PubMed Text format Abstract available

ROMEO C, Joly F, Ray-Coquard I, El Kouri C, et al
Non-pegylated liposomal doxorubicin (NPLD, Myocet(R))+carboplatin in patients with platinum sensitive ovarian cancers: A ARCAGY-GINECO phase IB-II trial.
Gynecol Oncol. 2018 Nov 14. pii: S0090-8258(18)31358.
PubMed Text format Abstract available

KOTOULA V, Lakis S, Tikas I, Giannoulatou E, et al
Pathogenic BRCA1 mutations may be necessary but not sufficient for tissue genomic heterogeneity: Deep sequencing data from ovarian cancer patients.
Gynecol Oncol. 2018 Nov 14. pii: S0090-8258(18)31417.
PubMed Text format Abstract available

SIN STK, Li Y, Liu M, Ma S, et al
TROP-2 exhibits tumor suppressive functions in cervical cancer by dual inhibition of IGF-1R and ALK signaling.
Gynecol Oncol. 2018 Nov 12. pii: S0090-8258(18)31354.
PubMed Text format Abstract available

SPEES LP, Wheeler SB, Varia M, Weinberger M, et al
Evaluating the urban-rural paradox: The complicated relationship between distance and the receipt of guideline-concordant care among cervical cancer patients.
Gynecol Oncol. 2018 Nov 12. pii: S0090-8258(18)31407.
PubMed Text format Abstract available

UPPAL S, Rebecca Liu J, Kevin Reynolds R, Rice LW, et al
Trends and comparative effectiveness of inpatient radical hysterectomy for cervical cancer in the United States (2012-2015).
Gynecol Oncol. 2018 Nov 10. pii: S0090-8258(18)31246.
PubMed Text format Abstract available

BUCKINGHAM L, Haggerty A, Graul A, Morgan M, et al
Sexual function following hysterectomy for endometrial cancer: A five-year follow up investigation.
Gynecol Oncol. 2018 Nov 9. pii: S0090-8258(18)31308.
PubMed Text format Abstract available

TORTORELLA L, Casarin J, Mara KC, Weaver AL, et al
Prediction of short-term surgical complications in women undergoing pelvic exenteration for gynecological malignancies.
Gynecol Oncol. 2018 Nov 8. pii: S0090-8258(18)31350.
PubMed Text format Abstract available

KURNIT KC, Previs RA, Soliman PT, Westin SN, et al
Prognostic factors impacting survival in early stage uterine carcinosarcoma.
Gynecol Oncol. 2018 Nov 8. pii: S0090-8258(18)31317.
PubMed Text format Abstract available

ASHLEY CW, Da Cruz Paula A, Kumar R, Mandelker D, et al
Analysis of mutational signatures in primary and metastatic endometrial cancer reveals distinct patterns of DNA repair defects and shifts during tumor progression.
Gynecol Oncol. 2018 Nov 8. pii: S0090-8258(18)31316.
PubMed Text format Abstract available

HALL E, Finch A, Jacobson M, Rosen B, et al
Effects of bilateral salpingo-oophorectomy on menopausal symptoms and sexual functioning among women with a BRCA1 or BRCA2 mutation.
Gynecol Oncol. 2018 Nov 7. pii: S0090-8258(18)31355.
PubMed Text format Abstract available

ZHONG Q, Hu Z, Li Q, Yi T, et al
Cyclin D1 silencing impairs DNA double strand break repair, sensitizes BRCA1 wildtype ovarian cancer cells to olaparib.
Gynecol Oncol. 2018 Nov 7. pii: S0090-8258(18)31310.
PubMed Text format Abstract available

TURASHVILI G, Gomez-Hidalgo NR, Flynn J, Gonen M, et al
Risk-based stratification of carcinomas concurrently involving the endometrium and ovary.
Gynecol Oncol. 2018 Nov 6. pii: S0090-8258(18)31315.
PubMed Text format Abstract available

LEE JY, Park JY, Park SY, Lee JW, et al
Real-world effectiveness of bevacizumab based on AURELIA in platinum-resistant recurrent ovarian cancer (REBECA): A Korean Gynecologic Oncology Group study (KGOG 3041).
Gynecol Oncol. 2018 Nov 5. pii: S0090-8258(18)31314.
PubMed Text format Abstract available

MULLEN MM, Kuroki LM, Thaker PH
Novel treatment options in platinum-sensitive recurrent ovarian cancer: A review.
Gynecol Oncol. 2018 Nov 5. pii: S0090-8258(18)31306.
PubMed Text format Abstract available

SPENCER RJ, Rice LW, Ye C, Woo K, et al
Disparities in the allocation of research funding to gynecologic cancers by Funding to Lethality scores.
Gynecol Oncol. 2018 Nov 4. pii: S0090-8258(18)31302.
PubMed Text format Abstract available

SELLA T, Stone RM
The impact of new drugs for breast and ovarian cancer on the occurrence of therapy-related myeloid neoplasms: Understanding the baseline incidence.
Gynecol Oncol. 2018;151:187-189.
PubMed Text format

LEEMAN A, Ebisch RMF, Kasius A, Bosgraaf RP, et al
Defining hrHPV genotypes in cervical intraepithelial neoplasia by laser capture microdissection supports reflex triage of self-samples using HPV16/18 and FAM19A4/miR124-2 methylation.
Gynecol Oncol. 2018;151:311-318.
PubMed Text format Abstract available

FIANO V, Trevisan M, Fasanelli F, Grasso C, et al
Methylation in host and viral genes as marker of aggressiveness in cervical lesions: Analysis in 543 unscreened women.
Gynecol Oncol. 2018;151:319-326.
PubMed Text format Abstract available

SPAANS VM, Scheunhage DA, Barzaghi B, de Kroon CD, et al
Independent validation of the prognostic significance of invasion patterns in endocervical adenocarcinoma: Pattern A predicts excellent survival.
Gynecol Oncol. 2018;151:196-201.
PubMed Text format Abstract available

October 2018

MATSUO K, Machida H, Mandelbaum RS, Konishi I, et al
Validation of the 2018 FIGO cervical cancer staging system.
Gynecol Oncol. 2018 Oct 30. pii: S0090-8258(18)31309.
PubMed Text format Abstract available

WANG Y, Jiang J, He L, Gong G, et al
Effect of lamin-A expression on migration and nuclear stability of ovarian cancer cells.
Gynecol Oncol. 2018 Oct 29. pii: S0090-8258(18)31313.
PubMed Text format Abstract available

DUSKA LR, Suh DH, Wilson M, Diane Yamada S, et al
International Gynecologic Cancer Society (IGCS) 2018: Meeting report.
Gynecol Oncol. 2018 Oct 27. pii: S0090-8258(18)31301.
PubMed Text format

TANGEN IL, Fasmer KE, Konings GF, Jochems A, et al
Blood steroids are associated with prognosis and fat distribution in endometrial cancer.
Gynecol Oncol. 2018 Oct 26. pii: S0090-8258(18)31307.
PubMed Text format Abstract available

DING L, Ding Y, Kong X, Wu J, et al
Dysregulation of Kruppel-like factor 12 in the development of endometrial cancer.
Gynecol Oncol. 2018 Oct 25. pii: S0090-8258(18)31311.
PubMed Text format Abstract available

HANSEN JM, Sood AK, Coleman RL, Westin SN, et al
Concordance of a laparoscopic scoring algorithm with primary surgery findings in advanced stage ovarian cancer.
Gynecol Oncol. 2018 Oct 23. pii: S0090-8258(18)31299.
PubMed Text format Abstract available

HINCHCLIFF E, Hong D, Le H, Chisholm G, et al
Characteristics and outcomes of patients with recurrent ovarian cancer undergoing early phase immune checkpoint inhibitor clinical trials.
Gynecol Oncol. 2018 Oct 23. pii: S0090-8258(18)31287.
PubMed Text format Abstract available

OLAWAIYE AB, Java JJ, Krivak TC, Friedlander M, et al
Corrigendum to "Does adjuvant chemotherapy dose modification have an impact on the outcome of patients diagnosed with advanced stage ovarian cancer? An NRG Oncology/Gynecologic Oncology Group study" [Gynecol. Oncol. 151 (2018) 18-23].
Gynecol Oncol. 2018 Oct 22. pii: S0090-8258(18)31303.
PubMed Text format

CIBULA D, Abu-Rustum NR, Fischerova D, Pather S, et al
Surgical treatment of "intermediate risk" lymph node negative cervical cancer patients without adjuvant radiotherapy-A retrospective cohort study and review of the literature.
Gynecol Oncol. 2018 Oct 20. pii: S0090-8258(18)31298.
PubMed Text format Abstract available

TA RM, Hecht JL, Lin DI
Discordant loss of mismatch repair proteins in advanced endometrial endometrioid carcinoma compared to paired primary uterine tumors.
Gynecol Oncol. 2018 Oct 16. pii: S0090-8258(18)31291.
PubMed Text format Abstract available

HUANG C, Lu H, Li J, Xie X, et al
SOX2 regulates radioresistance in cervical cancer via the hedgehog signaling pathway.
Gynecol Oncol. 2018 Oct 15. pii: S0090-8258(18)31284.
PubMed Text format Abstract available

TANNER EJ, Filippova OT, Gardner GJ, Long Roche KC, et al
A prospective trial of acute normovolemic hemodilution in patients undergoing primary cytoreductive surgery for advanced ovarian cancer.
Gynecol Oncol. 2018 Oct 15. pii: S0090-8258(18)31285.
PubMed Text format Abstract available

SAPIENZA LG, Jhingran A, Kollmeier MA, Lin LL, et al
Decrease in uterine perforations with ultrasound image-guided applicator insertion in intracavitary brachytherapy for cervical cancer: A systematic review and meta-analysis.
Gynecol Oncol. 2018 Oct 14. pii: S0090-8258(18)31290.
PubMed Text format Abstract available

CARTER NJ, Marshall ML, Susswein LR, Zorn KK, et al
Germline pathogenic variants identified in women with ovarian tumors.
Gynecol Oncol. 2018 Oct 12. pii: S0090-8258(18)31249.
PubMed Text format Abstract available

CIBULA D, McCluggage WG
Sentinel lymph node (SLN) concept in cervical cancer: Current limitations and unanswered questions.
Gynecol Oncol. 2018 Oct 11. pii: S0090-8258(18)31286.
PubMed Text format Abstract available

SALINARO JR, Puechl AM, Havrilesky LJ, Davidson BA, et al
Gender trends in gynecologic oncology authorship: Implications for the critical evaluation of gender distribution in academic rank and leadership positions.
Gynecol Oncol. 2018 Oct 9. pii: S0090-8258(18)31288.
PubMed Text format Abstract available

KIM HS, Kim JY, Lee YJ, Kim SH, et al
Expression of programmed cell death ligand 1 and immune checkpoint markers in residual tumors after neoadjuvant chemotherapy for advanced high-grade serous ovarian cancer.
Gynecol Oncol. 2018 Oct 9. pii: S0090-8258(18)31153.
PubMed Text format Abstract available

NAUMANN RW, Morris JC, Tait DL, Higgins RV, et al
Patients with BRCA mutations have superior outcomes after intraperitoneal chemotherapy in optimally resected high grade ovarian cancer.
Gynecol Oncol. 2018 Oct 8. pii: S0090-8258(18)31282.
PubMed Text format Abstract available

MONK BJ, Kauderer JT, Moxley KM, Bonebrake AJ, et al
A phase II evaluation of elesclomol sodium and weekly paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube or primary peritoneal cancer: An NRG oncology/gynecologic oncology group study.
Gynecol Oncol. 2018 Oct 8. pii: S0090-8258(18)31281.
PubMed Text format Abstract available

BELUR NAGARAJ A, Joseph P, Kovalenko O, Wang Q, et al
Evaluating class III antiarrhythmic agents as novel MYC targeting drugs in ovarian cancer.
Gynecol Oncol. 2018 Oct 6. pii: S0090-8258(18)31238.
PubMed Text format Abstract available

WANG J, Dean DC, Hornicek FJ, Shi H, et al
RNA sequencing (RNA-Seq) and its application in ovarian cancer.
Gynecol Oncol. 2018 Oct 5. pii: S0090-8258(18)31283.
PubMed Text format Abstract available

RASH JK, Lyle KD, Jairam-Thodla A, Ioffe Y, et al
Delivery of gynecologic oncology care: Optimizing scope of advanced practice providers to enhance patient care: A Society of Gynecologic Oncology Position Paper.
Gynecol Oncol. 2018 Oct 4. pii: S0090-8258(18)31237.
PubMed Text format

WANG W, Zou W, Liu JR
Tumor-infiltrating T cells in epithelial ovarian cancer: predictors of prognosis and biological basis of immunotherapy.
Gynecol Oncol. 2018;151:1-3.
PubMed Text format

ALOISI A, Casanova JM, Tseng JH, Seader KA, et al
Patterns of FIRST recurrence of stage IIIC1 endometrial cancer with no PARAAORTIC nodal assessment.
Gynecol Oncol. 2018 Oct 1. pii: S0090-8258(18)31240.
PubMed Text format Abstract available

MARTINEZ-GOMEZ C, Angeles MA, Martinez A, Ferron G, et al
Creation of a Miami Pouch in 10 logical steps.
Gynecol Oncol. 2018;151:178-179.
PubMed Text format

MATSUOKA A, Tate S, Nishikimi K, Shozu M, et al
Successful retroperitoneal lymphadenectomy for double inferior vena cava with preoperative assessment using contrast-enhanced and three-dimensional computed tomography.
Gynecol Oncol. 2018;151:180-181.
PubMed Text format

RODRIGUES LLS, Morgado MG, Sahasrabuddhe VV, De Paula VS, et al
Cervico-vaginal self-collection in HIV-infected and uninfected women from Tapajos region, Amazon, Brazil: High acceptability, hrHPV diversity and risk factors.
Gynecol Oncol. 2018;151:102-110.
PubMed Text format Abstract available

HORNE ZD, Dohopolski MJ, Pradhan D, Bhargava R, et al
Human papillomavirus infection mediates response and outcome of vulvar squamous cell carcinomas treated with radiation therapy.
Gynecol Oncol. 2018;151:96-101.
PubMed Text format Abstract available

September 2018

ELNAGGAR AC, Hade EM, O'Malley DM, Liang MI, et al
Time to chemotherapy in ovarian cancer: Compliance with ovarian cancer quality indicators at a National Cancer Institute-designated Comprehensive Cancer Center.
Gynecol Oncol. 2018 Sep 30. pii: S0090-8258(18)31233.
PubMed Text format Abstract available

NASSER S, Lathouras K, Nixon K, Campbell J, et al
Impact of right upper quadrant cytoreductive techniques with extensive liver mobilization on postoperative hepatic function and risk of liver failure in patients with advanced ovarian cancer.
Gynecol Oncol. 2018 Sep 29. pii: S0090-8258(18)31247.
PubMed Text format Abstract available

MATSUOKA A, Tate S, Nishikimi K, Shozu M, et al
Left cardiophrenic lymph node resection for advanced ovarian cancer with adhesion to the thoracic cavity.
Gynecol Oncol. 2018 Sep 27. pii: S0090-8258(18)31241.
PubMed Text format

ZHANG L, Xu XQ, Hu SY, Chen F, et al
Durability of clinical performance afforded by self-collected HPV testing: A 15-year cohort study in China.
Gynecol Oncol. 2018 Sep 27. pii: S0090-8258(18)31231.
PubMed Text format Abstract available

SHENOLIKAR R, Durden E, Meyer N, Lenhart G, et al
Incidence of secondary myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) in patients with ovarian or breast cancer in a real-world setting in the United States.
Gynecol Oncol. 2018 Sep 26. pii: S0090-8258(18)31176.
PubMed Text format Abstract available

MANGILI G, Cioffi R, Danese S, Frigerio L, et al
Does methotrexate (MTX) dosing in a 8-day MTX/FA regimen for the treatment of low-risk gestational trophoblastic neoplasia affect outcomes? The MITO-9 study.
Gynecol Oncol. 2018 Sep 26. pii: S0090-8258(18)31244.
PubMed Text format Abstract available

WANG W, Zhang F, Hu K, Hou X, et al
Image-guided, intensity-modulated radiation therapy in definitive radiotherapy for 1433 patients with cervical cancer.
Gynecol Oncol. 2018 Sep 25. pii: S0090-8258(18)31243.
PubMed Text format Abstract available

LIM SL, Moss HA, Secord AA, Lee PS, et al
Hysterectomy with sentinel lymph node biopsy in the setting of pre-operative diagnosis of endometrial intraepithelial neoplasia: A cost-effectiveness analysis.
Gynecol Oncol. 2018 Sep 23. pii: S0090-8258(18)31239.
PubMed Text format Abstract available

NIEMI RJ, Roine AN, Eraviita E, Kumpulainen PS, et al
FAIMS analysis of urine gaseous headspace is capable of differentiating ovarian cancer.
Gynecol Oncol. 2018 Sep 23. pii: S0090-8258(18)31235.
PubMed Text format Abstract available

TAYLOR JS, He W, Harrison R, Zhao H, et al
Disparities in treatment and survival among elderly ovarian cancer patients.
Gynecol Oncol. 2018 Sep 22. pii: S0090-8258(18)31171.
PubMed Text format Abstract available

HANNIBAL CG, Dehlendorff C, Kjaer SK
Use of paracetamol, low-dose aspirin, or non-aspirin non-steroidal anti-inflammatory drugs and risk of ovarian borderline tumors in Denmark.
Gynecol Oncol. 2018 Sep 21. pii: S0090-8258(18)31242.
PubMed Text format Abstract available

ZIVANOVIC O, Chi DS, Filippova O, Randall LM, et al
It's time to warm up to hyperthermic intraperitoneal chemotherapy for patients with ovarian cancer.
Gynecol Oncol. 2018 Sep 21. pii: S0090-8258(18)31218.
PubMed Text format Abstract available

HUA W, Zhao Y, Jin X, Yu D, et al
METTL3 promotes ovarian carcinoma growth and invasion through the regulation of AXL translation and epithelial to mesenchymal transition.
Gynecol Oncol. 2018 Sep 21. pii: S0090-8258(18)31234.
PubMed Text format Abstract available

BOITANO TKL, Smith HJ, Rushton T, Johnston MC, et al
Impact of enhanced recovery after surgery (ERAS) protocol on gastrointestinal function in gynecologic oncology patients undergoing laparotomy.
Gynecol Oncol. 2018 Sep 20. pii: S0090-8258(18)31220.
PubMed Text format Abstract available

ROBERTS ME, Aynardi JT, Chu CS
Uterine leiomyosarcoma: A review of the literature and update on management options.
Gynecol Oncol. 2018 Sep 20. pii: S0090-8258(18)31221.
PubMed Text format Abstract available

DOWDY SC, Cliby WA, Famuyide AO
Quality indicators in gynecologic oncology.
Gynecol Oncol. 2018 Sep 13. pii: S0090-8258(18)31175.
PubMed Text format

WANG D, Cao D, Jia C, Huang H, et al
Analysis of oncologic and reproductive outcomes after fertility-sparing surgery in apparent stage I adult ovarian granulosa cell tumors.
Gynecol Oncol. 2018 Sep 12. pii: S0090-8258(18)31214.
PubMed Text format Abstract available

ODA K, Hamanishi J, Matsuo K, Hasegawa K, et al
Genomics to immunotherapy of ovarian clear cell carcinoma: Unique opportunities for management.
Gynecol Oncol. 2018 Sep 11. pii: S0090-8258(18)31174.
PubMed Text format Abstract available

JAZAERI A, Coleman RL, Sood AK, Frumovitz MM, et al
A practical guide for the safe implementation of early phase drug development and immunotherapy program in gynecologic oncology practice.
Gynecol Oncol. 2018 Sep 10. pii: S0090-8258(18)31167.
PubMed Text format Abstract available

AZIZ D, Etemadmoghadam D, Caldon CE, Au-Yeung G, et al
19q12 amplified and non-amplified subsets of high grade serous ovarian cancer with overexpression of cyclin E1 differ in their molecular drivers and clinical outcomes.
Gynecol Oncol. 2018 Sep 9. pii: S0090-8258(18)31169.
PubMed Text format Abstract available

ZHAO H, Yu H, Zheng J, Ning N, et al
Lowly-expressed lncRNA GAS5 facilitates progression of ovarian cancer through targeting miR-196-5p and thereby regulating HOXA5.
Gynecol Oncol. 2018 Sep 7. pii: S0090-8258(18)31162.
PubMed Text format Abstract available

CONNOR JP, O'Shea A, McCool K, Sampene E, et al
Peri-operative allogeneic blood transfusion is associated with poor overall survival in advanced epithelial ovarian Cancer; potential impact of patient blood management on Cancer outcomes.
Gynecol Oncol. 2018 Sep 7. pii: S0090-8258(18)31170.
PubMed Text format Abstract available

MATSUO K, Machida H, Mandelbaum RS, Ragab OM, et al
Tumor-specific outcome of metachronous uterine malignancy after pelvic irradiation for cervical cancer.
Gynecol Oncol. 2018 Sep 6. pii: S0090-8258(18)31165.
PubMed Text format Abstract available

RAJKUMAR S, Polson A, Nath R, Lane G, et al
Prognostic implications of histological tumor regression (Bohm's score) in patients receiving neoadjuvant chemotherapy for high grade serous tubal & ovarian carcinoma.
Gynecol Oncol. 2018 Sep 6. pii: S0090-8258(18)31172.
PubMed Text format Abstract available

GHELARDI A, Parazzini F, Martella F, Pieralli A, et al
SPERANZA project: HPV vaccination after treatment for CIN2.
Gynecol Oncol. 2018 Sep 6. pii: S0090-8258(18)31163.
PubMed Text format

KIM HJ, Chang JS, Koom WS, Lee KC, et al
Radiotherapy is a safe and effective salvage treatment for recurrent cervical cancer.
Gynecol Oncol. 2018 Sep 5. pii: S0090-8258(18)31158.
PubMed Text format Abstract available

SCURRY J, van Zyl B, Gulliver D, Otton G, et al
Nucleotide excision repair protein ERCC1 and tumour-infiltrating lymphocytes are potential biomarkers of neoadjuvant platinum resistance in high grade serous ovarian cancer.
Gynecol Oncol. 2018 Sep 4. pii: S0090-8258(18)31160.
PubMed Text format Abstract available

SIMONDS HM, Botha MH, Neugut AI, Van Der Merwe FH, et al
Five-year overall survival following chemoradiation among HIV-positive and HIV-negative patients with locally advanced cervical carcinoma in a South African cohort.
Gynecol Oncol. 2018 Sep 4. pii: S0090-8258(18)31168.
PubMed Text format Abstract available

LIU Y, Weber Z, San Lucas FA, Deshpande A, et al
Assessing inter-component heterogeneity of biphasic uterine carcinosarcomas.
Gynecol Oncol. 2018 Sep 4. pii: S0090-8258(18)31173.
PubMed Text format Abstract available

MILLS KA, Roach ST, Quinn JM, Guo L, et al
SQ1274, a novel microtubule inhibitor, inhibits ovarian and uterine cancer cell growth.
Gynecol Oncol. 2018 Sep 3. pii: S0090-8258(18)31097.
PubMed Text format Abstract available

TSENG JH, Cowan RA, Afonso AM, Zhou Q, et al
Perioperative epidural use and survival outcomes in patients undergoing primary debulking surgery for advanced ovarian cancer.
Gynecol Oncol. 2018 Sep 2. pii: S0090-8258(18)31154.
PubMed Text format Abstract available

YEN TT, Miyamoto T, Asaka S, Chui MH, et al
Loss of ARID1A expression in endometrial samplings is associated with the risk of endometrial carcinoma.
Gynecol Oncol. 2018;150:426-431.
PubMed Text format Abstract available

DE VINCENZO R, Tortorella L, Ricci C, Cavaliere AF, et al
Locally advanced cervical cancer complicating pregnancy: A case of competing risks from the Catholic University of the Sacred Heart in Rome.
Gynecol Oncol. 2018;150:398-405.
PubMed Text format Abstract available

DEL CARMEN MG, Pareja R, Melamed A, Rodriguez J, et al
Isolated para-aortic lymph node metastasis in FIGO stage IA2-IB2 carcinoma of the cervix: Revisiting the role of surgical assessment.
Gynecol Oncol. 2018;150:406-411.
PubMed Text format Abstract available

ZIEBA S, Kowalik A, Zalewski K, Rusetska N, et al
Somatic mutation profiling of vulvar cancer: Exploring therapeutic targets.
Gynecol Oncol. 2018;150:552-561.
PubMed Text format Abstract available

August 2018

TEW WP, Sill MW, Walker JL, Secord AA, et al
Randomized phase II trial of bevacizumab plus everolimus versus bevacizumab alone for recurrent or persistent ovarian, fallopian tube or peritoneal carcinoma: An NRG oncology/gynecologic oncology group study.
Gynecol Oncol. 2018 Aug 31. pii: S0090-8258(18)31157.
PubMed Text format Abstract available

SCHLAPPE BA, Weaver AL, Ducie JA, Eriksson AGZ, et al
Multicenter study comparing oncologic outcomes between two nodal assessment methods in patients with deeply invasive endometrioid endometrial carcinoma: A sentinel lymph node algorithm versus a comprehensive pelvic and paraaortic lymphadenectomy.
Gynecol Oncol. 2018 Aug 31. pii: S0090-8258(18)31152.
PubMed Text format Abstract available

BOARDMAN CH, Brady WE, Dizon DS, Kunos CA, et al
A Phase I Evaluation of Extended Field Radiation Therapy With Concomitant Cisplatin Chemotherapy Followed by Paclitaxel and Carboplatin Chemotherapy in Women With Cervical Carcinoma Metastatic to the Para-aortic Lymph Nodes: An NRG Oncology/Gynecologi
Gynecol Oncol. 2018 Aug 31. pii: S0090-8258(18)31095.
PubMed Text format Abstract available

KIM SR, Pina A, Albert A, McAlpine J, et al
Does MMR status in endometrial cancer influence response to adjuvant therapy?
Gynecol Oncol. 2018 Aug 29. pii: S0090-8258(18)31151.
PubMed Text format Abstract available

SHINDE A, Li R, Amini A, Chen YJ, et al
Improved survival with adjuvant brachytherapy in stage IA endometrial cancer of unfavorable histology.
Gynecol Oncol. 2018 Aug 28. pii: S0090-8258(18)31159.
PubMed Text format Abstract available

VAN NIEUWENHUYSEN E, Busschaert P, Neven P, Han SN, et al
The genetic landscape of 87 ovarian germ cell tumors.
Gynecol Oncol. 2018 Aug 28. pii: S0090-8258(18)31130.
PubMed Text format Abstract available

LYCKE M, Kristjansdottir B, Sundfeldt K
A multicenter clinical trial validating the performance of HE4, CA125, risk of ovarian malignancy algorithm and risk of malignancy index.
Gynecol Oncol. 2018 Aug 24. pii: S0090-8258(18)31155.
PubMed Text format Abstract available

DIOUN S, Jorgensen JR, Miller EM, Tymon-Rosario J, et al
Unplanned hospitalizations in a racially and ethnically diverse population of women receiving chemotherapy for epithelial ovarian cancer.
Gynecol Oncol. 2018 Aug 24. pii: S0090-8258(18)31150.
PubMed Text format Abstract available

YUK JS, Lee JH
Six-year survival of patients with unsuspected uterine malignancy after laparoscopic versus laparotomic myomectomy: An 11-year national retrospective cohort study.
Gynecol Oncol. 2018 Aug 24. pii: S0090-8258(18)31156.
PubMed Text format Abstract available

RAUH-HAIN JA, Brewster WR, Behbakht K
Society of Gynecologic Oncology 2018 Annual Meeting on Women's Cancer: Meeting report.
Gynecol Oncol. 2018 Aug 24. pii: S0090-8258(18)31149.
PubMed Text format

CHANG JS, Kim SW, Kim YJ, Kim JY, et al
Involved-field radiation therapy for recurrent ovarian cancer: Results of a multi-institutional prospective phase II trial.
Gynecol Oncol. 2018 Aug 24. pii: S0090-8258(18)31129.
PubMed Text format Abstract available

NISHIKIMI K, Tate S, Matsuoka A, Shozu M, et al
Resection of a metastatic bulky subphrenic tumor for the treatment of advanced ovarian cancer using liver mobilization and the Pringle maneuver.
Gynecol Oncol. 2018 Aug 20. pii: S0090-8258(18)31134.
PubMed Text format Abstract available

OLAWAIYE AB, Java JJ, Krivak TC, Friedlander M, et al
Does adjuvant chemotherapy dose modification have an impact on the outcome of patients diagnosed with advanced stage ovarian cancer? An NRG Oncology/Gynecologic Oncology Group study.
Gynecol Oncol. 2018 Aug 19. pii: S0090-8258(18)31085.
PubMed Text format Abstract available

TSENG JH, Cowan RA, Zhou Q, Iasonos A, et al
Continuous improvement in primary Debulking surgery for advanced ovarian cancer: Do increased complete gross resection rates independently lead to increased progression-free and overall survival?
Gynecol Oncol. 2018 Aug 17. pii: S0090-8258(18)31131.
PubMed Text format Abstract available

SON JH, Lee JH, Jung JA, Kong TW, et al
Risk factors for septic adverse events and their impact on survival in advanced ovarian cancer patients treated with neoadjuvant chemotherapy and interval debulking surgery.
Gynecol Oncol. 2018 Aug 16. pii: S0090-8258(18)31098.
PubMed Text format Abstract available

BARBER EL, Rossi EC, Alexander A, Bilimoria K, et al
Benign hysterectomy performed by gynecologic oncologists: Is selection bias altering our ability to measure surgical quality?
Gynecol Oncol. 2018 Aug 15. pii: S0090-8258(18)31127.
PubMed Text format Abstract available

PERES LC, Cushing-Haugen KL, Anglesio M, Wicklund K, et al
Histotype classification of ovarian carcinoma: A comparison of approaches.
Gynecol Oncol. 2018 Aug 15. pii: S0090-8258(18)31133.
PubMed Text format Abstract available

ULM MA, ElNaggar AC, Tillmanns TD
Celecoxib versus ketorolac following robotic hysterectomy for the management of postoperative pain: An open-label randomized control trial.
Gynecol Oncol. 2018 Aug 15. pii: S0090-8258(18)31132.
PubMed Text format Abstract available

CONNOR EV, Newlin EM, Jelovsek JE, AlHilli MM, et al
Predicting non-home discharge in epithelial ovarian cancer patients: External validation of a predictive model.
Gynecol Oncol. 2018 Aug 11. pii: S0090-8258(18)31128.
PubMed Text format Abstract available

BISCH SP, Wells T, Gramlich L, Faris P, et al
Enhanced Recovery After Surgery (ERAS) in gynecologic oncology: System-wide implementation and audit leads to improved value and patient outcomes.
Gynecol Oncol. 2018 Aug 9. pii: S0090-8258(18)31096.
PubMed Text format Abstract available

WINTERHOFF BJ, Maile M, Mitra AK, Sebe A, et al
Corrigendum to "Single cell sequencing reveals heterogeneity within ovarian cancer epithelium and cancer associated stromal cells" [Gyncol. Oncol. 144 (2017) 598-606].
Gynecol Oncol. 2018 Aug 7. pii: S0090-8258(18)31079.
PubMed Text format

MOORE KN, O'Malley DM, Vergote I, Martin LP, et al
Safety and activity findings from a phase 1b escalation study of mirvetuximab soravtansine, a folate receptor alpha (FRalpha)-targeting antibody-drug conjugate (ADC), in combination with carboplatin in patients with platinum-sensitive ovarian cancer.
Gynecol Oncol. 2018 Aug 6. pii: S0090-8258(18)31081.
PubMed Text format Abstract available

MALLEN A, Soong TR, Townsend MK, Wenham RM, et al
Surgical prevention strategies in ovarian cancer.
Gynecol Oncol. 2018 Aug 4. pii: S0090-8258(18)31094.
PubMed Text format Abstract available

LI A, Xie R, Zhi Q, Deng Y, et al
BRCA germline mutations in an unselected nationwide cohort of Chinese patients with ovarian cancer and healthy controls.
Gynecol Oncol. 2018 Aug 2. pii: S0090-8258(18)31088.
PubMed Text format Abstract available

WORTMAN BG, Bosse T, Nout RA, Lutgens LCHW, et al
Molecular-integrated risk profile to determine adjuvant radiotherapy in endometrial cancer: Evaluation of the pilot phase of the PORTEC-4a trial.
Gynecol Oncol. 2018 Aug 2. pii: S0090-8258(18)31084.
PubMed Text format Abstract available

PINTO MP, Balmaceda C, Bravo ML, Kato S, et al
Patient inflammatory status and CD4+/CD8+ intraepithelial tumor lymphocyte infiltration are predictors of outcomes in high-grade serous ovarian cancer.
Gynecol Oncol. 2018 Aug 2. pii: S0090-8258(18)31089.
PubMed Text format Abstract available

WILFORD J, Osann K, Hsieh S, Monk B, et al
Validation of PROMIS emotional distress short form scales for cervical cancer.
Gynecol Oncol. 2018 Aug 2. pii: S0090-8258(18)31086.
PubMed Text format Abstract available

LEE J, Gubernick LR, Brodsky AL, Fehniger JE, et al
Missed opportunities: Genetic counseling and testing among an ethnically diverse cohort of women with endometrial cancer.
Gynecol Oncol. 2018 Aug 1. pii: S0090-8258(18)31087.
PubMed Text format Abstract available

LEVINE DA
The limits of aggressive surgical cytoreduction.
Gynecol Oncol. 2018;150:205-206.
PubMed Text format

ANGELES MA, Martinez-Gomez C, Martinez A, Ferron G, et al
Laparoscopic hand-assisted Miami Pouch after pelvic exenteration in 10 steps.
Gynecol Oncol. 2018;150:389-390.
PubMed Text format Abstract available

MANNING-GEIST BL, Hicks-Courant K, Gockley AA, Clark RM, et al
Moving beyond "complete surgical resection" and "optimal": Is low-volume residual disease another option for primary debulking surgery?
Gynecol Oncol. 2018;150:233-238.
PubMed Text format Abstract available

SHAH R, Xia C, Krailo M, Amatruda JF, et al
Is carboplatin-based chemotherapy as effective as cisplatin-based chemotherapy in the treatment of advanced-stage dysgerminoma in children, adolescents and young adults?
Gynecol Oncol. 2018;150:253-260.
PubMed Text format Abstract available

July 2018

BEHBAKHT K, Cohn DE, Straughn JM Jr
Hyperthermic intraperitoneal chemotherapy (HIPEC) is cost-effective in the management of primary ovarian cancer.
Gynecol Oncol. 2018 Jul 30. pii: S0090-8258(18)31083.
PubMed Text format

SONG M, Kumaran MN, Gounder M, Gibbon DG, et al
Phase I trial of selenium plus chemotherapy in gynecologic cancers.
Gynecol Oncol. 2018 Jul 29. pii: S0090-8258(18)31014.
PubMed Text format Abstract available

VERGOTE I, von Moos R, Manso L, Van Nieuwenhuysen E, et al
Tumor Treating Fields in combination with paclitaxel in recurrent ovarian carcinoma: Results of the INNOVATE pilot study.
Gynecol Oncol. 2018 Jul 27. pii: S0090-8258(18)31082.
PubMed Text format Abstract available

MATSUO K, Blake EA, Machida H, Mandelbaum RS, et al
Incidences and risk factors of metachronous vulvar, vaginal, and anal cancers after cervical cancer diagnosis.
Gynecol Oncol. 2018 Jul 24. pii: S0090-8258(18)31080.
PubMed Text format Abstract available

MEAGHER NS, Schuster K, Voss A, Budden T, et al
Does the primary site really matter? Profiling mucinous ovarian cancers of uncertain primary origin (MO-CUP) to personalise treatment and inform the design of clinical trials.
Gynecol Oncol. 2018 Jul 24. pii: S0090-8258(18)31077.
PubMed Text format Abstract available

WEBSTER EM, Burke WM, Ware HM, Jones BA, et al
Patient reported outcomes in evaluation of chemotherapy toxicity in women with gynecologic malignancies: A pilot study.
Gynecol Oncol. 2018 Jul 20. pii: S0090-8258(18)31064.
PubMed Text format Abstract available

NISHIO S, Shimokawa M, Tasaki K, Nasu H, et al
A phase II trial of irinotecan in patients with advanced or recurrent endometrial cancer and correlation with biomarker analysis.
Gynecol Oncol. 2018 Jul 20. pii: S0090-8258(18)31078.
PubMed Text format Abstract available

CHAN JK, Gardner AB, Mann AK, Kapp DS, et al
Hospital-acquired conditions after surgery for gynecologic cancer - An analysis of 82,304 patients.
Gynecol Oncol. 2018 Jul 20. pii: S0090-8258(18)31065.
PubMed Text format Abstract available

NISHIKIMI K, Tate S, Matsuoka A, Shozu M, et al
Metastatic cardiophrenic lymph node resection following full-thickness resection of right diaphragm for advanced ovarian carcinoma.
Gynecol Oncol. 2018 Jul 19. pii: S0090-8258(18)31067.
PubMed Text format Abstract available

GREEN RW, Valentin L, Alcazar JL, Chiappa V, et al
Endometrial cancer off-line staging using two-dimensional transvaginal ultrasound and three-dimensional volume contrast imaging: Intermethod agreement, interrater reliability and diagnostic accuracy.
Gynecol Oncol. 2018 Jul 17. pii: S0090-8258(18)31009.
PubMed Text format Abstract available

BI Y, Verginadis II, Dey S, Lin L, et al
Radiosensitization by the PARP inhibitor olaparib in BRCA1-proficient and deficient high-grade serous ovarian carcinomas.
Gynecol Oncol. 2018 Jul 16. pii: S0090-8258(18)31015.
PubMed Text format Abstract available

TIWARI R, Narayanan GS, Jayakumar V, Narayanan S, et al
The promise of image-guided brachytherapy of better clinical outcomes in treatment of cervical cancer: Does it deliver? An Indian scenario.
Gynecol Oncol. 2018 Jul 14. pii: S0090-8258(18)31068.
PubMed Text format Abstract available

GALINDO LJ, Hernandez-Beeftink T, Salas A, Jung Y, et al
HMGA2 and MED12 alterations frequently co-occur in uterine leiomyomas.
Gynecol Oncol. 2018 Jul 12. pii: S0090-8258(18)31063.
PubMed Text format Abstract available

BARNARD ME, Pyden A, Rice MS, Linares M, et al
Inter-pathologist and pathology report agreement for ovarian tumor characteristics in the Nurses' Health Studies.
Gynecol Oncol. 2018 Jul 9. pii: S0090-8258(18)31016.
PubMed Text format Abstract available

TIMMERMANS M, van der Aa MA, Lalisang RI, Witteveen PO, et al
Interval between debulking surgery and adjuvant chemotherapy is associated with overall survival in patients with advanced ovarian cancer.
Gynecol Oncol. 2018 Jul 9. pii: S0090-8258(18)31017.
PubMed Text format Abstract available

DENG K, Yang C, Tan Q, Song W, et al
Sites of distant metastases and overall survival in ovarian cancer: A study of 1481 patients.
Gynecol Oncol. 2018 Jul 9. pii: S0090-8258(18)31004.
PubMed Text format Abstract available

XUE R, Cai X, Xu H, Wu S, et al
The efficacy of concurrent weekly carboplatin with radiotherapy in the treatment of cervical cancer: A meta-analysis.
Gynecol Oncol. 2018 Jul 8. pii: S0090-8258(18)31018.
PubMed Text format Abstract available

BURGER RA, Deng W, Makker V, Collins Y, et al
Phase II evaluation of dalantercept in the treatment of persistent or recurrent epithelial ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study.
Gynecol Oncol. 2018 Jul 2. pii: S0090-8258(18)30999.
PubMed Text format Abstract available

SECORD AA, Previs RA, Nixon AB
Cabozantinib in ovarian clear cell cancers: UnMET expectations.
Gynecol Oncol. 2018;150:1-2.
PubMed Text format

CIUCCI A, Ferrandina G, Mascilini F, Filippetti F, et al
Estrogen receptor beta: Potential target for therapy in adult granulosa cell tumors?
Gynecol Oncol. 2018;150:158-165.
PubMed Text format Abstract available

NALDINI A, Vizzielli G, Perrone E, Gallotta V, et al
Robotic video endoscopic inguinal lymphadenectomy (R-VEIL) for vulvar cancer with sentinel node mapping using indocyanine green and near-infrared fluorescence imaging technology.
Gynecol Oncol. 2018;150:203-204.
PubMed Text format Abstract available

MARTINEZ-GOMEZ C, Angeles MA, Martinez A, Ferron G, et al
Laparoscopic anterior pelvic exenteration in 10 steps.
Gynecol Oncol. 2018;150:201-202.
PubMed Text format

LEES BF, Stewart TP, Rash JK, Baron SR, et al
Abuse, cancer and sexual dysfunction in women: A potentially vicious cycle.
Gynecol Oncol. 2018;150:166-172.
PubMed Text format Abstract available

CHARAKORN C, Thadanipon K, Chaijindaratana S, Rattanasiri S, et al
The association between serum squamous cell carcinoma antigen and recurrence and survival of patients with cervical squamous cell carcinoma: A systematic review and meta-analysis.
Gynecol Oncol. 2018;150:190-200.
PubMed Text format Abstract available

June 2018

MEYER LA, He W, Sun CC, Zhao H, et al
Neoadjuvant chemotherapy in elderly women with ovarian cancer: Rates of use and effectiveness.
Gynecol Oncol. 2018 Jun 29. pii: S0090-8258(18)31002.
PubMed Text format Abstract available

ROGERI CD, Silveira HCS, Causin RL, Villa LL, et al
Methylation of the hsa-miR-124, SOX1, TERT, and LMX1A genes as biomarkers for precursor lesions in cervical cancer.
Gynecol Oncol. 2018 Jun 27. pii: S0090-8258(18)30990.
PubMed Text format Abstract available

ZHANG XS, Zhang YM, Li B, Fan B, et al
Risk reduction of endometrial and ovarian cancer after bisphosphonates use: A meta-analysis.
Gynecol Oncol. 2018 Jun 27. pii: S0090-8258(18)30988.
PubMed Text format Abstract available

VERDOODT F, Dehlendorff C, Friis S, Kjaer SK, et al
Non-aspirin NSAID use and ovarian cancer mortality.
Gynecol Oncol. 2018 Jun 27. pii: S0090-8258(18)31000.
PubMed Text format Abstract available

LEATH CA 3RD, Monk BJ
Twenty-first century cervical cancer management: A historical perspective of the gynecologic oncology group/NRG oncology over the past twenty years.
Gynecol Oncol. 2018 Jun 26. pii: S0090-8258(18)31005.
PubMed Text format Abstract available

GOCKLEY AA, Kolin DL, Awtrey CS, Lindeman NI, et al
Durable response in a woman with recurrent low-grade endometrioid endometrial cancer and a germline BRCA2 mutation treated with a PARP inhibitor.
Gynecol Oncol. 2018 Jun 21. pii: S0090-8258(18)30937.
PubMed Text format Abstract available

RAUH LA, Saks EJ, Nakad-Rodriguez D, Showalter TN, et al
Cervical cancer care in rural Virginia: The impact of distance from an academic medical center on outcomes & the role of non-specialized radiation centers.
Gynecol Oncol. 2018 Jun 20. pii: S0090-8258(18)31001.
PubMed Text format Abstract available

NIEVES-NEIRA W, Kim JJ, Matei D
Hormonal strategies in gynecologic cancer: Bridging biology and therapy.
Gynecol Oncol. 2018 Jun 20. pii: S0090-8258(18)30947.
PubMed Text format

GEBHARDT BJ, Vargo JA, Kim H, Houser CJ, et al
Image-based multichannel vaginal cylinder brachytherapy for the definitive treatment of gynecologic malignancies in the vagina.
Gynecol Oncol. 2018 Jun 18. pii: S0090-8258(18)30987.
PubMed Text format Abstract available

ROSS MS, Burriss ME, Winger DG, Edwards RP, et al
Unplanned postoperative intensive care unit admission for ovarian cancer cytoreduction is associated with significant decrease in overall survival.
Gynecol Oncol. 2018 Jun 18. pii: S0090-8258(18)30984.
PubMed Text format Abstract available

CLARK RM, Rice LW, Del Carmen MG
Thirty-day unplanned hospital readmission in ovarian cancer patients undergoing primary or interval cytoreductive surgery: systematic literature review.
Gynecol Oncol. 2018 Jun 18. pii: S0090-8258(18)30985.
PubMed Text format Abstract available

URBAN RR, Pappas TC, Bullock RG, Munroe DG, et al
Combined symptom index and second-generation multivariate biomarker test for prediction of ovarian cancer in patients with an adnexal mass.
Gynecol Oncol. 2018 Jun 18. pii: S0090-8258(18)30946.
PubMed Text format Abstract available

TORRES D, Wang C, Kumar A, Bakkum-Gamez JN, et al
Factors that influence survival in high-grade serous ovarian cancer: A complex relationship between molecular subtype, disease dissemination, and operability.
Gynecol Oncol. 2018 Jun 17. pii: S0090-8258(18)30944.
PubMed Text format Abstract available

CHAN JK, Brady W, Monk BJ, Brown J, et al
A phase II evaluation of sunitinib in the treatment of persistent or recurrent clear cell ovarian carcinoma: An NRG Oncology/Gynecologic Oncology Group Study (GOG-254).
Gynecol Oncol. 2018 Jun 16. pii: S0090-8258(18)30941.
PubMed Text format Abstract available

LI N, Zhan X, Zhan X
The lncRNA SNHG3 regulates energy metabolism of ovarian cancer by an analysis of mitochondrial proteomes.
Gynecol Oncol. 2018 Jun 16. pii: S0090-8258(18)30989.
PubMed Text format Abstract available

BODY N, Gregoire J, Renaud MC, Sebastianelli A, et al
Tips and tricks to improve sentinel lymph node mapping with Indocyanin green in endometrial cancer.
Gynecol Oncol. 2018 Jun 14. pii: S0090-8258(18)30943.
PubMed Text format Abstract available

GRAETZ I, Anderson JN, McKillop CN, Stepanski EJ, et al
Use of a web-based app to improve postoperative outcomes for patients receiving gynecological oncology care: A randomized controlled feasibility trial.
Gynecol Oncol. 2018 Jun 11. pii: S0090-8258(18)30983.
PubMed Text format Abstract available

BOLZE PA, Mathe M, Hajri T, You B, et al
First-line hysterectomy for women with low-risk non-metastatic gestational trophoblastic neoplasia no longer wishing to conceive.
Gynecol Oncol. 2018 Jun 8. pii: S0090-8258(18)30942.
PubMed Text format Abstract available

MICHAEL STRAUGHN J JR, Boitano T, Smith HJ, Dilley SE, et al
Treatment of low-grade endometrial stromal sarcoma in a nulligravid woman.
Gynecol Oncol. 2018 Jun 7. pii: S0090-8258(18)30923.
PubMed Text format Abstract available

BUDA A, Gasparri ML, Puppo A, Mereu L, et al
Lymph node evaluation in high-risk early stage endometrial cancer: A multi-institutional retrospective analysis comparing the sentinel lymph node (SLN) algorithm and SLN with selective lymphadenectomy.
Gynecol Oncol. 2018 Jun 7. pii: S0090-8258(18)30945.
PubMed Text format Abstract available

WOOLDERINK JM, De Bock GH, de Hullu JA, Hollema H, et al
Characteristics of Lynch syndrome associated ovarian cancer.
Gynecol Oncol. 2018 Jun 4. pii: S0090-8258(18)30240.
PubMed Text format Abstract available

STOLER MH, Wright TC Jr, Parvu V, Vaughan L, et al
The Onclarity Human Papillomavirus Trial: Design, methods, and baseline results.
Gynecol Oncol. 2018;149:498-505.
PubMed Text format Abstract available

May 2018

STOLNICU S, Barsan I, Hoang L, Patel P, et al
Stromal invasion pattern identifies patients at lowest risk of lymph node metastasis in HPV-associated endocervical adenocarcinomas, but is irrelevant in adenocarcinomas unassociated with HPV.
Gynecol Oncol. 2018 May 30. pii: S0090-8258(18)30848.
PubMed Text format Abstract available

AREND RC, Jones BA, Martinez A, Goodfellow P, et al
Endometrial cancer: Molecular markers and management of advanced stage disease.
Gynecol Oncol. 2018 May 27. pii: S0090-8258(18)30902.
PubMed Text format Abstract available

LINDEMANN K, Gao B, Mapagu C, Fereday S, et al
Response rates to second-line platinum-based therapy in ovarian cancer patients challenge the clinical definition of platinum resistance.
Gynecol Oncol. 2018 May 25. pii: S0090-8258(18)30907.
PubMed Text format Abstract available

GIANNOPOULOU L, Mastoraki S, Buderath P, Strati A, et al
ESR1 methylation in primary tumors and paired circulating tumor DNA of patients with high-grade serous ovarian cancer.
Gynecol Oncol. 2018 May 25. pii: S0090-8258(18)30922.
PubMed Text format Abstract available

YAGUR Y, Weitzner O, Gemer O, Lavie O, et al
Postoperative radiation rates in stage IIA1 cervical cancer: Is surgical treatment justified? An Israeli Gynecologic Oncology Group Study.
Gynecol Oncol. 2018 May 25. pii: S0090-8258(18)30903.
PubMed Text format Abstract available

AHMED A, Deng W, Tew W, Bender D, et al
Pre-operative assessment and post-operative outcomes of elderly women with gynecologic cancers, primary analysis of NRG CC-002: An NRG oncology group/gynecologic oncology group study.
Gynecol Oncol. 2018 May 25. pii: S0090-8258(18)30909.
PubMed Text format Abstract available

SALVO G, Frumovitz M, Pareja R, Lee J, et al
Simple trachelectomy with pelvic lymphadenectomy as a viable treatment option in pregnant patients with stage IB1 (>/=2cm) cervical cancer: Bridging the gap to fetal viability.
Gynecol Oncol. 2018 May 24. pii: S0090-8258(18)30908.
PubMed Text format Abstract available

AGHAJANIAN C, Filiaci V, Dizon DS, Carlson JW, et al
A phase II study of frontline paclitaxel/carboplatin/bevacizumab, paclitaxel/carboplatin/temsirolimus, or ixabepilone/carboplatin/bevacizumab in advanced/recurrent endometrial cancer.
Gynecol Oncol. 2018 May 24. pii: S0090-8258(18)30905.
PubMed Text format Abstract available

BAIOCCHI G, Mantoan H, Chen MJ, Faloppa CC, et al
Uterine transposition after radical trachelectomy.
Gynecol Oncol. 2018 May 23. pii: S0090-8258(18)30896.
PubMed Text format

MAYOR P, Starbuck K, Zsiros E
Adoptive cell transfer using autologous tumor infiltrating lymphocytes in gynecologic malignancies.
Gynecol Oncol. 2018 May 23. pii: S0090-8258(18)30920.
PubMed Text format Abstract available

KALAMPOKAS E, Payne F, Gurumurthy M
An update on the use of immunohistochemistry and molecular pathology in the diagnosis of pre-invasive and malignant lesions in gynecological oncology.
Gynecol Oncol. 2018 May 21. pii: S0090-8258(18)30910.
PubMed Text format Abstract available

MUELLER JJ, Schlappe BA, Kumar R, Olvera N, et al
Massively parallel sequencing analysis of mucinous ovarian carcinomas: genomic profiling and differential diagnoses.
Gynecol Oncol. 2018 May 21. pii: S0090-8258(18)30895.
PubMed Text format Abstract available

KOTSOPOULOS J, Gronwald J, Karlan B, Rosen B, et al
Age-specific ovarian cancer risks among women with a BRCA1 or BRCA2 mutation.
Gynecol Oncol. 2018 May 21. pii: S0090-8258(18)30898.
PubMed Text format Abstract available

VON GRUENIGEN VE, Huang HQ, Cella D, Zevon M, et al
Quality of life, symptoms and care needs in patients with persistent or recurrent platinum-resistant ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study.
Gynecol Oncol. 2018 May 17. pii: S0090-8258(18)30904.
PubMed Text format Abstract available

ROLSTON A, Spencer RJ, Kevin Reynolds R, Rice LW, et al
Factors associated with outcomes and inpatient 90-day cost of care in endometrial cancer patients undergoing hysterectomy - implications for bundled care payments.
Gynecol Oncol. 2018 May 16. pii: S0090-8258(18)30897.
PubMed Text format Abstract available

PHILP L, Jembere N, Wang L, Gao J, et al
Pap tests in the diagnosis of cervical cancer: Help or hinder?
Gynecol Oncol. 2018 May 15. pii: S0090-8258(18)30906.
PubMed Text format Abstract available

O'SHEA A, McCool K, Harrison R, Sampene E, et al
Neoadjuvant chemotherapy is associated with more anemia and perioperative blood transfusions than primary debulking surgery in women with advanced stage ovarian cancer.
Gynecol Oncol. 2018 May 15. pii: S0090-8258(18)30901.
PubMed Text format Abstract available

TSENG JH, Aloisi A, Sonoda Y, Gardner GJ, et al
Less versus more radical surgery in stage IB1 cervical cancer: A population-based study of long-term survival.
Gynecol Oncol. 2018 May 15. pii: S0090-8258(18)30849.
PubMed Text format Abstract available

FELIX AS, Sinnott JA, Vetter MH, Rhoades J, et al
Detection of endometrial cancer cells in the fallopian tube lumen is associated with adverse prognostic factors and reduced survival.
Gynecol Oncol. 2018 May 10. pii: S0090-8258(18)30893.
PubMed Text format Abstract available

RUSCITO I, Darb-Esfahani S, Kulbe H, Bellati F, et al
The prognostic impact of cancer stem-like cell biomarker aldehyde dehydrogenase-1 (ALDH1) in ovarian cancer: A meta-analysis.
Gynecol Oncol. 2018 May 10. pii: S0090-8258(18)30892.
PubMed Text format Abstract available

NASIOUDIS D, Mastroyannis SA, Albright BB, Haggerty AF, et al
Adjuvant chemotherapy for stage I ovarian clear cell carcinoma: Patterns of use and outcomes.
Gynecol Oncol. 2018 May 8. pii: S0090-8258(18)30845.
PubMed Text format Abstract available

DAVIS M, Strickland K, Easter SR, Worley M Jr, et al
The impact of health insurance status on the stage of cervical cancer diagnosis at a tertiary care center in Massachusetts.
Gynecol Oncol. 2018 May 8. pii: S0090-8258(18)30887.
PubMed Text format Abstract available

BAERT T, Van Camp J, Vanbrabant L, Busschaert P, et al
Influence of CA125, platelet count and neutrophil to lymphocyte ratio on the immune system of ovarian cancer patients.
Gynecol Oncol. 2018 May 8. pii: S0090-8258(18)30891.
PubMed Text format Abstract available

YI Y, Bryce CL, Adambekov S, Edwards RP, et al
Cost-effectiveness analysis of biopsy strategies for endometrial cancer diagnosis in women with postmenopausal bleeding: Pipelle sampling curette versus dilatation & curettage.
Gynecol Oncol. 2018 May 7. pii: S0090-8258(18)30843.
PubMed Text format Abstract available

TEMPFER CB, Giger-Pabst U, Seebacher V, Petersen M, et al
A phase I, single-arm, open-label, dose escalation study of intraperitoneal cisplatin and doxorubicin in patients with recurrent ovarian cancer and peritoneal carcinomatosis.
Gynecol Oncol. 2018 May 6. pii: S0090-8258(18)30851.
PubMed Text format Abstract available

KONSTANTINOPOULOS PA, Brady WE, Farley J, Armstrong A, et al
Phase II study of single-agent cabozantinib in patients with recurrent clear cell ovarian, primary peritoneal or fallopian tube cancer (NRG-GY001).
Gynecol Oncol. 2018 May 5. pii: S0090-8258(18)30850.
PubMed Text format Abstract available

NEBGEN DR, Hurteau J, Holman LL, Bradford A, et al
Bilateral salpingectomy with delayed oophorectomy for ovarian cancer risk reduction: A pilot study in women with BRCA1/2 mutations.
Gynecol Oncol. 2018 May 4. pii: S0090-8258(18)30842.
PubMed Text format Abstract available

RICE LW
Expanding the pipeline. The 2018 Society of Gynecologic Oncology presidential address. Sunday, March 25, 2018. By Laurel W. Rice, MD. 2017-2018 SGO president.
Gynecol Oncol. 2018 May 2. pii: S0090-8258(18)30837.
PubMed Text format

TRIMBLE CL
Towards identifying new therapeutic targets in cancers attributable to HPV.
Gynecol Oncol. 2018;149:225-226.
PubMed Text format

HINTEN F, Molijn A, Eckhardt L, Massuger LFAG, et al
Vulvar cancer: Two pathways with different localization and prognosis.
Gynecol Oncol. 2018;149:310-317.
PubMed Text format Abstract available

April 2018

NISKAKOSKI A, Pasanen A, Porkka N, Eldfors S, et al
Converging endometrial and ovarian tumorigenesis in Lynch syndrome: Shared origin of synchronous carcinomas.
Gynecol Oncol. 2018 Apr 28. pii: S0090-8258(18)30844.
PubMed Text format Abstract available

MAYADEV J, Klapheke A, Yashar C, Hsu IC, et al
Underutilization of brachytherapy and disparities in survival for patients with cervical cancer in California.
Gynecol Oncol. 2018 Apr 27. pii: S0090-8258(18)30841.
PubMed Text format Abstract available

NAGLE CM, Crosbie EJ, Brand A, Obermair A, et al
The association between diabetes, comorbidities, body mass index and all-cause and cause-specific mortality among women with endometrial cancer.
Gynecol Oncol. 2018 Apr 26. pii: S0090-8258(18)30283.
PubMed Text format Abstract available

BROWN J, Naumann RW, Brady WE, Coleman RL, et al
Clinical trial methodology in rare gynecologic tumor research: Strategies for success.
Gynecol Oncol. 2018 Apr 23. pii: S0090-8258(18)30285.
PubMed Text format Abstract available

WANG J, Garbutt C, Ma H, Gao P, et al
Expression and role of autophagy-associated p62 (SQSTM1) in multidrug resistant ovarian cancer.
Gynecol Oncol. 2018 Apr 23. pii: S0090-8258(18)30835.
PubMed Text format Abstract available

ROSSI A, Frechette L, Miller D, Miller E, et al
Acceptability and feasibility of a Fitbit physical activity monitor for endometrial cancer survivors.
Gynecol Oncol. 2018 Apr 21. pii: S0090-8258(18)30838.
PubMed Text format Abstract available

FERGUSON SE, Panzarella T, Lau S, Gien LT, et al
Prospective cohort study comparing quality of life and sexual health outcomes between women undergoing robotic, laparoscopic and open surgery for endometrial cancer.
Gynecol Oncol. 2018 Apr 19. pii: S0090-8258(18)30836.
PubMed Text format Abstract available

EL-ZEIN M, Bouten S, Louvanto K, Gilbert L, et al
Validation of a new HPV self-sampling device for cervical cancer screening: The Cervical and Self-Sample In Screening (CASSIS) study.
Gynecol Oncol. 2018 Apr 17. pii: S0090-8258(18)30274.
PubMed Text format Abstract available

MATODA M, Takeshima N, Michimae H, Iwata T, et al
Postoperative chemotherapy for node-positive cervical cancer: Results of a multicenter phase II trial (JGOG1067).
Gynecol Oncol. 2018 Apr 13. pii: S0090-8258(18)30286.
PubMed Text format Abstract available

BERGSTROM JE, Scott ME, Alimi Y, Yen TT, et al
Narcotics reduction, quality and safety in gynecologic oncology surgery in the first year of enhanced recovery after surgery protocol implementation.
Gynecol Oncol. 2018 Apr 13. pii: S0090-8258(18)30273.
PubMed Text format Abstract available

CHAPEL DB, Yamada SD, Cowan M, Lastra RR, et al
Immunohistochemistry for mismatch repair protein deficiency in endometrioid endometrial carcinoma yields equivalent results when performed on endometrial biopsy/curettage or hysterectomy specimens.
Gynecol Oncol. 2018 Apr 13. pii: S0090-8258(18)30282.
PubMed Text format Abstract available

JIANG F, Wan XR, Xu T, Feng FZ, et al
Evaluation and suggestions for improving the FIGO 2000 staging criteria for gestational trophoblastic neoplasia: A ten-year review of 1420 patients.
Gynecol Oncol. 2018 Apr 10. pii: S0090-8258(18)30271.
PubMed Text format Abstract available

UYAR D, Neary J, Monroe A, Nugent M, et al
Implementation of a quality improvement project for universal genetic testing in women with ovarian cancer.
Gynecol Oncol. 2018 Apr 10. pii: S0090-8258(18)30239.
PubMed Text format Abstract available

LIU J, Nicum S, Reichardt P, Croitoru K, et al
Assessment and management of diarrhea following VEGF receptor TKI treatment in patients with ovarian cancer.
Gynecol Oncol. 2018 Apr 4. pii: S0090-8258(18)30238.
PubMed Text format Abstract available

ARMBRUSTER SD, Sun CC, Westin SN, Bodurka DC, et al
Prospective assessment of patient-reported outcomes in gynecologic cancer patients before and after pelvic exenteration.
Gynecol Oncol. 2018 Apr 2. pii: S0090-8258(18)30234.
PubMed Text format Abstract available

DOCKERY LE, Motwani A, Ding K, Doescher M, et al
Improving cancer care for American Indians with cervical cancer in the Indian Health Service (IHS) system - Navigation may not be enough.
Gynecol Oncol. 2018;149:89-92.
PubMed Text format Abstract available

MANRRIQUEZ E, Chapman JS, Mak J, Blanco AM, et al
Disparities in genetics assessment for women with ovarian cancer: Can we do better?
Gynecol Oncol. 2018;149:84-88.
PubMed Text format Abstract available

DOLL KM
Investigating Black-White disparities in gynecologic oncology: Theories, conceptual models, and applications.
Gynecol Oncol. 2018;149:78-83.
PubMed Text format Abstract available

TEMKIN SM, Rimel BJ, Bruegl AS, Gunderson CC, et al
A contemporary framework of health equity applied to gynecologic cancer care: A Society of Gynecologic Oncology evidenced-based review.
Gynecol Oncol. 2018;149:70-77.
PubMed Text format Abstract available

HAGOPIAN GS, Lieber M, Dottino PR, Margaret Kemeny M, et al
The impact of nativity on cervical cancer survival in the public hospital system of Queens, New York.
Gynecol Oncol. 2018;149:63-69.
PubMed Text format Abstract available

RAMEY SJ, Asher D, Kwon D, Ahmed AA, et al
Delays in definitive cervical cancer treatment: An analysis of disparities and overall survival impact.
Gynecol Oncol. 2018;149:53-62.
PubMed Text format Abstract available

DILLEY S, Erickson BK, Phillips CE, Kennemer CR, et al
Do differences in medical comorbidities and treatment impact racial disparities in epithelial ovarian cancer?
Gynecol Oncol. 2018;149:49-52.
PubMed Text format Abstract available

COWAN RA, Tseng J, Ali N, Dearie H, et al
Exploring the impact of income and race on survival for women with advanced ovarian cancer undergoing primary debulking surgery at a high-volume center.
Gynecol Oncol. 2018;149:43-48.
PubMed Text format Abstract available

RAUH-HAIN JA, Melamed A, Schaps D, Bregar AJ, et al
Racial and ethnic disparities over time in the treatment and mortality of women with gynecological malignancies.
Gynecol Oncol. 2018;149:4-11.
PubMed Text format Abstract available

LEE J, Gerber D, Aphinyanaphongs Y, Curtin JP, et al
Laparoscopy decreases the disparity in postoperative complications between black and white women after hysterectomy for endometrial cancer.
Gynecol Oncol. 2018;149:22-27.
PubMed Text format Abstract available

DUBIL EA, Tian C, Wang G, Tarney CM, et al
Racial disparities in molecular subtypes of endometrial cancer.
Gynecol Oncol. 2018;149:106-116.
PubMed Text format Abstract available

STAPLES JN, Wong MS, Rimel BJ
An educational intervention to improve human papilloma virus (HPV) and cervical cancer knowledge among African American college students.
Gynecol Oncol. 2018;149:101-105.
PubMed Text format Abstract available

DEL CARMEN MG, Rice LW
Towards the elimination of health care disparities in gynecologic oncology: Call to action.
Gynecol Oncol. 2018;149:1-3.
PubMed Text format

MAO X, Qin X, Li L, Zhou J, et al
A 15-long non-coding RNA signature to improve prognosis prediction of cervical squamous cell carcinoma.
Gynecol Oncol. 2018;149:181-187.
PubMed Text format Abstract available

MOORE KN, Mirza MR, Matulonis UA
The poly (ADP ribose) polymerase inhibitor niraparib: Management of toxicities.
Gynecol Oncol. 2018;149:214-220.
PubMed Text format Abstract available

March 2018

BONHOF CS, Mols F, Vos MC, Pijnenborg JMA, et al
Course of chemotherapy-induced peripheral neuropathy and its impact on health-related quality of life among ovarian cancer patients: A longitudinal study.
Gynecol Oncol. 2018 Mar 28. pii: S0090-8258(18)30232.
PubMed Text format Abstract available

WU H, Zhang J
Decreased expression of TFAP2B in endometrial cancer predicts poor prognosis: A study based on TCGA data.
Gynecol Oncol. 2018 Mar 28. pii: S0090-8258(18)30237.
PubMed Text format Abstract available

CUNNINGHAM-ERVES J, Forbes L, Ivankova N, Mayo-Gamble T, et al
Black mother's intention to vaccinate daughters against HPV: A mixed methods approach to identify opportunities for targeted communication.
Gynecol Oncol. 2018 Mar 24. pii: S0090-8258(18)30219.
PubMed Text format Abstract available

MATSUOKA A, Tate S, Nishikimi K, Shozu M, et al
Efficacy of soft coagulation in retroperitoneal lymphadenectomy for ovarian cancer.
Gynecol Oncol. 2018 Mar 21. pii: S0090-8258(18)30231.
PubMed Text format

LONG J, Zhu JY, Liu YB, Fu K, et al
Helicase POLQ-like (HELQ) as a novel indicator of platinum-based chemoresistance for epithelial ovarian cancer.
Gynecol Oncol. 2018 Mar 20. pii: S0090-8258(18)30176.
PubMed Text format Abstract available

CHEN L, Luan S, Xia B, Liu Y, et al
Integrated analysis of HPV-mediated immune alterations in cervical cancer.
Gynecol Oncol. 2018 Mar 20. pii: S0090-8258(18)30070.
PubMed Text format Abstract available

KIM J, Kim S, Lee HS, Yang W, et al
Prognostic implication of programmed cell death 1 protein and its ligand expressions in endometrial cancer.
Gynecol Oncol. 2018 Mar 20. pii: S0090-8258(18)30132.
PubMed Text format Abstract available

MCDONALD JF
Back to the future - The integration of big data with machine learning is re-establishing the importance of predictive correlations in ovarian cancer diagnostics and therapeutics.
Gynecol Oncol. 2018 Mar 20. pii: S0090-8258(18)30233.
PubMed Text format

HAN C, Bellone S, Siegel ER, Altwerger G, et al
A novel multiple biomarker panel for the early detection of high-grade serous ovarian carcinoma.
Gynecol Oncol. 2018 Mar 20. pii: S0090-8258(18)30230.
PubMed Text format Abstract available

WILSON AJ, Stubbs M, Liu P, Ruggeri B, et al
The BET inhibitor INCB054329 reduces homologous recombination efficiency and augments PARP inhibitor activity in ovarian cancer.
Gynecol Oncol. 2018 Mar 20. pii: S0090-8258(18)30229.
PubMed Text format Abstract available

AGRAWAL S, Chen L, Tergas AI, Hou JY, et al
Identifying modifiable and non-modifiable risk factors associated with prolonged length of stay after hysterectomy for uterine cancer.
Gynecol Oncol. 2018 Mar 17. pii: S0090-8258(18)30220.
PubMed Text format Abstract available

VENIGALLA S, Chowdhry AK, Shalowitz DI
Survival implications of staging lymphadenectomy for non-endometrioid endometrial cancers.
Gynecol Oncol. 2018 Mar 17. pii: S0090-8258(18)30218.
PubMed Text format Abstract available

IDAHL A, Hermansson A, Lalos A
Social support and ovarian cancer incidence - A Swedish prospective population-based study.
Gynecol Oncol. 2018 Mar 17. pii: S0090-8258(18)30214.
PubMed Text format Abstract available

CARLTON AL, Illendula A, Gao Y, Llaneza DC, et al
Small molecule inhibition of the CBFbeta/RUNX interaction decreases ovarian cancer growth and migration through alterations in genes related to epithelial-to-mesenchymal transition.
Gynecol Oncol. 2018 Mar 15. pii: S0090-8258(18)30174.
PubMed Text format Abstract available

ESKANDER RN, Kauderer J, Tewari KS, Mannel RS, et al
Correlation between Surgeon's assessment and radiographic evaluation of residual disease in women with advanced stage ovarian cancer reported to have undergone optimal surgical cytoreduction: An NRG Oncology/Gynecologic Oncology Group study.
Gynecol Oncol. 2018 Mar 14. pii: S0090-8258(18)30216.
PubMed Text format Abstract available

TORTORELLA L, Langstraat CL, Weaver AL, McGree ME, et al
Uterine serous carcinoma: Reassessing effectiveness of platinum-based adjuvant therapy.
Gynecol Oncol. 2018 Mar 14. pii: S0090-8258(18)30141.
PubMed Text format Abstract available

UCCELLA S, Mele MC, Quagliozzi L, Rinninella E, et al
Assessment of preoperative nutritional status using BIA-derived phase angle (PhA) in patients with advanced ovarian cancer: Correlation with the extent of cytoreduction and complications.
Gynecol Oncol. 2018 Mar 14. pii: S0090-8258(18)30215.
PubMed Text format Abstract available

BRUCE SF, Carr DN, Burton ER, Sorosky JI, et al
Implementation of an abdominal closure bundle to reduce surgical site infection in patients on a gynecologic oncology service undergoing exploratory laparotomy.
Gynecol Oncol. 2018 Mar 14. pii: S0090-8258(18)30217.
PubMed Text format Abstract available

KO EM, Havrilesky LJ, Alvarez RD, Zivanovic O, et al
Society of Gynecologic Oncology Future of Physician Payment Reform Task Force report: The Endometrial Cancer Alternative Payment Model (ECAP).
Gynecol Oncol. 2018 Mar 12. pii: S0090-8258(18)30130.
PubMed Text format Abstract available

RAMZAN AA, Fischer S, Buss MK, Urban RR, et al
Opioid use in gynecologic oncology in the age of the opioid epidemic: Part II - Balancing safety & accessibility.
Gynecol Oncol. 2018 Mar 12. pii: S0090-8258(18)30127.
PubMed Text format Abstract available

QU XM, Velker VM, Leung E, Kwon JS, et al
The role of adjuvant therapy in stage IA serous and clear cell uterine cancer: A multi-institutional pooled analysis.
Gynecol Oncol. 2018 Mar 12. pii: S0090-8258(18)30172.
PubMed Text format Abstract available

PRZYBYL J, Kidzinski L, Hastie T, Debiec-Rychter M, et al
Gene expression profiling of low-grade endometrial stromal sarcoma indicates fusion protein-mediated activation of the Wnt signaling pathway.
Gynecol Oncol. 2018 Mar 12. pii: S0090-8258(18)30177.
PubMed Text format Abstract available

MATSUO K, Yabuno A, Hom MS, Shida M, et al
Significance of abnormal peritoneal cytology on survival of women with stage I-II endometrioid endometrial cancer.
Gynecol Oncol. 2018 Mar 12. pii: S0090-8258(18)30131.
PubMed Text format Abstract available

STEWART LE, Beck TL, Giannakopoulos NV, Rendi MH, et al
Impact of oophorectomy and hormone suppression in low grade endometrial stromal sarcoma: A multicenter review.
Gynecol Oncol. 2018 Mar 11. pii: S0090-8258(18)30180.
PubMed Text format Abstract available

YI L, Zhang H, Zou J, Luo P, et al
Adjuvant chemoradiotherapy versus radiotherapy alone in high-risk endometrial cancer: A systematic review and meta-analysis.
Gynecol Oncol. 2018 Mar 9. pii: S0090-8258(18)30175.
PubMed Text format Abstract available

GOSTNER JM, Obermayr E, Braicu IE, Concin N, et al
Immunobiochemical pathways of neopterin formation and tryptophan breakdown via indoleamine 2,3-dioxygenase correlate with circulating tumor cells in ovarian cancer patients- A study of the OVCAD consortium.
Gynecol Oncol. 2018 Mar 9. pii: S0090-8258(18)30139.
PubMed Text format Abstract available

VON GRUENIGEN VE, Karlan BY
Sexual harassment in the work place: Its impact on gynecologic oncology and women's health.
Gynecol Oncol. 2018 Mar 8. pii: S0090-8258(18)30137.
PubMed Text format Abstract available

SCHORGE JO, Bregar AJ, Durfee J, Berkowitz RS, et al
Meigs to modern times: The evolution of debulking surgery in advanced ovarian cancer.
Gynecol Oncol. 2018 Mar 7. pii: S0090-8258(18)30142.
PubMed Text format Abstract available

SCHUURMAN MS, Kruitwagen RFPM, Portielje JEA, Roes EM, et al
Treatment and outcome of elderly patients with advanced stage ovarian cancer: A nationwide analysis.
Gynecol Oncol. 2018 Mar 4. pii: S0090-8258(18)30136.
PubMed Text format Abstract available

LIAO CI, Chow S, Chen LM, Kapp DS, et al
Trends in the incidence of serous fallopian tube, ovarian, and peritoneal cancer in the US.
Gynecol Oncol. 2018 Mar 4. pii: S0090-8258(18)30069.
PubMed Text format Abstract available

KANAO H, Aoki Y, Hisa T, Takeshima N, et al
Laparoscopic laterally extended endopelvic resection (LEER) for cervical carcinoma recurring at the pelvic sidewall after concurrent chemoradiotherapy: Our experience in three cases.
Gynecol Oncol. 2018 Mar 3. pii: S0090-8258(18)30112.
PubMed Text format Abstract available

BUSKWOFIE A, Huang Y, Tergas AI, Hou JY, et al
Impact of hospital volume on racial disparities and outcomes for endometrial cancer.
Gynecol Oncol. 2018 Mar 2. pii: S0090-8258(18)30138.
PubMed Text format Abstract available

HARKENRIDER MM, Altoos B, Small W Jr.
Prognostic significance of residual lymph node status after definitive chemoradiotherapy in patients with node-positive cervical cancer.
Gynecol Oncol. 2018;148:437-438.
PubMed Text format

MINION LE, Tewari KS
Cervical cancer - State of the science: From angiogenesis blockade to checkpoint inhibition.
Gynecol Oncol. 2018;148:609-621.
PubMed Text format Abstract available

POWELL CB, Alabaster A, Stoller N, Armstrong MA, et al
Bone loss in women with BRCA1 and BRCA2 mutations.
Gynecol Oncol. 2018;148:535-539.
PubMed Text format Abstract available

STECKLEIN SR, Frumovitz M, Klopp AH, Gunther JR, et al
Effectiveness of definitive radiotherapy for squamous cell carcinoma of the vulva with gross inguinal lymphadenopathy.
Gynecol Oncol. 2018;148:474-479.
PubMed Text format Abstract available

FILIPPOV-LEVY N, Cohen-Schussheim H, Trope CG, Hetland Falkenthal TE, et al
Expression and clinical role of long non-coding RNA in high-grade serous carcinoma.
Gynecol Oncol. 2018;148:559-566.
PubMed Text format Abstract available

TE GROOTENHUIS NC, Pouwer AW, de Bock GH, Hollema H, et al
Prognostic factors for local recurrence of squamous cell carcinoma of the vulva: A systematic review.
Gynecol Oncol. 2018;148:622-631.
PubMed Text format Abstract available

February 2018

XIAO X, Dong D, He W, Song L, et al
Mismatch repair deficiency is associated with MSI phenotype, increased tumor-infiltrating lymphocytes and PD-L1 expression in immune cells in ovarian cancer.
Gynecol Oncol. 2018 Feb 26. pii: S0090-8258(18)30128.
PubMed Text format Abstract available

WRIGHT JD, Havrilesky LJ, Cohn DE, Huang Y, et al
Estimating potential for savings for low risk endometrial cancer using the Endometrial Cancer Alternative Payment Model (ECAP): A companion paper to the Society of Gynecologic Oncology Report on the Endometrial Cancer Alternative Payment Model.
Gynecol Oncol. 2018 Feb 26. pii: S0090-8258(18)30129.
PubMed Text format Abstract available

WEAVER DT, Raphel TJ, Melamed A, Rauh-Hain JA, et al
Modeling treatment outcomes for patients with advanced ovarian cancer: Projected benefits of a test to optimize treatment selection.
Gynecol Oncol. 2018 Feb 24. pii: S0090-8258(18)30126.
PubMed Text format Abstract available

HUVILA J, Laajala TD, Edqvist PH, Mardinoglu A, et al
Combined ASRGL1 and p53 immunohistochemistry as an independent predictor of survival in endometrioid endometrial carcinoma.
Gynecol Oncol. 2018 Feb 24. pii: S0090-8258(18)30135.
PubMed Text format Abstract available

BARRINGTON DA, Champion ML, Boitano TKL, Walters-Haygood CL, et al
Characteristics of African American women at high-risk for ovarian cancer in the southeast: Results from a Gynecologic Cancer Risk Assessment Clinic.
Gynecol Oncol. 2018 Feb 24. pii: S0090-8258(18)30133.
PubMed Text format Abstract available

JAREID M, Thalabard JC, Aarflot M, Bovelstad HM, et al
Levonorgestrel-releasing intrauterine system use is associated with a decreased risk of ovarian and endometrial cancer, without increased risk of breast cancer. Results from the NOWAC Study.
Gynecol Oncol. 2018 Feb 23. pii: S0090-8258(18)30125.
PubMed Text format Abstract available

PAREJA R, Echeverri L, Rendon G, Munsell M, et al
Radical parametrectomy after 'cut-through' hysterectomy in low-risk early-stage cervical cancer: Time to consider this procedure obsolete.
Gynecol Oncol. 2018 Feb 23. pii: S0090-8258(18)30134.
PubMed Text format Abstract available

LHEUREUX S, McCourt C, Rimel BJ, Duska L, et al
Moving forward with actionable therapeutic targets and opportunities in endometrial cancer: A NCI clinical trials planning meeting report.
Gynecol Oncol. 2018 Feb 21. pii: S0090-8258(18)30124.
PubMed Text format Abstract available

LEFKOWITS C, Buss MK, Ramzan AA, Fischer S, et al
Opioid use in gynecologic oncology in the age of the opioid epidemic: Part I - Effective opioid use across clinical settings, a society of gynecologic oncology evidence-based review.
Gynecol Oncol. 2018 Feb 20. pii: S0090-8258(18)30066.
PubMed Text format Abstract available

KELLENBERGER LD, Petrik J
Hyperglycemia promotes insulin-independent ovarian tumor growth.
Gynecol Oncol. 2018 Feb 17. pii: S0090-8258(18)30122.
PubMed Text format Abstract available

OZA A, Kaye S, Van Tornout J, Sessa C, et al
Phase 2 study evaluating intermittent and continuous linsitinib and weekly paclitaxel in patients with recurrent platinum resistant ovarian epithelial cancer.
Gynecol Oncol. 2018 Feb 14. pii: S0090-8258(18)30058.
PubMed Text format Abstract available

LI Y, Wu T, Wang Y, Yang L, et al
gamma-Glutamyl cyclotransferase contributes to tumor progression in high grade serous ovarian cancer by regulating epithelial-mesenchymal transition via activating PI3K/AKT/mTOR pathway.
Gynecol Oncol. 2018 Feb 8. pii: S0090-8258(18)30062.
PubMed Text format Abstract available

CRANE EK, Brown J
Early stage mucinous ovarian cancer: A review.
Gynecol Oncol. 2018 Feb 8. pii: S0090-8258(18)30074.
PubMed Text format Abstract available

DESAI P, Wallace R, Anderson ML, Howard BV, et al
An analysis of the association between statin use and risk of endometrial and ovarian cancers in the Women's Health Initiative.
Gynecol Oncol. 2018 Feb 5. pii: S0090-8258(18)30038.
PubMed Text format Abstract available

HACKER KE, Reynolds RK, Uppal S
Ongoing strategies and updates on pain management in gynecologic oncology patients.
Gynecol Oncol. 2018 Feb 3. pii: S0090-8258(18)30073.
PubMed Text format Abstract available

SWANSON CL, Kumar A, Maharaj JM, Kemppainen JL, et al
Increasing genetic counseling referral rates through bundled interventions after ovarian cancer diagnosis.
Gynecol Oncol. 2018 Feb 3. pii: S0090-8258(18)30072.
PubMed Text format Abstract available

MILLER KR, Patel JN, Zhang Q, Norris EJ, et al
HOXA4/HOXB3 gene expression signature as a biomarker of recurrence in patients with high-grade serous ovarian cancer following primary cytoreductive surgery and first-line adjuvant chemotherapy.
Gynecol Oncol. 2018 Feb 2. pii: S0090-8258(18)30061.
PubMed Text format Abstract available

THARAVICHITKUL E, Chakrabandhu S, Klunklin P, Onchan W, et al
Intermediate-term results of trans-abdominal ultrasound (TAUS)-guided brachytherapy in cervical cancer.
Gynecol Oncol. 2018 Feb 2. pii: S0090-8258(18)30047.
PubMed Text format Abstract available

STROHL AE, Lurain JR
Nonmetastatic Excised Gestational Choriocarcinoma: To Treat or Not to Treat.
Gynecol Oncol. 2018;148:237-238.
PubMed Text format

NAUMANN RW, Brown J
Ovarian cancer screening with the Risk of Ovarian Cancer Algorithm (ROCA): Good, bad, or just expensive?
Gynecol Oncol. 2018 Feb 1. pii: S0090-8258(18)30068.
PubMed Text format Abstract available

KIM SI, Lee S, Jeong CW, Kim HS, et al
Robot-assisted anterior pelvic exenteration in vulvovaginal malignant melanoma.
Gynecol Oncol. 2018;148:430-431.
PubMed Text format Abstract available

FU S, Lairson DR, Chan W, Wu CF, et al
Mean medical costs associated with vaginal and vulvar cancers for commercially insured patients in the United States and Texas.
Gynecol Oncol. 2018;148:342-348.
PubMed Text format Abstract available

KANG WD, Ju UC, Kim SM
Is human papillomavirus genotype important in predicting disease progression in women with biopsy-proven negative or CIN1 of atypical squamous cell of undetermined significance (ASC-US) cytology?
Gynecol Oncol. 2018;148:305-310.
PubMed Text format Abstract available

January 2018

ARMBRUSTER SD, Song J, Gatus L, Lu KH, et al
Endometrial cancer survivors' sleep patterns before and after a physical activity intervention: A retrospective cohort analysis.
Gynecol Oncol. 2018 Jan 30. pii: S0090-8258(18)30067.
PubMed Text format Abstract available

DEWDNEY SB, Dancisak AC, Lachance JA, Grendys EC Jr, et al
Society of Gynecologic Oncology Clinical Outcomes Registry: From small beginnings come great things.
Gynecol Oncol. 2018 Jan 30. pii: S0090-8258(18)30060.
PubMed Text format Abstract available

GRIMM C, Polterauer S, Helmy-Bader S, Zikan M, et al
A collagen-fibrin patch for the prevention of symptomatic lymphoceles after pelvic lymphadenectomy in women with gynecologic malignancies: A randomized clinical trial.
Gynecol Oncol. 2018 Jan 30. pii: S0090-8258(18)30044.
PubMed Text format Abstract available

GUNDERSON CC, Matulonis U, Moore KN
Management of the toxicities of common targeted therapeutics for gynecologic cancers.
Gynecol Oncol. 2018 Jan 30. pii: S0090-8258(18)30042.
PubMed Text format Abstract available

KESSOUS R, Octeau D, Klein K, Tonin PN, et al
Distinct homologous recombination gene expression profiles after neoadjuvant chemotherapy associated with clinical outcome in patients with ovarian cancer.
Gynecol Oncol. 2018 Jan 29. pii: S0090-8258(18)30055.
PubMed Text format Abstract available

HENRY CE, Llamosas E, Daniels B, Coopes A, et al
ROR1 and ROR2 play distinct and opposing roles in endometrial cancer.
Gynecol Oncol. 2018 Jan 29. pii: S0090-8258(18)30064.
PubMed Text format Abstract available

NITECKI R, Diver EJ, Kamdar MM, Boruta DM 2nd, et al
Patterns of palliative care referral in ovarian cancer: A single institution 5year retrospective analysis.
Gynecol Oncol. 2018 Jan 27. pii: S0090-8258(18)30056.
PubMed Text format Abstract available

ZHANG HR, Lai SY, Huang LJ, Zhang ZF, et al
Myosin 1b promotes cell proliferation, migration, and invasion in cervical cancer.
Gynecol Oncol. 2018 Jan 27. pii: S0090-8258(18)30065.
PubMed Text format Abstract available

PENNINGTON KP, McTiernan A
The role of physical activity in breast and gynecologic cancer survivorship.
Gynecol Oncol. 2018 Jan 27. pii: S0090-8258(18)30059.
PubMed Text format Abstract available

KATO K, Okamoto S, Ota E, Takeshima N, et al
Secondary debulking surgery for para-aortic nodal recurrence in endometrial cancer requiring circumferential resection of the inferior vena cava.
Gynecol Oncol. 2018 Jan 27. pii: S0090-8258(18)30063.
PubMed Text format

SAMIMI G, Trabert B, Duggan MA, Robinson JL, et al
Processing of fallopian tube, ovary, and endometrial surgical pathology specimens: A survey of U.S. laboratory practices.
Gynecol Oncol. 2018 Jan 25. pii: S0090-8258(18)30048.
PubMed Text format Abstract available

KRISHNAN V, Schaar B, Tallapragada S, Dorigo O, et al
Tumor associated macrophages in gynecologic cancers.
Gynecol Oncol. 2018 Jan 22. pii: S0090-8258(18)30046.
PubMed Text format Abstract available

DOSTALEK L, Zikan M, Fischerova D, Kocian R, et al
SLN biopsy in cervical cancer patients with tumors larger than 2cm and 4cm.
Gynecol Oncol. 2018 Jan 21. pii: S0090-8258(18)30001.
PubMed Text format Abstract available

BARROILHET L, Matulonis U
The NCI-MATCH trial and precision medicine in gynecologic cancers.
Gynecol Oncol. 2018 Jan 20. pii: S0090-8258(18)30040.
PubMed Text format Abstract available

GRAY HJ, Bell-McGuinn K, Fleming GF, Cristea M, et al
Phase I combination study of the PARP inhibitor veliparib plus carboplatin and gemcitabine in patients with advanced ovarian cancer and other solid malignancies.
Gynecol Oncol. 2018 Jan 15. pii: S0090-8258(17)31620.
PubMed Text format Abstract available

BERGSTROM J, Aloisi A, Armbruster S, Yen TT, et al
Minimally invasive hysterectomy surgery rates for endometrial cancer performed at National Comprehensive Cancer Network (NCCN) Centers.
Gynecol Oncol. 2018 Jan 12. pii: S0090-8258(18)30002.
PubMed Text format Abstract available

SHALOWITZ DI, Cohn DE
Cancer care delivery research in gynecologic oncology.
Gynecol Oncol. 2018 Jan 10. pii: S0090-8258(17)31618.
PubMed Text format

TRABERT B, Aarestrup J, Ulrich LG, Wentzensen N, et al
Birth weight and the risk of histological subtypes of ovarian and endometrial cancers: Results from the Copenhagen School Health Records Register.
Gynecol Oncol. 2018 Jan 10. pii: S0090-8258(17)31622.
PubMed Text format Abstract available

PARK SH, Cheon H, Chong GO, Jeong SY, et al
Prognostic significance of residual lymph node status after definitive chemoradiotherapy in patients with node-positive cervical cancer.
Gynecol Oncol. 2018 Jan 9. pii: S0090-8258(18)30037.
PubMed Text format Abstract available

HAGEMANN AR, McCourt CK, Varaday SS, Moore KN, et al
Defining and mitigating the challenges of an older and obese population in minimally invasive gynecologic cancer surgery.
Gynecol Oncol. 2018 Jan 9. pii: S0090-8258(17)31608.
PubMed Text format Abstract available

SAED GM, Fletcher NM, Diamond MP, Morris RT, et al
Novel expression of CD11b in epithelial ovarian cancer: Potential therapeutic target.
Gynecol Oncol. 2018 Jan 9. pii: S0090-8258(17)31606.
PubMed Text format Abstract available

BACORRO W, Dumas I, Escande A, Gouy S, et al
Dose-volume effects in pathologic lymph nodes in locally advanced cervical cancer.
Gynecol Oncol. 2018 Jan 8. pii: S0090-8258(17)31621.
PubMed Text format Abstract available

MATSUOKA A, Tate S, Nishikimi K, Shozu M, et al
Retroperitoneal lymphadenectomy for ovarian cancer with double inferior vena cava.
Gynecol Oncol. 2018 Jan 5. pii: S0090-8258(17)31619.
PubMed Text format

MUKERJI B, Baptiste C, Chen L, Tergas AI, et al
Racial disparities in young women with endometrial cancer.
Gynecol Oncol. 2018 Jan 4. pii: S0090-8258(17)31623.
PubMed Text format Abstract available

DONG L, Wang MZ, Zhao XL, Feng RM, et al
Human papillomavirus viral load as a useful triage tool for non-16/18 high-risk human papillomavirus positive women: A prospective screening cohort study.
Gynecol Oncol. 2018;148:103-110.
PubMed Text format Abstract available

GOROSTIDI M, Villalain C, Ruiz R, Jaunarena I, et al
Technique for precaval and laterocaval nodes excision at extraperitoneal paraaortic lymphadenectomy.
Gynecol Oncol. 2018;148:233-234.
PubMed Text format Abstract available

SATMARY W, Holschneider CH, Brunette LL, Natarajan S, et al
Vulvar intraepithelial neoplasia: Risk factors for recurrence.
Gynecol Oncol. 2018;148:126-131.
PubMed Text format Abstract available

December 2017

TOUHAMI O, Gregoire J, Renaud MC, Sebastianelli A, et al
The utility of sentinel lymph node mapping in the management of endometrial atypical hyperplasia.
Gynecol Oncol. 2017 Dec 28. pii: S0090-8258(17)31617.
PubMed Text format Abstract available

SOISSON S, Ganz PA, Gaffney D, Rowe K, et al
Long-term, adverse genitourinary outcomes among endometrial cancer survivors in a large, population-based cohort study.
Gynecol Oncol. 2017 Dec 27. pii: S0090-8258(17)31616.
PubMed Text format Abstract available

XIANG L, Jiang W, Ye S, He T, et al
ERBB2 mutation: A promising target in non-squamous cervical cancer.
Gynecol Oncol. 2017 Dec 23. pii: S0090-8258(17)31614.
PubMed Text format Abstract available

SUD S, Holmes J, Eblan M, Chen R, et al
Clinical characteristics associated with racial disparities in endometrial cancer outcomes: A surveillance, epidemiology and end results analysis.
Gynecol Oncol. 2017 Dec 21. pii: S0090-8258(17)31607.
PubMed Text format Abstract available

MONTEALEGRE JR, Peckham-Gregory EC, Marquez-Do D, Dillon L, et al
Racial/ethnic differences in HPV 16/18 genotypes and integration status among women with a history of cytological abnormalities.
Gynecol Oncol. 2017 Dec 21. pii: S0090-8258(17)31597.
PubMed Text format Abstract available

GEPPERT B, Lonnerfors C, Bollino M, Persson J, et al
Sentinel lymph node biopsy in endometrial cancer-Feasibility, safety and lymphatic complications.
Gynecol Oncol. 2017 Dec 20. pii: S0090-8258(17)31602.
PubMed Text format Abstract available

TRAN AQ, Erim DO, Sullivan SA, Cole AL, et al
Cost effectiveness of neoadjuvant chemotherapy followed by interval cytoreductive surgery versus primary cytoreductive surgery for patients with advanced stage ovarian cancer during the initial treatment phase.
Gynecol Oncol. 2017 Dec 19. pii: S0090-8258(17)31598.
PubMed Text format Abstract available

FORNALIK H, Fornalik N
Robotic hysterectomy and pelvic lymphadenectomy without Trendelenburg position (BMI 36).
Gynecol Oncol. 2017 Dec 19. pii: S0090-8258(17)31549.
PubMed Text format

LEE J, Lin JB, Chang CL, Sun FJ, et al
Impact of para-aortic recurrence risk-guided intensity-modulated radiotherapy in locally advanced cervical cancer with positive pelvic lymph nodes.
Gynecol Oncol. 2017 Dec 18. pii: S0090-8258(17)31550.
PubMed Text format Abstract available

MIAO M, Deng G, Luo S, Zhou J, et al
A phase II study of apatinib in patients with recurrent epithelial ovarian cancer.
Gynecol Oncol. 2017 Dec 13. pii: S0090-8258(17)31596.
PubMed Text format Abstract available

MATSUO K, Ross MS, Im DD, Klobocista MM, et al
Significance of venous thromboembolism in women with uterine carcinosarcoma.
Gynecol Oncol. 2017 Dec 13. pii: S0090-8258(17)31546.
PubMed Text format Abstract available

BRAGA A, Campos V, Filho JR, Lin LH, et al
Is chemotherapy always necessary for patients with nonmetastatic gestational trophoblastic neoplasia with histopathological diagnosis of choriocarcinoma?
Gynecol Oncol. 2017 Dec 13. pii: S0090-8258(17)31554.
PubMed Text format Abstract available

CASTLE PE, Pierz A, Stoler MH
A systematic review and meta-analysis on the attribution of human papillomavirus (HPV) in neuroendocrine cancers of the cervix.
Gynecol Oncol. 2017 Dec 13. pii: S0090-8258(17)31548.
PubMed Text format Abstract available

DILLEY S, Miller K, Huh W
HPV vaccination.
Gynecol Oncol. 2017 Dec 12. pii: S0090-8258(17)31547.
PubMed Text format

BERNARDS SS, Pennington KP, Harrell MI, Agnew KJ, et al
Clinical characteristics and outcomes of patients with BRCA1 or RAD51C methylated versus mutated ovarian carcinoma.
Gynecol Oncol. 2017 Dec 9. pii: S0090-8258(17)31551.
PubMed Text format Abstract available

KIM SI, Lee JW, Lee M, Kim HS, et al
Genomic landscape of ovarian clear cell carcinoma via whole exome sequencing.
Gynecol Oncol. 2017 Dec 9. pii: S0090-8258(17)31552.
PubMed Text format Abstract available

COYLE C, Short D, Jackson L, Sebire NJ, et al
What is the optimal duration of human chorionic gonadotrophin surveillance following evacuation of a molar pregnancy? A retrospective analysis on over 20,000 consecutive patients.
Gynecol Oncol. 2017 Dec 9. pii: S0090-8258(17)31555.
PubMed Text format Abstract available

BIZZARRI N, Ghirardi V, Kucukmetin A
Indocyanine green-assisted parametrial dissection during type C1 radical hysterectomy after sentinel lymph node biopsy in early stage cervical cancer.
Gynecol Oncol. 2017 Dec 6. pii: S0090-8258(17)31496.
PubMed Text format Abstract available

WALLACE S, Hanson KT, Dowdy SC, Habermann EB, et al
Impact of surgical approach and patient factors on Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) survey scoring in gynecologic surgery.
Gynecol Oncol. 2017 Dec 5. pii: S0090-8258(17)31525.
PubMed Text format Abstract available

SMITH D, Stewart CJR, Clarke EM, Lose F, et al
ER and PR expression and survival after endometrial cancer.
Gynecol Oncol. 2017 Dec 4. pii: S0090-8258(17)31537.
PubMed Text format Abstract available

WORLEY MJ JR, Elias KM, Horowitz NS, Quade BJ, et al
Durable remission for a woman with refractory choriocarcinoma treated with anti-endoglin monoclonal antibody and bevacizumab: A case from the New England Trophoblastic Disease Center, Brigham and Women's Hospital and Dana-Farber Cancer Institute.
Gynecol Oncol. 2017 Dec 4. pii: S0090-8258(17)31539.
PubMed Text format Abstract available

ANNUNZIATA CM, Kohn EC
Clinical trials in gynecologic oncology: Past, present, and future.
Gynecol Oncol. 2017 Dec 3. pii: S0090-8258(17)31536.
PubMed Text format Abstract available

URBAN RR, He H, Alfonso R, Hardesty MM, et al
The end of life costs for Medicare patients with advanced ovarian cancer.
Gynecol Oncol. 2017 Dec 3. pii: S0090-8258(17)31533.
PubMed Text format Abstract available

WEN KC, Sung PL, Chou YT, Pan CM, et al
The role of EpCAM in tumor progression and the clinical prognosis of endometrial carcinoma.
Gynecol Oncol. 2017 Dec 2. pii: S0090-8258(17)31543.
PubMed Text format Abstract available

AVIKI EM, Abu-Rustum NR
A call to standardize our approach to fertility-sparing surgery in patients with gynecologic cancers.
Gynecol Oncol. 2017;147:491-492.
PubMed Text format

BITLER BG, Watson ZL, Wheeler LJ, Behbakht K, et al
PARP inhibitors: Clinical utility and possibilities of overcoming resistance.
Gynecol Oncol. 2017;147:695-704.
PubMed Text format Abstract available

NOMURA H, Nagashima M, Aoki Y, Takeshima N, et al
Resection of the inferior pubic ramus to completely remove locally advance adenoid cystic carcinoma of Bartholin's gland.
Gynecol Oncol. 2017;147:723-724.
PubMed Text format Abstract available

PEI X, Xiang L, Ye S, He T, et al
Cycles of cisplatin and etoposide affect treatment outcomes in patients with FIGO stage I-II small cell neuroendocrine carcinoma of the cervix.
Gynecol Oncol. 2017;147:589-596.
PubMed Text format Abstract available

KUMAR A, Hurtt CC, Cliby WA, Martin JR, et al
Concomitant venous thromboembolism at the time of primary EOC diagnosis: Perioperative outcomes and survival analyses.
Gynecol Oncol. 2017;147:514-520.
PubMed Text format Abstract available

REISER E, Aust S, Seebacher V, Reinthaller A, et al
Preoperative C-reactive protein serum levels as a predictive diagnostic marker in patients with adnexal masses.
Gynecol Oncol. 2017;147:690-694.
PubMed Text format Abstract available

CYBULSKA P, Goss C, Tew WP, Parameswaran R, et al
Corrigendum to "Indications for and complications of transfusion and the management of gynecologic malignancies" [Gynecol. Oncol. 146 (2017) 416-426].
Gynecol Oncol. 2017 Dec 1. pii: S0090-8258(17)31540.
PubMed Text format

MAHANTSHETTY U, Teni T, Naga P, Hotwani C, et al
Impact of HPV 16/18 infection on clinical outcomes in locally advanced cervical cancers treated with radical radio (chemo) therapy - A prospective observational study.
Gynecol Oncol. 2017 Dec 1. pii: S0090-8258(17)31544.
PubMed Text format Abstract available

LI J, Li S, Yu H, Wang J, et al
The efficacy and safety of first-line single-agent chemotherapy regimens in low-risk gestational trophoblastic neoplasia: A network meta-analysis.
Gynecol Oncol. 2017 Dec 1. pii: S0090-8258(17)31541.
PubMed Text format Abstract available

November 2017

HAMILTON CA, Miller A, Casablanca Y, Horowitz NS, et al
Clinicopathologic characteristics associated with long-term survival in advanced epithelial ovarian cancer: an NRG Oncology/Gynecologic Oncology Group ancillary data study.
Gynecol Oncol. 2017 Nov 28. pii: S0090-8258(17)31528.
PubMed Text format Abstract available

ZHU J, Chen Z, Yong L
Systematic profiling of alternative splicing signature reveals prognostic predictor for ovarian cancer.
Gynecol Oncol. 2017 Nov 27. pii: S0090-8258(17)31538.
PubMed Text format Abstract available

KITSON SJ, Lindsay J, Sivalingam VN, Lunt M, et al
The unrecognized burden of cardiovascular risk factors in women newly diagnosed with endometrial cancer: A prospective case control study.
Gynecol Oncol. 2017 Nov 24. pii: S0090-8258(17)31529.
PubMed Text format Abstract available

MURALI R, Grisham RN, Soslow RA
The roles of pathology in targeted therapy of women with gynecologic cancers.
Gynecol Oncol. 2017 Nov 23. pii: S0090-8258(17)31530.
PubMed Text format Abstract available

MOSS HA, Havrilesky LJ
The use of patient-reported outcome tools in Gynecologic Oncology research, clinical practice, and value-based care.
Gynecol Oncol. 2017 Nov 23. pii: S0090-8258(17)31507.
PubMed Text format Abstract available

GULERIA S, Jensen A, Kjaer SK
Risk of borderline ovarian tumors among women with benign ovarian tumors: A cohort study.
Gynecol Oncol. 2017 Nov 23. pii: S0090-8258(17)31534.
PubMed Text format Abstract available

HOROWITZ NS, Larry Maxwell G, Miller A, Hamilton CA, et al
Predictive modeling for determination of microscopic residual disease at primary cytoreduction: An NRG Oncology/Gynecologic Oncology Group 182 Study.
Gynecol Oncol. 2017 Nov 22. pii: S0090-8258(17)31371.
PubMed Text format Abstract available

LEE YJ, Chung YS, Lee JY, Nam EJ, et al
Impact of the time interval from completion of neoadjuvant chemotherapy to initiation of postoperative adjuvant chemotherapy on the survival of patients with advanced ovarian cancer.
Gynecol Oncol. 2017 Nov 21. pii: S0090-8258(17)31532.
PubMed Text format Abstract available

TOZZI R, Casarin J, Garruto-Campanile R, Majd HS, et al
Morbidity and reversal rate of ileostomy after bowel resection during Visceral-Peritoneal Debulking (VPD) in patients with stage IIIC-IV ovarian cancer.
Gynecol Oncol. 2017 Nov 20. pii: S0090-8258(17)31527.
PubMed Text format Abstract available

HEINZELMANN-SCHWARZ V, Knipprath Meszaros A, Stadlmann S, Jacob F, et al
Letrozole may be a valuable maintenance treatment in high-grade serous ovarian cancer patients.
Gynecol Oncol. 2017 Nov 17. pii: S0090-8258(17)31458.
PubMed Text format Abstract available

CHAMPER M, Huang Y, Hou JY, Tergas AI, et al
Adherence to treatment recommendations and outcomes for women with ovarian cancer at first recurrence.
Gynecol Oncol. 2017 Nov 15. pii: S0090-8258(17)31504.
PubMed Text format Abstract available

CHOLLI P, Bradford L, Manga S, Nulah K, et al
Screening for cervical cancer among HIV-positive and HIV-negative women in Cameroon using simultaneous co-testing with careHPV DNA testing and visual inspection enhanced by digital cervicography: Findings of initial screening and one-year follow-up.
Gynecol Oncol. 2017 Nov 15. pii: S0090-8258(17)31497.
PubMed Text format Abstract available

CHONG GO, Lee YH, Han HS, Lee HJ, et al
Prognostic value of pre-treatment human papilloma virus DNA status in cervical cancer.
Gynecol Oncol. 2017 Nov 15. pii: S0090-8258(17)31498.
PubMed Text format Abstract available

SHISLER R, Sinnott JA, Wang V, Hebert C, et al
Life after endometrial cancer: A systematic review of patient-reported outcomes.
Gynecol Oncol. 2017 Nov 14. pii: S0090-8258(17)31503.
PubMed Text format Abstract available

LIE AK, Trope A, Skare GB, Bjorge T, et al
HPV genotype profile in a Norwegian cohort with ASC-US and LSIL cytology with three year cumulative risk of high grade cervical neoplasia.
Gynecol Oncol. 2017 Nov 11. pii: S0090-8258(17)31453.
PubMed Text format Abstract available

TAKIUCHI T, Blake EA, Matsuo K, Sood AK, et al
Aspirin use and endometrial cancer risk and survival.
Gynecol Oncol. 2017 Nov 10. pii: S0090-8258(17)31448.
PubMed Text format Abstract available

SHAH JS, Gard GB, Yang J, Maidens J, et al
Combining serum microRNA and CA-125 as prognostic indicators of preoperative surgical outcome in women with high-grade serous ovarian cancer.
Gynecol Oncol. 2017 Nov 10. pii: S0090-8258(17)31500.
PubMed Text format Abstract available

COSGROVE CM, Tritchler DL, Cohn DE, Mutch DG, et al
An NRG Oncology/GOG study of molecular classification for risk prediction in endometrioid endometrial cancer.
Gynecol Oncol. 2017 Nov 10. pii: S0090-8258(17)31459.
PubMed Text format Abstract available

TIMMERMANS M, Schuurman MS, Ho VKY, Massuger LF, et al
Centralization of ovarian cancer in the Netherlands: Hospital of diagnosis no longer determines patients' probability of undergoing surgery.
Gynecol Oncol. 2017 Nov 9. pii: S0090-8258(17)31505.
PubMed Text format Abstract available

MERT I, Kumar A, Sheedy SP, Weaver AL, et al
Clinical significance of enlarged cardiophrenic lymph nodes in advanced ovarian cancer: Implications for survival.
Gynecol Oncol. 2017 Nov 9. pii: S0090-8258(17)31446.
PubMed Text format Abstract available

NIETO K, Adams W, Pham N, Block AM, et al
Adjuvant therapy in patients with clear cell endometrial carcinoma: An analysis of the National Cancer Database.
Gynecol Oncol. 2017 Nov 9. pii: S0090-8258(17)31506.
PubMed Text format Abstract available

HOPPENOT C, Eckert MA, Tienda SM, Lengyel E, et al
Who are the long-term survivors of high grade serous ovarian cancer?
Gynecol Oncol. 2017 Nov 8. pii: S0090-8258(17)31454.
PubMed Text format Abstract available

HINCHCLIFF E, Melamed A, Bregar A, Diver E, et al
Factors associated with delivery of neoadjuvant chemotherapy in women with advanced stage ovarian cancer.
Gynecol Oncol. 2017 Nov 8. pii: S0090-8258(17)31460.
PubMed Text format Abstract available

SPAANS VM, Nyoman Bayu Mahendra I, Purwoto G, Trietsch MD, et al
The landscape of somatic mutations in Indonesian cervical cancer is predominated by the PI3K pathway.
Gynecol Oncol. 2017 Nov 4. pii: S0090-8258(17)31369.
PubMed Text format Abstract available

ISHIKAWA M, Kasamatsu T, Tsuda H, Fukunaga M, et al
Prognostic factors and optimal therapy for stages I-II neuroendocrine carcinomas of the uterine cervix: A multi-center retrospective study.
Gynecol Oncol. 2017 Nov 4. pii: S0090-8258(17)31449.
PubMed Text format Abstract available

CHAN JK, Kapp DS
Clear Cell Ovarian Cancer: Optimum Management and Prognosis Remain Hazy.
Gynecol Oncol. 2017;147:237-239.
PubMed Text format

ALTMAN AD, McGee J, May T, Lane K, et al
Neoadjuvant chemotherapy and chemotherapy cycle number: A national multicentre study.
Gynecol Oncol. 2017;147:257-261.
PubMed Text format Abstract available

October 2017

FONNES T, Berg HF, Bredholt T, Edqvist PD, et al
Asparaginase-like protein 1 is an independent prognostic marker in primary endometrial cancer, and is frequently lost in metastatic lesions.
Gynecol Oncol. 2017 Oct 30. pii: S0090-8258(17)31447.
PubMed Text format Abstract available

MAESTA I, Nitecki R, Horowitz NS, Goldstein DP, et al
Effectiveness and toxicity of first-line methotrexate chemotherapy in low-risk postmolar gestational trophoblastic neoplasia: The New England Trophoblastic Disease Center experience.
Gynecol Oncol. 2017 Oct 29. pii: S0090-8258(17)31450.
PubMed Text format Abstract available

NING MS, Ahobila V, Jhingran A, Stecklein SR, et al
Outcomes and patterns of relapse after definitive radiation therapy for oligometastatic cervical cancer.
Gynecol Oncol. 2017 Oct 28. pii: S0090-8258(17)31420.
PubMed Text format Abstract available

LEE JH, Lee SW, Kim JR, Kim YS, et al
Tumour size, volume, and marker expression during radiation therapy can predict survival of cervical cancer patients: a multi-institutional retrospective analysis of KROG 16-01.
Gynecol Oncol. 2017 Oct 27. pii: S0090-8258(17)31360.
PubMed Text format Abstract available

CHENG H, Peng J, Yang Z, Zhang G, et al
Prognostic significance of lymphadenectomyin malignant ovarian sex cord stromal tumor: A retrospective cohort study and meta-analysis.
Gynecol Oncol. 2017 Oct 26. pii: S0090-8258(17)31444.
PubMed Text format Abstract available

RONCOLATO FT, Berton-Rigaud D, O'Connell R, Lanceley A, et al
Validation of the modified Glasgow Prognostic Score (mGPS) in recurrent ovarian cancer (ROC) - Analysis of patients enrolled in the GCIG Symptom Benefit Study (SBS).
Gynecol Oncol. 2017 Oct 26. pii: S0090-8258(17)31422.
PubMed Text format Abstract available

LIN DI, Chudnovsky Y, Duggan B, Zajchowski D, et al
Comprehensive genomic profiling reveals inactivating SMARCA4 mutations and low tumor mutational burden in small cell carcinoma of the ovary, hypercalcemic-type.
Gynecol Oncol. 2017 Oct 25. pii: S0090-8258(17)31355.
PubMed Text format Abstract available

SHALOWITZ DI, Nivasch E, Burger RA, Schapira MM, et al
Are patients willing to travel for better ovarian cancer care?
Gynecol Oncol. 2017 Oct 24. pii: S0090-8258(17)31421.
PubMed Text format Abstract available

YI Y, Tsai SH, Cheng JC, Wang EY, et al
APELA promotes tumour growth and cell migration in ovarian cancer in a p53-dependent manner.
Gynecol Oncol. 2017 Oct 24. pii: S0090-8258(17)31419.
PubMed Text format Abstract available

LAAN JJ, van Lonkhuijzen LRCW, van Os RM, Tytgat KM, et al
Socioeconomic status as an independent risk factor for severe late bowel toxicity after primary radiotherapy for cervical cancer.
Gynecol Oncol. 2017 Oct 23. pii: S0090-8258(17)31416.
PubMed Text format Abstract available

MATSUO K, Ross MS, Yunokawa M, Johnson MS, et al
Salvage chemotherapy with taxane and platinum for women with recurrent uterine carcinosarcoma.
Gynecol Oncol. 2017 Oct 19. pii: S0090-8258(17)31368.
PubMed Text format Abstract available

TANNER E, Puechl A, Levinson K, Havrilesky LJ, et al
Use of a novel sentinel lymph node mapping algorithm reduces the need for pelvic lymphadenectomy in low-grade endometrial cancer.
Gynecol Oncol. 2017 Oct 19. pii: S0090-8258(17)31423.
PubMed Text format Abstract available

YAMAMOTO K, Nagao S, Suzuki K, Kogiku A, et al
Pelvic fractures after definitive and postoperative radiotherapy for cervical cancer: A retrospective analysis of risk factors.
Gynecol Oncol. 2017 Oct 18. pii: S0090-8258(17)31359.
PubMed Text format Abstract available

ARIMA R, Hautakoski A, Marttila M, Arffman M, et al
Cause-specific mortality in endometrioid endometrial cancer patients with type 2 diabetes using metformin or other types of antidiabetic medication.
Gynecol Oncol. 2017 Oct 17. pii: S0090-8258(17)31417.
PubMed Text format Abstract available

JONES MR, Kamara D, Karlan BY, Pharoah PDP, et al
Genetic epidemiology of ovarian cancer and prospects for polygenic risk prediction.
Gynecol Oncol. 2017 Oct 17. pii: S0090-8258(17)31361.
PubMed Text format Abstract available

CHEN BJ, Byrne FL, Takenaka K, Modesitt SC, et al
Transcriptome landscape of long intergenic non-coding RNAs in endometrial cancer.
Gynecol Oncol. 2017 Oct 16. pii: S0090-8258(17)31367.
PubMed Text format Abstract available

SCHULTZ KAP, Harris AK, Finch M, Dehner LP, et al
DICER1-related Sertoli-Leydig cell tumor and gynandroblastoma: Clinical and genetic findings from the International Ovarian and Testicular Stromal Tumor Registry.
Gynecol Oncol. 2017 Oct 13. pii: S0090-8258(17)31358.
PubMed Text format Abstract available

DOCKERY LE, Tew WP, Ding K, Moore KN, et al
Tolerance and toxicity of the PARP inhibitor olaparib in older women with epithelial ovarian cancer.
Gynecol Oncol. 2017 Oct 13. pii: S0090-8258(17)31364.
PubMed Text format Abstract available

POZZAR RA, Berry DL
Patient-centered research priorities in ovarian cancer: A systematic review of potential determinants of guideline care.
Gynecol Oncol. 2017 Oct 10. pii: S0090-8258(17)31365.
PubMed Text format Abstract available

DE LIMA MAP, Neto PJN, Lima LPM, Goncalves Junior J, et al
Association between Epstein-Barr virus (EBV) and cervical carcinoma: A meta-analysis.
Gynecol Oncol. 2017 Oct 9. pii: S0090-8258(17)31366.
PubMed Text format Abstract available

NASIOUDIS D, Frey MK, Chapman-Davis E, Caputo TA, et al
Fertility-preserving surgery for advanced stage ovarian germ cell tumors.
Gynecol Oncol. 2017 Oct 9. pii: S0090-8258(17)31370.
PubMed Text format Abstract available

XIA Z, Cochrane DR, Anglesio MS, Wang YK, et al
LINE-1 retrotransposon-mediated DNA transductions in endometriosis associated ovarian cancers.
Gynecol Oncol. 2017 Oct 9. pii: S0090-8258(17)31356.
PubMed Text format Abstract available

BUDA A, Di Martino G, Restaino S, De Ponti E, et al
The impact on survival of two different staging strategies in apparent early stage endometrial cancer comparing sentinel lymph nodes mapping algorithm and selective lymphadenectomy: An Italian retrospective analysis of two reference centers.
Gynecol Oncol. 2017 Oct 9. pii: S0090-8258(17)31357.
PubMed Text format Abstract available

PEPIN K, Bregar A, Davis M, Melamed A, et al
Intensive care admissions among ovarian cancer patients treated with primary debulking surgery and neoadjuvant chemotherapy-interval debulking surgery.
Gynecol Oncol. 2017 Oct 4. pii: S0090-8258(17)31352.
PubMed Text format Abstract available

MATSUO K, Machida H, Frimer M, Marcus JZ, et al
Prognosis of women with stage I endometrioid endometrial cancer and synchronous stage I endometrioid ovarian cancer.
Gynecol Oncol. 2017 Oct 3. pii: S0090-8258(17)31351.
PubMed Text format Abstract available

SINGH S, Swarer K, Resnick K
Longer operative time is associated with increased post-operative complications in patients undergoing minimally-invasive surgery for endometrial cancer.
Gynecol Oncol. 2017 Oct 2. pii: S0090-8258(17)31348.
PubMed Text format Abstract available

HENSLEY ML
Difficult Choices in Stage I Uterine Leiomyosarcoma- it's okay to "stand there".
Gynecol Oncol. 2017;147:1-2.
PubMed Text format

POLTERAUER S, Schwameis R, Grimm C, Macuks R, et al
Prognostic value of lymph node ratio and number of positive inguinal nodes in patients with vulvar cancer.
Gynecol Oncol. 2017;147:92-97.
PubMed Text format Abstract available

September 2017

DEVOR EJ, Miecznikowski J, Schickling BM, Gonzalez-Bosquet J, et al
Dysregulation of miR-181c expression influences recurrence of endometrial endometrioid adenocarcinoma by modulating NOTCH2 expression: An NRG Oncology/Gynecologic Oncology Group study.
Gynecol Oncol. 2017 Sep 29. pii: S0090-8258(17)31349.
PubMed Text format Abstract available

DUCIE JA, Eriksson AGZ, Ali N, McGree ME, et al
Comparison of a sentinel lymph node mapping algorithm and comprehensive lymphadenectomy in the detection of stage IIIC endometrial carcinoma at higher risk for nodal disease.
Gynecol Oncol. 2017 Sep 28. pii: S0090-8258(17)31354.
PubMed Text format Abstract available

PHILP L, Covens A, Vicus D, Kupets R, et al
Feasibility and safety of same-day discharge after laparoscopic radical hysterectomy for cervix cancer.
Gynecol Oncol. 2017 Sep 28. pii: S0090-8258(17)31350.
PubMed Text format Abstract available

QIU C, Lu N, Wang X, Zhang Q, et al
Gene expression profiles of ovarian low-grade serous carcinoma resemble those of fallopian tube epithelium.
Gynecol Oncol. 2017 Sep 28. pii: S0090-8258(17)31353.
PubMed Text format Abstract available

TORRES D, Kumar A, Wallace SK, Bakkum-Gamez JN, et al
Intraperitoneal disease dissemination patterns are associated with residual disease, extent of surgery, and molecular subtypes in advanced ovarian cancer.
Gynecol Oncol. 2017 Sep 27. pii: S0090-8258(17)31345.
PubMed Text format Abstract available

COSGROVE CM, Cohn DE, Goodfellow PJ
Primum non nocere: Are we ready for POLE testing in endometrial cancer?
Gynecol Oncol. 2017 Sep 22. pii: S0090-8258(17)31339.
PubMed Text format

CYBULSKA P, Schiavone MB, Sawyer B, Gardner GJ, et al
Trocar site hernia development in patients undergoing robotically assisted or standard laparoscopic staging surgery for endometrial cancer.
Gynecol Oncol. 2017 Sep 22. pii: S0090-8258(17)31302.
PubMed Text format Abstract available

NELSON G, Dowdy SC, Lasala J, Mena G, et al
Enhanced recovery after surgery (ERAS(R)) in gynecologic oncology - Practical considerations for program development.
Gynecol Oncol. 2017 Sep 22. pii: S0090-8258(17)31347.
PubMed Text format

MAKKONEN P, Heinavaara S, Sarkeala T, Anttila A, et al
Impact of organized and opportunistic Pap testing on the risk of cervical cancer in young women - A case-control study from Finland.
Gynecol Oncol. 2017 Sep 21. pii: S0090-8258(17)31335.
PubMed Text format Abstract available

TOUHAMI O, Gregoire J, Renaud MC, Sebastianelli A, et al
Performance of sentinel lymph node (SLN) mapping in high-risk endometrial cancer.
Gynecol Oncol. 2017 Sep 21. pii: S0090-8258(17)31338.
PubMed Text format Abstract available

SHAH JS, Guerra R, Bodurka DC, Sun CC, et al
Factors influencing fertility-sparing treatment for gynecologic malignancies: A survey of Society of Gynecologic Oncology members.
Gynecol Oncol. 2017 Sep 21. pii: S0090-8258(17)31343.
PubMed Text format Abstract available

BARBER EL, Rossi EC, Gehrig PA
Surgical readmission and survival in women with ovarian cancer: Are short-term quality metrics incentivizing decreased long-term survival?
Gynecol Oncol. 2017 Sep 20. pii: S0090-8258(17)31340.
PubMed Text format Abstract available

DO JH, Choi KH, Ahn JS, Jeon JY, et al
Effects of a complex rehabilitation program on edema status, physical function, and quality of life in lower-limb lymphedema after gynecological cancer surgery.
Gynecol Oncol. 2017 Sep 20. pii: S0090-8258(17)31272.
PubMed Text format Abstract available

RUSTIN G, Vergote I, Micha JP, Duska LR, et al
A multicenter, open-label, expanded phase 2 study to evaluate the safety and efficacy of etirinotecan pegol, a polymer conjugate of irinotecan, in women with recurrent platinum-resistant or refractory ovarian cancer.
Gynecol Oncol. 2017 Sep 18. pii: S0090-8258(17)31264.
PubMed Text format Abstract available

MOORE KN, Tritchler D, Kaufman KM, Lankes H, et al
Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.
Gynecol Oncol. 2017 Sep 18. pii: S0090-8258(17)31261.
PubMed Text format Abstract available

LEE SW, Lee SH, Kim J, Kim YS, et al
Magnetic resonance imaging during definitive chemoradiotherapy can predict tumor recurrence and patient survival in locally advanced cervical cancer: A multi-institutional retrospective analysis of KROG 16-01.
Gynecol Oncol. 2017 Sep 18. pii: S0090-8258(17)31265.
PubMed Text format Abstract available

TANGEN IL, Veneris JT, Halle MK, Werner HM, et al
Expression of glucocorticoid receptor is associated with aggressive primary endometrial cancer and increases from primary to metastatic lesions.
Gynecol Oncol. 2017 Sep 16. pii: S0090-8258(17)31337.
PubMed Text format Abstract available

DANTAS PRS, Maesta I, Filho JR, Junior JA, et al
Does hormonal contraception during molar pregnancy follow-up influence the risk and clinical aggressiveness of gestational trophoblastic neoplasia after controlling for risk factors?
Gynecol Oncol. 2017 Sep 16. pii: S0090-8258(17)31310.
PubMed Text format Abstract available

RAUH LA, Pannone AF, Cantrell LA
Hormone replacement therapy after treatment for cervical cancer: Are we adhering to standard of care?
Gynecol Oncol. 2017 Sep 16. pii: S0090-8258(17)31333.
PubMed Text format Abstract available

GEBHARDT B, Gill B, Glaser S, Kim H, et al
Image-guided tandem and cylinder brachytherapy as monotherapy for definitive treatment of inoperable endometrial carcinoma.
Gynecol Oncol. 2017 Sep 15. pii: S0090-8258(17)31309.
PubMed Text format Abstract available

AZAIS H, Ghesquiere L, Petitnicolas C, Borghesi Y, et al
Pretherapeutic staging of locally advanced cervical cancer: Inframesenteric paraaortic lymphadenectomy accuracy to detect paraaortic metastases in comparison with infrarenal paraaortic lymphadenectomy.
Gynecol Oncol. 2017 Sep 14. pii: S0090-8258(17)31334.
PubMed Text format Abstract available

BINDER PS, Kuroki LM, Zhao P, Cusworth S, et al
Benefit of combination chemotherapy and radiation stratified by grade of stage IIIC endometrial cancer.
Gynecol Oncol. 2017 Sep 12. pii: S0090-8258(17)31269.
PubMed Text format Abstract available

LILYQUIST J, LaDuca H, Polley E, Davis BT, et al
Frequency of mutations in a large series of clinically ascertained ovarian cancer cases tested on multi-gene panels compared to reference controls.
Gynecol Oncol. 2017 Sep 7. pii: S0090-8258(17)31268.
PubMed Text format Abstract available

PISU M, Kenzik KM, Rim SH, Funkhouser EM, et al
Values and worries of ovarian cancer patients.
Gynecol Oncol. 2017 Sep 6. pii: S0090-8258(17)31267.
PubMed Text format Abstract available

COWAN RA, Tseng J, Murthy V, Srivastava R, et al
Feasibility, safety and clinical outcomes of cardiophrenic lymph node resection in advanced ovarian cancer.
Gynecol Oncol. 2017 Sep 6. pii: S0090-8258(17)31270.
PubMed Text format Abstract available

SCHLUMBRECHT M, Baeker Bispo JA, Balise RR, Huang M, et al
Variation in type II endometrial cancer risk by Hispanic subpopulation: An exploratory analysis.
Gynecol Oncol. 2017 Sep 6. pii: S0090-8258(17)31271.
PubMed Text format Abstract available

HUO D, Anderson D, Palmer JR, Herbst AL, et al
Incidence rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix: Update after 40-year follow-up.
Gynecol Oncol. 2017;146:566-571.
PubMed Text format Abstract available

POUWER AW, Hinten F, van der Velden J, Smolders RGV, et al
Volume-controlled versus short drainage after inguinofemoral lymphadenectomy in vulvar cancer patients: A Dutch nationwide prospective study.
Gynecol Oncol. 2017;146:580-587.
PubMed Text format Abstract available

RAO YJ, Chin RI, Hui C, Mutch DG, et al
Improved survival with definitive chemoradiation compared to definitive radiation alone in squamous cell carcinoma of the vulva: A review of the National Cancer Database.
Gynecol Oncol. 2017;146:572-579.
PubMed Text format Abstract available

LOPEZ LABROUSSE MI, Frumovitz M, Guadalupe Patrono M, Ramirez PT, et al
Sentinel lymph node mapping in minimally invasive surgery: Role of imaging with color-segmented fluorescence (CSF).
Gynecol Oncol. 2017;146:676-677.
PubMed Text format Abstract available

May 2017

ARGENTA PA
Attacking obesity-related diseases at the source - Is bariatric surgery the next wave in cancer prevention?
Gynecol Oncol. 2017;145:219-220.
PubMed Text format

April 2017

BOULAY E, Galczynski K, Canis M, Bourdel N, et al
Laparoscopic pelvic lymphadenectomy in 10 steps - let's make it easier!
Gynecol Oncol. 2017;145:217-218.
PubMed Text format

HERZOG TJ, Cohn DE
Dose Dense Chemotherapy for Front-line Ovarian Cancer Treatment: The Price is Right?
Gynecol Oncol. 2017;145:1-2.
PubMed Text format

February 2017

WESTIN SN, Coleman RL
Individualized Medicine in Ovarian Cancer: Are We There Yet?
Gynecol Oncol. 2017;144:229-231.
PubMed Text format

January 2017

KIM HS, Lee M
Video endoscopic inguinal lymphadenectomy (VEIL) for vulvar cancer.
Gynecol Oncol. 2017;144:225-226.
PubMed Text format

FRUMOVITZ M
Sentinel Lymph Node Biopsy for Cervical Cancer Patients - What's It Gonna Take?
Gynecol Oncol. 2017;144:3-4.
PubMed Text format

December 2016

NAROD S, Sopik V
Neoadjuvant chemotherapy for advanced-stage ovarian cancer: Are the ASCO and SGO recommendations warranted?
Gynecol Oncol. 2016 Dec 22. pii: S0090-8258(16)31615.
PubMed Text format

April 2016

NAROD SA
Talc and ovarian cancer.
Gynecol Oncol. 2016 Apr 16. pii: S0090-8258(16)30139.
PubMed Text format

ALVAREZ RD, Matulonis UA, Herzog TJ, Coleman RL, et al
Moving beyond the platinum sensitive/resistant paradigm for patients with recurrent ovarian cancer.
Gynecol Oncol. 2016 Apr 3. pii: S0090-8258(16)30063.
PubMed Text format

February 2016

NAROD SA, Sopik V, Giannakeas V
Should we screen for ovarian cancer? A commentary on the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) randomized trial.
Gynecol Oncol. 2016 Feb 25. pii: S0090-8258(16)30044.
PubMed Text format

Thank you for your interest in scientific medicine.

AMEDEO Gynecology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: